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ABSTRACT OF THE DISSERTATION 
 
Linear Bilateral Extended 2,2′:6′,2′′-Terpyridine: Versatile Building Block in Supramolecular 
Chemistry 
by 
Janis Veliks 
Doctor of Philosophy in Chemistry 
University of Zurich, 2014 
Professor Jay S. Siegel 
 
The rational design and synthesis of supramolecular architectures and metal-organic 
frameworks (MOFs) require building blocks with defined dimensions, topology, and 
functions. Combination of organic ligands and metal ions allows accessing angles and 
topologies that are unavailable if only organic motifs are used. Therefore, there is a constant 
need for novel construction materials to tackle different challenging supramolecular targets.  
The aim of this thesis is to study tridentate 2,2′:6′,2′′-terpyridine (terpy) based ligands, 
which mimic the linear geometry of bidentate 5,5′-functionalized 2,2′-bipyridine. Therefore, 
the concept of linear bilateral extended terpy was introduced by fusing five-membered furan 
rings at the flanking positions of the 2,2′:6′,2′′-terpyridine. In this way substituents can be 
placed almost perpendicular to the coordination vector of terpy. This ligand design allows the 
synthesis of metal complexes which have both octahedral geometry and topological properties 
of linear 2,2′-bipyridine. 
At first, the synthesis of 2,6-bis(2-substituted-furo[2,3-c]pyridine-5-yl)pyridine 
derivatives (linear bilateral extended terpy), previously developed in Siegel group, was 
improved and optimized. The corresponding alkyl, aryl, and heteroaryl substituted ligands 
were successfully prepared. The synthesis of 2:1 ligand to metal complexes with metals 
preferring octahedral geometry (Fe2+, Ru2+and Zn2+) afforded molecular “crossings” and 
“corners”. The X-ray crystallography showed that the flanking substituents at these 
complexes are spanned relative to each other with an obtuse angle, which increases in the 
sequence of Fe2+<Ru2+<Zn2+. The photophysical properties of both ligands and metal 
complexes in solution and solid state were studied. 
The Ru(II) complex of non-symmetric mixed bipyridine/terpyridine ligand with Δ-
TRISPHAT- counterion in dichloromethane exhibits unusual thixotropic gelation properties. 
The critical gelation concentration of this metallogelator is 1.13 wt% (4.8 mM) at room 
temperature. 
Furthermore, a novel synthetic methodology towards the linear bilateral extended 
terpy Ru(II) complexes, starting from 5,5′′-bis-(methoxymethoxy)-4,4′′-bis-(substituted-
ethynyl)-2,2′:6′,2′′-terpyridines, was developed, which involves one-pot MOM cleavage, 
cycloisomerization, and metal complexation.  
 The Fe(II) containing molecular “crossing” bearing 4-pyridyl substituents at the 
flanking positions in the presence of Cu(I), or Ag(I) ions assembled into the 2D, or 3D 
heterometallic MOFs, respectively. The MOF based on Fe(II) and Ag(I) consists of a twofold 
interpenetrated 3D network with the diamondoid topology, whereas Fe(II), Cu(I) MOF is 
made of 2D honeycomb-like layers. 
Finally, this thesis describes synthetic efforts towards the long-standing goal – the 
kinetic synthesis of the molecular Borromean link. Linear bilateral extended terpyridine 
ligands possess valuable geometric properties, which facilitated significant progress towards 
this goal. The revised route involves the synthesis of the threaded ring-in-ring complex 
containing functionalized linear terpy ligands suitable for the Eglinton reaction. The final 
macrocyclization step proved to be chemically feasible – the mass-spectroscopic data 
supports that the product with an expected molecular weight was obtained, but the formation 
of other topological isomers of the Borromean link cannot be excluded. Therefore, in order to 
prove the correct topology unambiguously, additional evidences should be provided in future. 
These results establish a solid base for further investigations towards the kinetic synthesis of 
the molecular Borromean link. 
  
ZUSAMMENFASSUNG DER DISSERTATION 
 
Linear bilateral erweitertes 2,2′:6′,2′′-Terpyridin: Ein vielseitiger Baustein in der 
Supramolekularen Chemie 
von 
Janis Veliks 
Doctor of Philosophy in Chemistry 
University of Zurich, 2014 
Professor Jay S. Siegel 
 
Das rationale Design supramolekularer Architekturen und metall-organischer Gerüste 
(MOFs) erfordert Bausteine mit definierten Dimensionen, Topologien und Funktionen. Die 
Kombination organischer Liganden mit Metallionen ermöglicht Winkel und Topologien, 
welche nicht verfügbar wären, falls nur organische Bestandteile verwendet würden. Um 
verschiedene anspruchsvolle Zielverbindungen anzugehen, besteht somit ein konstanter 
Bedarf an neuartigen Bauteilen. 
Ziel dieser Doktorarbeit ist die Untersuchung dreizähniger, auf 2,2':6',2''-Terpyridin 
(terpy) basierender Liganden, welche die lineare Geometrie zweizähniger 5,5'-
funktionalisierter 2,2'-Bipyridine nachahmen. Es wurde das Konzept des linear bilateral 
erweiterten terpy eingeführt und fünfgliedrige Furanringe in die flankierenden Positionen des 
2,2':6',2''-Terpyridin eingebaut. Hiermit können Substituenten fast rechtwinklig zum 
Koordinationsvektor des terpy angebracht werden. Die Bauform dieses Liganden ermöglich 
die Synthese von Metallkomplexen welche eine oktaedrische Geometrie und die 
topologischen Eigenschaften des linearen 2,2'-Bipyridin aufweisen. 
In einem ersten Schritt wurde die Synthese von 2,6-bis(2-substituierte-Furo[2,3-
c]pyridin-5-yl)pyridin-Derivaten, welche in der Siegel-Gruppe entwickelt worden war, 
optimiert. Die entsprechenden alkyl-, aryl-, und heteroarylsubstituierten Liganden wurden 
erfolgreich dargestellt. Die Synthese von Komplexen mit zwei Liganden pro Metall, welches 
die oktaedrische Geometrie bevorzugt (Fe2+, Ru2+ und Zn2+), ergab molekulare “Kreuze” und 
“Ecken”. Die Röntgenstrukturanalyse zeigte, dass die flankierenden Substituenten in einem 
stumpfen Winkel zueinander stehen, welcher in der Sequenz Fe2+<Ru2+<Zn2+ zunimmt. Die 
photophysikalischen Eigenschaften der Liganden und Metallkopmlexe in Lösung wurden 
zudem untersucht. 
Der Ru(II)-Komplex nicht-symmetrischer gemischter Bipyridin/Terpyridin-Liganden 
mit Δ-TRISPHAT--Gegenionen in Dichlormethan wies aussergewöhnliche thixotropische 
Vergelungseigenschaften auf. Die kritische Vergelungskonzentration dieses Metallogelators 
bei Raumtemperatur liegt bei 1.13 Gew.-% (4.8 mM). 
Weiter wurde eine neuartige synthetische Methodologie in Richtung linear bilateral 
erweiterter terpy-Ru(II)-Komplexen, ausgehend von 5,5′′-bis-(Methoxymethoxy)-4,4′′-bis-
(substituierte-ethynyl)-2,2′:6′,2′′-terpyridinen, entwickelt, welche eine Eintopf-Sequenz mit 
der Abspaltung von MOM, der Zykloisomerisierung und der Metallkomplexierung umfasst. 
Das Fe(II) enthaltende molekulare “Kreuz”, das an den flankierenden Positionen 4-
Pyridyl-Substituenten aufweist, assemblierte in der Anwesenheit von Cu(I)- oder Ag(I)-Ionen 
zu heterometallischen 2D- respektive 3D-MOFs. Der auf Fe(II) und Ag(I) basierende MOF 
besteht aus zweifach ineinander gewobenen 3D-Netwerken mit diamantoider Topologie, 
während der Fe(II)-Cu(I)-MOF aus wabenartigen 2D-Schichten besteht. 
Schliesslich beschreibt diese Doktorarbeit synthetische Bemühungen in Richtung des 
langjährigen Ziels – die kinetische Synthese der molekularen Borromäischen Verknüpfung. 
Linear bilateral erweiterte Terpyridin-Liganden besitzen nützliche geometrische 
Eigenschaften, welche einen signifikanten Fortschritt in Richtung dieses Ziels ermöglichten. 
Der überarbeitete Syntheseweg schliesst die Synthese des Ring-in-Ring-Komplex mit ein, der 
über funktionalisierte lineare terpy-Liganden verfügt, die für die Eglington-Reaktion geeignet 
sind. Der abschliessende Makrozyklisierungsschritt erwies sich als chemisch durchführbar – 
die massenspektroskopischen Daten bekräftigen, dass das Produkt mit der entsprechenden 
molekularen Masse erhalten wurde, die Bildung anderer topologischer Isomere der 
Borromäischen Verknüpfung kann jedoch nicht ausgeschlossen werden. Um die korrekte 
Topologie eindeutig zu beweisen, müssen deshalb in Zukunft weitere Nachweise geliefert 
werden. Diese Resulate bilden ein solides Fundament für weitere Untersuchungen zur 
kinetischen Synthese der Borromäischen Verknüpfung. 
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Chapter 1. Directional Building Blocks in Supramolecular Chemistry 
 
 4 
1.1. Introduction 
 
In order to build macroscopic objects, for example, a two-dimensional fence or a three-
dimensional building (Figure 1.1), appropriate construction materials are needed. The design 
of architectures on the molecular scale also requires building blocks with defined dimensions, 
angles, and chemical properties. 
    
Figure 1.1. Designed macroscopic objects: 2D fence and 3D building.1,2 
 
It is important to have a library from where chemists can select the most suitable starting 
materials, which fulfil both the topology and function of the expected synthetic target. 
Biological systems are excellent examples where relatively limited amount of building blocks, 
like amino acids and nucleotides, act as construction materials for the synthesis of 
complicated nanomachines – ATP-synthase or ion pumps, efficient and specific catalytic 
systems – enzymes, and molecules for information storage – DNA.3 
In 1960s-70s, supramolecular chemistry emerged from the seminal work of Lehn4, 
Pedersen5, and Cram6. Inspired by biochemistry and materialized by the tools of organic and 
inorganic chemistry, it deals with non-covalent interactions such as hydrogen-bonding, donor-
acceptor, π-π interactions, metal coordination, mechanical bonding, and others.7,8 Since the 
birth of this field, supramolecular chemistry has become an important driving force for 
creating new materials with valuable properties.7,9-11  
Metal coordination with organic ligands is one of the most commonly used design 
elements, offering a vast range of interactions – from weak and labile to strong and inert12. 
Geometries of metal coordination spheres have a predictable character, which is an important 
feature for the design. Also, directional ligands with defined coordination sites (Figure 1.2) 
predetermine the geometry of assemblies. A rapidly growing field of metal-organic 
frameworks (MOFs) successfully applies such design principles by using metal nodes and 
organic spacers13. 
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Figure 1.2. Directional pyridine based ligands and common transition metal coordination 
geometries.14 
 
Therefore, there is a constant need for new molecules possessing defined geometry 
and functions. This thesis deals with the synthesis, characterization and supramolecular 
applications of novel tridentate ligands based on 2,6-bis(2-substituted-furo[2,3-c]pyridine-5-
yl)pyridine scaffold* (Figure 1.3, B). These ligands are topological analogs of bidentate 5,5′-
substituted-2,2′-bipyridines (bipy) – a complement to the directional “Stub”, “W”, “V or Λ”, 
and “C” 2,2′:6′,2′′-terpyridines (terpy) (Figure 1.3, A). This ligand design allows the synthesis 
of metal complexes which have both octahedral geometry and topological properties of linear 
2,2′-bipyridine. The following work shows that such building blocks have various 
applications in supramolecular chemistry, like the assembly of heterometallic MOFs, 
thixotropic metal-organic gels, and the design element towards the synthesis of the molecular 
Borromean link. 
 
                                                
* In this thesis such ligands are referred to as linear bilateral extended terpyridines or simply 
as linear terpy. 
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Figure 1.3. A. The “Stub”, “W”, “V or Λ”, and “C” motifs based on terpy. B. Fused five-
membered rings to terpy mimicking 5,5′-functionalized bipy. 
 
This chapter provides a short overview of the importance of directional building 
blocks in supramolecular chemistry and the field of MOFs, highlighting the heterometallic 
MOFs. Also, the most important routes towards the synthesis of 2,2′:6′,2′′-terpyridine 
derivatives are shortly summarized. 
 
1.2. Thermodynamic Assembly versus Kinetic Synthesis 
 
Depending on the strengths and stability of the non-covalent interactions, two 
completely different approaches towards the synthesis of supramolecular assemblies can be 
distinguished. Thermodynamic assembly15, or as many refer to it as “self-assembly”7,10,16, 
deals with the dynamic character of kinetically labile interactions (Figure 1.4). The 
multicomponent mixture undergoes kinetically reversible reaction, and the outcome is driven 
by the shift of the equilibrium towards the thermodynamically most stable product. Such 
approach often is extremely efficient, because it usually involves only one step, thus 
providing highly advanced assemblies in just one pot17.  
 
Figure 1.4. Thermodynamic assembly of the supramolecular architectures. 
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Figure 1.5. Kinetic or stepwise synthesis of the supramolecular architectures. 
 
However, the outcome of such approach is often difficult to predict, and in many successful 
examples serendipity plays a crucial role18,19. The results are often rationalized after the actual 
product has been obtained.20-22 
The kinetic synthesis is a diametrically opposite approach, which is based on the step-
by-step construction of the supramolecular target via kinetically stable intermediates and 
irreversible reactions (Figure 1.5), offering the synthesis of otherwise inaccessible products23-
26. This approach offers greater predictability, which is an important key factor for the rational 
design. In my opinion, such approach has more intellectual beauty than “simply mixing things 
together” and hoping for the positive outcome.  However, multistep syntheses often have 
several drawbacks: they are more laborious, the total yields are lower, and sometimes a 
complicated purification is required. Nevertheless, both approaches require the building 
blocks with defined and predictable geometry in order to reach the expected synthetic targets.  
 
1.3. Directional Building Blocks and Metal Coordination-Driven Assemblies 
 
1.3.1. Finite Assemblies 
 
In 1987, Lehn, Siegel et al. showed that 2,2′- bipyridine based ligands 1 and 3 in the 
presence of copper(I) assemble into the double-stranded helicates (Figure 1.6).27 The proper 
choice of the ligand geometry and the coordination mode of metal ions resulted into a 
predictable assembly of components with the expected geometry. 
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Figure 1.6. Synthesis of Cu(I) helicates. 
 
The search for 90° angle fragments in chemistry motivated the construction of the first 
molecular square.28 In 1990, Fujita et al. reported that the reaction between the square planar 
palladium(II) complex 5 and linear 4,4′-bipyridine (6) resulted in the formation of the 
molecular square assembly in high yield (Figure 1.7).29,30 Later, Stang group also showed 
similar molecular squares based on Pt(II) complexes.31 
 
Figure 1.7. Fujita’s synthesis of the Pd(II) based molecular square. 
  
Linear ligands with perpendicular coordination sites in the presence of metal ions can 
form molecular grid assemblies [n×n], where n is the number of coordination sites. The first 
example of molecular grid was reported by Osborn and coworkers in 1992 (Figure 1.8).32 The 
ditopic ligand 8 in the presence of Cu(I) formed the [2×2] grid assembly 9. Such systems 
were studied because of their potential application in the bottom-up nanofabrication.33,34 
Examples of [2×2] to [5×5] molecular grids are known in the literature.35 
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Figure 1.8. Osborn’s assembly of the [2×2] molecular grid. 
 
Figure 1.9. The design of 2D polygons by combination of ditopic building blocks. Adapted 
with permission from ref.14. Copyright 2013 ACS. 
 
The design of supramolecular assemblies from directional building blocks was 
promoted by the work of Stang, Fujita, Raymond and others.9,16,36 The two-dimensional 
molecular polygons can be designed by choosing the proper directional metal “acceptors” and 
organic “donors”. Schematic representation of this approach is shown in Figure 1.9. 
 
Figure 1.10. Metal-based precursors offering various angles for the construction of 
supramolecular assemblies.14,28,36 
 
For this purpose various Pt(II) and Pd(II) containing building blocks were developed, giving 
access to the angles ranging from 0 ° to 180 ° (Figure 1.10).  
For example, a strain-free molecular triangle can be synthesized by the combination of 
180° and 60° motifs.37 Already in 1970, attempts towards the synthesis of 2-pyridylgold(I) 
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to achieve complex topologies. Of the various strategies devel-
oped in recent years using metal!ligand coordination, directional
bonding,8 symmetry interaction,9 molecular paneling,10 weak link,11
and dimetallic building block12 approaches are the most exten-
sively used and adopted. These synthetic strategies have led to a
wide variety of 2D and 3D molecular architectures of diﬀerent
shapes and sizes, which can be modulated through the judicious
choice of metals and ligands. The metal!ligand bond serves as
the cornerstone in all of these design principles. Mechanistically,
the ﬁrst four approaches rely on thermodynamic control; the
global minimum of the reaction coordinate is the desired
product. The weak link approach utilizes both thermodynamic
and kinetic control to access a variety of large, open, and ﬂexible
2D and 3D structures.
2.1. Directional Bonding Approach
The directional bonding approach is a general, high-yielding
synthetic strategy that gives access to a wide variety of 2D and 3D
supramolecular ensembles.8 Since the seminal studies on the
rational synthesis of molecular squares in the early 1990s by
Fujita23,24 and Stang's25 group a plethora of metalla-macrocycles
and metallacages have been assembled using this design strategy.
This rational design strategy allows for a combinatorial molecular
library consisting of complementary building blocks that allows
one to think retrosynthetically on how best to achieve the
geometry of a particular discrete assembly.
There are two basic structural requirements for the construc-
tion of supramolecular architectures by this approach. First, the
complementary precursor units must be structurally rigid with
predeﬁned bite angles; and second, the appropriate stoichiometric
ratio of the precursors must be used. The donor building blocks are
generally organic ligands having two or more binding sites possess-
ing angular orientations ranging from 0 to 180! (Figure 1).
The acceptors are metal-containing subunits that are vital in
this design approach because they possess available coordination
sites, which are at a ﬁxed angle relative to one another for binding
incoming ligands. The symmetry and number of binding sites
within each precursor unit guide the shape of the target assembly.
While the design of monocyclic ensembles requires subunits
having symmetry axes no higher than a 2-fold axis, polycyclic
entities require one of the subunits to possess a symmetry axis
higher than 2-fold. In this strategy, the shapes of the resulting
monocyclic entities resemble convex polygons and those of
polycyclic frameworks bear a resemblance to canonical polyhe-
dra. For example, a molecular rectangle can be designed by the
combination of two 0 acceptor units with 180 two donor units
and vice versa. A molecular triangle can be prepared by the
combination of three 60! donor units and three 180! acceptors.
A molecular square can be accessed in diﬀerent ways: the
combination of four ditopic 90! angular units and four 180!
linear units or the 2:2 assembly of two diﬀerent 90! angular units.
Three-dimensional polyhedral architectures can be designed
using a combination of angular and linear subunits that have
more than two binding sites (Figure 2). For example, a truncated
tetrahedron can be designed by combining four tridentate
subunits, where the angles between the binding sites are 120!,
with six ditopic subunits having an angular disposition of
80!90!. A trigonal bipyramid can be formed in several ways,
such as by combining two tritopic units, where the binding sites
are orthogonal to each other, with three 80!90! ditopic units or
by combining two tridentate 60! building blocks with three
ditopic units which have 90! angles between the donor sites.
Similarly, eight tritopic subunits possessing 90! angles between
their binding sites and 12 linear ditopic units lead to the
formation of a cube. Although it is assumed that the angle
subtended at the angular subunit does not change upon incor-
poration into the assembly, in practice the angles can distort up to
several degrees. Nevertheless, due to the relatively weak nature of
metal!ligandbonds compared to covalent ones, the ﬁnal geometry
of the supramolecular entity remains more or less intact.
2.2. Symmetry Interaction Approach
This design strategy has been developed as a rational synthetic
approach for the synthesis of high-symmetry coordination
clusters using metal!ligand bonds. It is based on the geometric
relationship between the chelating ligands and the metals used.
The strong binding aﬃnity and coordination mode of chelating
ligands, along with the inherent symmetry of the coordination
sites available on the naked metal center, act as the driving force
for the assembly process. In general, multibranched chelating
ligands with rigid backbones are used in conjunction with transi-
tion metals or main groupmetals. The orientation of the multiple
binding sites that are rigidly ﬁxed is critical to the selectivity of a
particular molecular geometry and helps to avoid the formation
of oligomers and polymers. Similar to the directional bonding
approach, it relies on the thermodynamic control and kinetic
reversibility for error checking and self-correction.
Figure 1. C mbination of vari us uilding units for accessing convex
polygons and canonical polyhedra.
Figure 2. Three-dimensional architectures formed by the combination
of ditopic and tritopic subunits by the directional bonding approach.
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(16) provided the triangular structure 17 – the result of serendipity rather than design (Figure 
1.11).38 Such structure fulfills both the linear coordination geometry of Au(I) and 60° angle 
between pyridine nitrogen and metal center.  
 
Figure 1.11. The formation of molecular triangle from 2-pyridylgold(I). 
 
Newkome and coworkers showed a beautiful example of the rationally designed angular 
2,2′:6′,2′′-terpyridine based ligand 18 which assembled into molecular triangles 19 when 
metals preferring octahedral geometry were used (Figure 1.12).39 Many other molecular 
triangles were obtained using this approach.37,40,41 
 
Figure 1.12. Newkome’s synthesis of molecular triangle. 
 
Similarly, the ditopic ~108° angular terpy ligand 20 in the presence of Fe(II), Ru(II) 
and Zn(II) metal ions gave the molecular pentagons 21 (Figure 1.13).42 Hasenknopf et al.43 
and Jiang et al.44 also reported on the other metal-organic pentagonal structures.  
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Figure 1.13. Newkome’s synthesis of molecular pentagon. 
 
Various higher molecular polygons44, such as hexagons45-47, less predictable 
heptagons48 and octagonas49 were also prepared using directional building blocks. 
In 1988, Saalfrank et al. synthesized the first example of a metal-organic cage which 
was obtained serendipitously.50 However, the rational design of three-dimensional assemblies 
can be tackled by the combination of ditopic and tritopic motifs, as shown in Figure 1.14.16 
 
 
Figure 1.14. The design of 3D polyhedrons by the combination of ditopic and tritpoic 
building blocks. Adapted with permission from ref.14. Copyright 2013 ACS. 
 
Fujita et al. showed that the three-fold symmetric directional ligand 22 in the presence of the 
orthogonal Pd(II) complex 5 assembles into the molecular cage 23 resembling octahedron 
(Figure 1.15).51 On the other hand, the combination of the tritopic ligand 22, the complex 5 
and ditopic linear ligands (topological analogs to 4,4′-bipyridine) afforded the trigonal 
prismatic cages 24 which were able to incorporate aromatic guests within their cavities.52  
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to achieve complex topologies. Of the various strategies devel-
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and dimetallic building block12 approaches are the most exten-
sively used and adopted. These synthetic strategies have led to a
wide variety of 2D and 3D molecular architectures of diﬀerent
shapes and sizes, which can be modulated through the judicious
choice of metals and ligands. The metal!ligand bond serves as
the cornerstone in all of these design principles. Mechanistically,
the ﬁrst four approaches rely on thermodynamic control; the
global minimum of the reaction coordinate is the desired
product. The weak link approach utilizes both thermodynamic
and kinetic control to access a variety of large, open, and ﬂexible
2D and 3D structures.
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and metallacages have been assembled using this design strategy.
This rational design strategy allows for a combinatorial molecular
library consisting of complementary building blocks that allows
one to think retrosynthetically on how best to achieve the
geometry of a particular discrete assembly.
There are two basic structural requirements for the construc-
tion of supramolecular architectures by this approach. First, the
complementary precursor units must be structurally rigid with
predeﬁned bite angles; and second, the appropriate stoichiometric
ratio of the precursors must be used. The donor building blocks are
generally organic ligands having two or more binding sites possess-
ing angular orientations ranging from 0 to 180! (Figure 1).
The acceptors are metal-containing subunits that are vital in
this design approach because they possess available coordination
sites, which are at a ﬁxed angle relative to one another for binding
incoming ligands. The symmetry and number of binding sites
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using a combination of angular and linear subunits that have
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subunits, where the angles between the binding sites are 120!,
with six ditopic subunits having an angular disposition of
80!90!. A trigonal bipyramid can be formed in several ways,
such as by combining two tritopic units, where the binding sites
are orthogonal to each other, with three 80!90! ditopic units or
by combining two tridentate 60! building blocks with three
ditopic units which have 90! angles between the donor sites.
Similarly, eight tritopic subunits possessing 90! angles between
their binding sites and 12 linear ditopic units lead to the
formation of a cube. Although it is assumed that the angle
subtended at the angular subunit does not change upon incor-
poration into the assembly, in practice the angles can distort up to
several degrees. Nevertheless, due to the relatively weak nature of
metal!ligandbonds compared to covalent ones, the ﬁnal geometry
of the supram lecular entity remains more or less intact.
2.2. Symmetry Interaction Approach
This design strategy has been developed as a rational synthetic
approach for the synthesis of high-symmetry coordination
clusters using metal!ligand bonds. It is based on the geometric
relationship between the chelating ligands and the metals used.
The strong binding aﬃnity and coordination mode of chelating
ligands, along with the inherent symmetry of the coordination
sites available on the naked metal center, act as the driving force
for the assembly process. In general, multibranched chelating
ligands with rigid backbones are used in conjunction with transi-
tion metals or main groupmetals. The orientation of the multiple
binding sites that are rigidly ﬁxed is critical to the selectivity of a
particular molecular geometry and helps to avoid the formation
of oligomers and polymers. Similar to the directional bonding
approach, it relies on the thermodynamic control and kinetic
reversibility for error checking and self-correction.
Figure 1. Combination of various building units for accessing convex
polygons and canonical polyhedra.
Figure 2. Three-dimensional architectures formed by the combination
of ditopic and tritopic subunits by the directional bonding approach.
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Figure 1.15. Fujita’s assembly of molecular cages. 
The synthesis of molecular cages opened new perspectives in such fields as host-guest 
chemistry53, molecular recognition54, reactivity modulation55, and catalysis56, because of their 
nanoscale cavities with unique environment not found in a bulk solution. Again, directional 
ligands play a crucial role in designing new molecular cages.36 
 
1.3.2. Polymeric Assemblies 
 
The finite metal-organic assemblies are a logical outcome of the interplay between 
serendipity, rational design and geometries offered by both organic and inorganic chemistry. 
However, infinite, polymeric networks can also be designed from the metal ions and organic 
ligands. 
In 1990, the pioneering work by Robson and coworkers57 initiated the new, rapidly 
growing field of metal-organic frameworks (MOFs) – polymeric hybrid crystalline materials 
consisting of organic linkers and metal nodes. They showed that the rational choice of the 
tetrahedral organic ligand 25 and Cu(I) ions resulted in the formation of the infinite, double-
interpenetrating coordination framework with diamond-like topology (Figure 1.16). 
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Figure 1.16. The first metal-organic framework by Robson et al. 
 
In 1994, Fujita group synthesized the 2D MOF 26 consisting of 4,4′-bipyridine (6) 
linkers and Cd(II) metal nodes (Figure 1.17). Fujita predicted that “construction of the inner 
cavities mainly surrounded by organic components is attractive since the shape, size, and 
function of the cavity become designable”.58 
 
Figure 1.17. Synthesis of 2D MOF based on 4,4′-bipyridine linkers and Cd(II) metal nodes. 
 
By replacing metal ions with inorganic clusters, Yaghi et al. revolutionized the field of 
MOFs in 1999. Instead of single metal ions, these metal clusters, or as they called them 
secondary building units (SBUs), can be used as rigid nodes to construct the polymeric 
frameworks.59 They showed that the linear 1,4-benzenedicarboxylate linker 27 with SBU 
Zn4O cluster forms a highly porous crystalline material MOF-5 with the cubic net topology 
(Figure 1.18). The MOF-5 remains stable even after the removal of incorporated solvent 
molecules and heating up to 300 °C. 
a b c  
Figure 1.18. Reticular construction of MOFs by Yaghi: a) MOF-5; b) IRMOF-10; c) IRMOF-
16. Adapted with permission from ref.60 Copyright 2002 AAAS. 
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R1 ! H), hereafter termed IRMOF-1, in 90%
yield.
The simplicity of the method and the facility
with which IRMOF-1 can be obtained indicated
that the use of other ditopic carboxylate links
(Scheme 1) under closely related, if not identi-
cal, conditions would yield the same type of
frameworks with diverse pore sizes and func-
tionalities. Indeed, using each of the links R2-
BDC, R3-BDC, R4-BDC, R5-BDC, R6-BDC,
R7-BDC, 2,6-NDC, BPDC, HPDC, PDC, and
TPDC instead of BDC yielded IRMOF-2
through -16, including the noninterpenetrating
structures of BPDC, HPDC, PDC, and TPDC.
Each member of the IRMOF series has been
isolated and was formulated subsequently by
chemical microanalysis and single-crystal XRD
studies (11, 12).
All IRMOFs have the expected topology of
CaB6 (13) adapted by the prototype IRMOF-1
(Fig. 1, 1) in which an oxide-cent red Zn4O
tetrahedron is edge-bridged by six carboxylates
to give the octahedron-sha ed secondary build-
ing unit (SBU) that reticulates into a three-
dimensional (3D) cubic porous network. How-
ever, the IRMOFs differ in the nature of func-
tional groups decorating the pores and in the
metrics of their pore structure. In IRMOF-2
through -7, BDC links with bromo, amino,
n-propoxy, n-pentoxy, cyclobutyl, and fused
benzene functional groups reticulate into the
desired structure wherein the groups point into
the voids (Fig. 1, 2 to 7). Thus, we can use a
wide variety of carboxylate links diverse in
their functional groups—rare aspects that here-
tofore remained largely absent in crystalline
solid state and porous materials research. Pore
expansion is also within the scope of this chem-
istry, as illustrated by the structures of IR-
MOF-8 through -16 (Fig. 1), in which progres-
sively longer links have been successfully used.
Previous geometric analysis of the primitive
cubic system showed that expansion of links
results in interpenetrating frameworks, some-
times with optimal porosity (14). In fact, with
the exception of the noninterpenetrating struc-
ture involving 2,6-NDC (IRMOF-8) (Fig. 1, 8),
BPDC, HPDC, PDC, and TPDC (IRMOF-9,
-11, -13, and -15, respectively) are each reticu-
lated as doubly interpenetrating structures.
However, by carrying out the original reactions
under more dilute conditions, noninterpenetrat-
ing counterparts have been successfully
achieved for all links including TPDC (IRMOF-
10, -12, -14, and -16) (Fig. 1, 10, 12, 14, and
16). Thus, our strategies have allowed the syn-
thesis of both interpenetrating and noninterpen-
etrating forms of the same extended structure.
Comparison of the percent free volume in
crystals of IRMOF-1 through -16 (Fig. 2)
shows that it varies in small increments (1 to
5%) from 55.8% in IRMOF-5 to 91.1% in
IRMOF-16. Remarkably, the lowest percent
free volume obtained in this series exceeds
that found in some of the most open zeolites,
such as faujasite (15) in which the free space
is 45 to 50% of the crystal volume. In fact,
Fig. 1. Single crystal x-ray
structures of IRMOF-n
(n! 1 through 7, 8, 10, 12,
14, and 16), labeled respec-
tively. The doubly inter-
penetrated IRMOFs (9, 11,
13, and 15) are not shown
[see text and (23)]. Color
scheme is as follows: Zn
(blue polyhedra), O (red
spheres), C (black spheres),
Br (green spheres in 2),
amino-groups (blue spheres
in 3). The large yellow
spheres represent the largest
van der Waals spheres that
would fit in the cavities
without touching the frame-
works. All hydrogen atoms
have been omitted, and only
one orientation of disor-
dered atoms is shown for
clarity.
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Yaghi group also synthesized MOFs with similar structures and topologies but with different 
pore sizes by simply changing the dimensions of the organic linkers such as dicarboxylates 27, 
28, and 29 (Figure 1.18). This design principle is known as the reticular chemistry, and the 
resulting structures are called isoreticular structures or IRMOFs (Figure 1.18, examples a, b 
and c).60,61 Since then, a huge number of different MOFs were prepared with various 
topologies, porosity and potential applications. Due to the high porosity of these solid, 
zeolite-like materials, the major focus is the search for MOFs suitable for gas adsorption, 
storage and separation; however, recent progress in the field showed that MOFs have huge 
potential also in catalysis, optoelectronics, magnetic materials, and other specific 
applications.13 It follows that there is an essential need for novel organic linkers to adjust the 
structure, topology and function of MOFs, since the organic linkers can be easily modified 
and adjusted for the desired application.14 
Most of the MOFs reported to date contain the same metal centers or clusters. In 1994, 
Robson et al. showed that the metal porphyrin based ligand can assemble into the MOF 
structure with copper centers having different oxidation states (Cu(I) and Cu(II)).62 To date, 
there are significantly less examples of heterometallic MOFs reported as compared to a huge 
number of homometallic MOFs63; despite the fact, there is a growing interest in such 
materials. Additional metal center could not only tune the pore size and topology of a network 
but also bring interesting luminiscent64, magnetic or catalytic properties65, and improved gas 
adsorption63,66-69. However, the rapid development of this field is limited to the currently 
available organic ligands. The ligands for this purpose should be able to address various metal 
coordination modes and geometries. Most of the heterometallic MOFs reported to date 
contain only few types of organic ligands, and there is a clear need for novel, directional 
ligands. In their 2011 review article, Das et al. wrote that “construction of functional mixed 
metal–organic frameworks (M’MOFs) is still in an early stage”.65 
The rational approach to the synthesis of heterometallic MOFs involves preformed 
metalloligands. Several such ligands are shown in Figure 1.19.70 
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Figure 1.19. Several metalloligands used for the construction of heterometallic MOFs. 
 
Noro et al. reported on the pyridine carboxylate based metalloligands 29 and 3071,72 
that were used in assembly of 2D Zn(II), Cu(II) MOFs. Kitaura et al. showed the synthesis of 
the salen based metallo ligands 31 for the assembly of mixed 3D Zn(II),Cu(II) or Co(II) 
MOFs (Figure 1.20).73 
 
Figure 1.20. Construction of heterometallic Zn(II),Cu(II) 3D MOF. Adapted with permission 
from ref.73. Copyright 2004 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 
 
The polymeric 1D ladders and 2D layers containing Cu(II) and Cd(II) metal centers were 
prepared from the pyridine functionalized acac-type ligand 34.74 The interesting diketone 
metalloligand 33 afforded Mn(II), Cu(II) 2D framework.75 Several porphyrine-based ligands, 
like 36, 37, and 38, were also useful in the construction of heterometallic MOFs.76-79 
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soluble in DMF, DMSO, and pyridine and slightly soluble in
MeOH.
The metalloligand [Cu(H2salphdc)]·H2O reacts with
Zn(NO3)·6H2O to afford a 3D coordination framework
1·2DMF ([Zn3(OH)2(LCu)2]·2DMF). Figure 2a shows the
coordination environments around the CuII and ZnII ions of
1·2DMF. This crystal has two crystallographically independ-
ent ZnII ions. One (Zn(1)) is tetrahedrally coordinated to two
hydroxide anions and two carboxylate oxygen atoms of LCu
and the other (Zn(2)) is octahedrally coordinated to two
hydroxide anions and four carboxylate oxygen atoms of LCu to
form an infinite chain structure. These chains are further
linked by LCu to form a 3D porous structure, which possesses
one-dimensional (1D) large channels with a cross-section of
approximately 14! 14"2 (Figure 2b) and a large free void
space of about 53% if the van der Waals radii of the
constituting atoms are considered. Only one DMF molecule
per CuII ion was determined by crystallography to be in the
channel, and this is tightly anchored to the framework by a
hydrogen bond with the carboxylate oxygen atom. The
absence of other guest molecules in the channel of 1·2DMF
was attributed to the disorder of included guest molecules as a
result of the large channel size of 1·2DMF.
Interestingly, coordinatively unsaturated CuII ions line up
along the c-axis with an intermetallic distance of 6.1". To our
knowledge, this is the first example of metallo Schiff base
moieties being embedded regularly in the pore wall of a 3D
porous framework. Although similar frameworks were
reported with 4,4’-biphenyldicarboxylate and 2,6-naphthale-
nedicarboxylate,[10] the present porous structure with UMCs
has added a new dimension to metal–organic framework
chemistry. Bulk samples of this material are stable in air and
are insoluble in common organic solvents. The IR spectrum of
the material shows no absorptions bands characteristic of any
protonated salphdc ligand, thus confirming complete depro-
tonation of [Cu(H2salphdc)]. X-ray powder diffraction
(XRPD) measurements with heating under reduced pressure
were performed to examine the stability of the framework
(Figure 3). The XRPD pattern of as-prepared 1 measured at
Figure 1. ORTEP drawing of [Cu(H2salphdc)]·H2O. Water molecules
and hydrogen atoms are omitted for clarity.
Figure 2. a) The building unit in the 3D porous coordination polymer,
1·2DMF. The hydrogen atoms and DMF molecule are omitted for
clarity. b) 3D porous structure of 1·2DMF viewed down the c-axis (Zn,
yellow; Cu, green; O, red; C, gray; N, blue). One of the doubly disor-
dered phenylenediamine groups and the Cu atoms are omitted for
clarity.
Figure 3. XRPD patters of as-synthesized 1 with heating from 298 to
523 K. a) Simulated pattern from single-crystal data and the b)–f)
XRPD patterns at 298, 373, 423, 473, and 523 K, respectively.
Angewandte
Chemie
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Figure 1.21. Stepwise synthesis of Cu(II), Cd(II) 2D MOF. 
 
The principle of the stepwise construction of Cu(II), Cd(II) 2D MOF via the 
metalloligand 37 is depicted schematically in Figure 1.21.80 
 
 
Figure 1.22. Construction of the heterometallic MOF from the three-fold symmetric 
metalloligand 39. Adapted with permission from ref.81. Copyright 2005 American Chemical 
Society. 
 
Halper and coworkers prepared interesting three-fold symmetric metalloligands 40 
containing Co(II) or Fe(II), which in the presence of Ag(I) ions assembled into the 
heterometallic MOF (Figure 1.22).81 
Yaghi group showed that different metal ions can also be incorporated in the already 
preformed MOF structure if open coordination sites are available within the framework 
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symmetry of the ligands used in earlier MOF syntheses
(Scheme 1).5-9 Dipyrrin complexes are stable, have rich
electronic absorption spectra, and can be isolated by using
conventional flash chromatography. The geometry of the
resulting complexes allows for the introduction of a second
ligating site with a definite directionality, making suitable
monomers for preparing extended structures.19-23 A pyridyl
functionalized dipyrrin was synthesized as previously de-
scribed22,23 and combined with the appropriate metal salt to
obtain the desired building blocks [Co(4-pyrdpm)3] and
[Fe(4-pyrdpm)3] (4-pyrdpm ) 5-(4-pyridyl)-4,6-dipyrrinato)
in modest yields.
[Co(4-pyrdpm)3] and [Fe(4-pyrdpm)3] are neutral, air and
moisture stable, highly colored complexes with intense
electronic absorption features characteristic of these com-
pounds.19-21 Both complexes have been characterized by
single-crystal X-ray diffraction studies, and the molecular
structure of each is shown in Figure 1. The essentially
isostructural complexes have a distorted octahedral coordina-
tion geometry (Co-N ∼1.94 Å, Fe-N ∼1.96 Å). As
anticipated, the three pyridyl moieties are poised in a pseudo-
3-fold symmetric fashion pointing away from the tris(chelate)
metal center.
To obtain the desired MOF, the discrete coordination
compound [Co(4-pyrdpm)3] was combined with 1 equiv of
AgOTf (OTf ) trifluoromethanesulfonate, triflate) in ben-
zene solution at concentrations ranging from∼0.2 to 1.3 mM.
The mixture immediately generated a red precipitate that was
dissolved by dilution with acetonitrile (see Supporting
Information). The mixtures were shielded from light, and
upon slow evaporation, the solutions generated large, orange
crystals after 1-2 weeks. The bright orange color of the
crystals was indicative of the [Co(4-pyrdpm)3] core; this was
confirmed by the diffuse reflectance UV-vis spectrum of
these crystals, which showed an absorption feature centered
at 557 nm with another broad, intense absorption at >610
nm. Similar spectral features are found in the [Co(4-
pyrdpm)3] monomer complex (Figure S1). In addition, IR
spectra of the crystals had several features indicative of the
dipyrrin complex (1380, 1346, 1021, 995 cm-1).23
A single-crystal X-ray diffraction study of the orange
crystals revealed the formation of a heterometallic MOF
(Figure 2). The material crystallized in the orthorhombic
space group Pbcn, with the [Co(4-pyrdpm)3] complexes
linked together via the pyridyl nitrogen atoms to silver(I)
centers. Each silver(I) ion is bound by three pyridyl groups
and one triflate counterion, in a distorted trigonal pyramidal
coordination geometry. The triflate anion binds to the apical
position of the coordination sphere with a Ag-O bond length
of 2.57 Å. The average Ag-N bond length of 2.24 Å is
comparable to those found in other extended solids based
on organic building blocks. The cobalt(III) coordination
sphere maintains the octahedral geometry found in the
(19) Bru¨ckner, C.; Zhang, Y.; Rettig, S. J.; Dolphin, D. Inorg. Chim. Acta
1997, 263, 279-286.
(20) Cohen, S. M.; Halper, S. R. Inorg. Chim. Acta 2002, 341, 12-16.
(21) Halper, S. R.; Cohen, S. M. Chem. Eur. J. 2003, 9, 4661-4669.
(22) Halper, S. R.; Cohen, S. M. Angew. Chem., Int. Ed. 2004, 43, 2385-
2388.
(23) Halper, S. R.; Malachowski, M. R.; Delaney, H. M.; Cohen, S. M.
Inorg. Chem. 2004, 43, 1242-1249.
Scheme 1. Synthesis of Heterometallic Frameworks MOF-M/Ag-1
Figure 1. Structural diagram of [Co(4-pyrdpm)3] (top) and [Fe(4-pyrdpm)3]
(bottom) with partial atom numbering schemes (ORTEP, 50% probability
ellipsoids). Hydrogen atoms and solvent have been omitted for clarity.
Figure 2. ORTEP representation (50% probability ellipsoids) of the
packing in MOF-Co/Ag-1 viewed down the crystallographic b-axis. Only
one of two interpenetrated networks is shown in order to highlight the
connectivity the lattice. Solvent molecules, hydrogen atoms, and counterions
have been omitted for clarity.
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(Figure 1.23).82 They successfully employed strong oxophilicity of aluminum, which allowed 
the construction of 2,2′-bipyridine-5,5′-dicarboxylate based MOF-253 containing Al(III) 
metal centers and open bipy coordination sites. Subsequently, the available coordination sites 
were metallated with PdCl2. Such heterometallic porous material exhibits significantly 
enhanced selectivity for the adsorption of CO2 over N2. 
 
Figure 1.23. Metal insertion in 2,2′-bipyridine based MOF-253. Adapted with 
permission from ref.82. Copyright 2010 American Chemical Society. 
 
The further development of this field strongly depends on the creation of new 
metalloligands addressing various coordination geometries and topologies. The current state 
of the heterometallic MOF field indicates that there is an urgent need for such new systems. 
 
1.4. Synthesis of Functionalized 2,2′:6′,2′′-Terpyridines 
 
In our pursuit towards development of novel directional 2,2′:6′,2′′-terpyridines based 
ligands, a short overview of the most common synthetic routes to 2,2′:6′,2′′-terpyridines 
derivatives is provided below. 
In 1931, Morgan and Burstall first isolated 2,2′:6′,2′′-terpyridine as a side-product 
from the high temperature reaction of pyridine in the presence of FeCl3.83 Since then, it has 
become one of the most important chelating ligands with a broad spectrum of various 
applications.84-86 2,2′:6′,2′′-Terpyridine derivatives are attractive design elements in 
supramolecular chemistry, because they are able to form 2:1 ligand to metal complexes with 
many transition metals preferring octahedral coordination geometry.84,87 
There are two major synthetic strategies to the substituted 2,2′:6′,2′′-terpyridine 
derivatives: ring construction by condensation reactions and the synthesis via cross-coupling 
chemistry.86 
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Abstract: Reaction of AlCl3 ·6H2O with 2,2′-bipyridine-5,5′-dicar-
boxylic acid (H2bpydc) affords Al(OH)(bpydc) (1, MOF-253), the
first metal-organic framework with open 2,2′-bipyridine (bpy)
coordination sites. The material displays a BET surface area of
2160 m2/g and readily complexes metals to afford, for example,
1 ·xPdCl2 (x ) 0.08, 0.83) and 1 ·0.97Cu(BF4)2. EXAFS spec-
troscopy performed on 1 ·0.83PdCl2 reveals the expected square
planar coordination geometry, matching the structure of the model
complex (bpy)PdCl2. Significantly, the selectivity factor for binding
CO2 over N2 under typical flue gas conditions is observed to
increase from 2.8 in 1 to 12 in 1 ·0.97Cu(BF4)2.
Owing to their high surface areas and tunable pore functionality,
metal-organic frameworks are currently under investigation for a
variety of potential applications, including gas storage,1 gas
separations,2 and catalysis.3 Of particular promise are frameworks
with surfaces bearing exposed metal centers, since these can
dramatically enhance (selective) gas uptake or serve as a source of
catalytic activity.4 Such metal sites have typically been created
either by desolvation of a framework featuring metal-bound solvent
molecules or via some form of postsynthetic modification to the
organic bridging ligands.5 The direct formation of frameworks
bearing chelating ligand sites that are open to metal insertion is
rare,3a,b,6 since typically metal binding at these sites would occur
during framework synthesis. In our efforts to generate compounds
of this type, we considered the possibility that a hard oxophilic
metal cation might preferentially coordinate the carboxylate groups
of a mixed donor ligand such as 2,2′-bipyridine-5,5′-dicarboxylate
(bpydc2-), leading to a framework with the softer donor groups
available to bind metals. Here, we show that this strategy can indeed
be successfully employed in generating Al(OH)(bpydc) (MOF-253),
the first metal-organic framework featuring open 2,2′-bipyridine
(bpy) ligand sites. Subsequent complexation of Pd2+ and Cu2+ is
demonstrated, with the latter resulting in a material that exhibits a
significantly enhanced selectivity for the adsorption of CO2 over
N2.
The synthesis of Al(OH)(bpydc) was accomplished in direct analogy
with the recently reported framework Al(OH)(bpdc) (bpdc2- ) 4,4′-
biphenyldicarboxylate).7 Reaction of H2bpydc with AlCl3 ·6H2O in
DMF at 120 °C for 24 h afforded Al(OH)(bpydc) ·2.6DMF
(1 ·2.6DMF) as a white microcrystalline solid. Thermogravimetric
analysis of the product revealed a weight loss of 40% upon heating to
200 °C, consistent with loss of 2.6 solvent molecules per formula unit,
with no further weight loss up to 400 °C. Accordingly, the solid was
soaked in methanol and then heated at 250 °C under dynamic vacuum
for 24 h to yield the fully desolvated framework Al(OH)(bpydc) (1).
X-ray powder diffraction data show 1 to be isostructural with
Al(OH)(bpdc).7 A full-pattern decomposition of the data was
performed through a Pawley refinement using the Al(OH)(bpdc)
unit cell parameters as a starting point, resulting in refined
orthorhombic unit cell parameters of a ) 23.59(10) Å, b ) 6.91(3)
Å, and c ) 19.84(8) Å. Based upon the refinement, it is clear that
Al(OH)(bpydc) crystallizes as an sra net with a rod-shaped
secondary building unit in an extended MIL-53 structure. A crystal
model of the structure was built by replacing the biphenyl moiety
of Al(OH)(bpdc) with bipyridine (see Figure 1). Here, one-
dimensi nal chains of hydroxide-bridged, octahedrally coordinated
Al3+ cations are linked via bpydc2- ligands to give a three-
dimensional framework with rhombic channels running along the
b axis. Note that the pyridine rings should have only a small energy
barrier associated with rotation away from the coplanar configu-
ration depicted, thereby enabling insertion of up to one metal center
per bpy unit.
NMR spectroscopy was employed to confirm the bulk composi-
tion of 1 (see Supporting Information, Figures S5-S7). As in the
activated form of MIL-53,8 the 1H MAS NMR spectrum exhibits
two broad peaks, attributable to the aromatic and bridging hydroxide
protons. The six sharp resonances in the 13C cross-polarization MAS
NMR spectrum confirm the presence of bpydc2- in the structure.
Most importantly, the 27Al MAS NMR spectrum shows a solitary
† University of California-Berkeley.
‡ University of California-Los Angeles.
§ The University of Adelaide.
Figure 1. Synthesis and representative structure of Al(OH)(bpydc) (1,
MOF-253), with subsequent insertion of PdCl2 into open bpy ligand sites.
Orange octahedra represent Al atoms, while yellow, green, red, blue, and
gray spheres represent Pd, Cl, O, N, and C atoms, respectively; H atoms
are omitted for clarity.
Published on Web 09/17/2010
10.1021/ja106935d © 2010 American Chemical Society14382 9 J. AM. CHEM. SOC. 2010, 132, 14382–14384
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Several classical ring construction routes are depicted in Figure 1.24. The Kröhnke 
condensation88,89 involves a reaction between the N-heteropyridinium salt 41 and the enone 42 
in the presence of ammonium source (route A). Similarly, the condensation of the pyridyl 
disubstituted 1,5-diketone 44 in the presence of ammonium acetate gives the terpyridine 43 
(route B).90,91 In Jameson synthesis92, condensation of the dithioacetal 45 with the enolate 46 
(route C) affords 4′-methylthio substituted terpyridines.  
 
Figure 1.24. Classical synthetic routes to the 2,2′:6′,2′′-terpyridine derivatives via ring 
construction. 
 
Sasaki-Kröhnke synthesis93 is based on the diketone intermediate 47 which is converted to the 
pyridinium iodide 48 (Figure 1.24, route D). Subsequent condensation with the α,β-
unsaturated aldehyde 49 provides the terpyridine 43. Many of these routes give moderate 
yields, and complicated purification is often required. 
 
Figure 1.25. Palladium catalyzed cross-coupling routes to 2,2′:6′,2′′-terpyridine derivatives. 
 
The palladium catalyzed cross-coupling approach is a convenient and efficient 
strategy, providing access to various substituted terpyridines in good yields. 
The palladium catalyzed Stille coupling reaction between the 2,6-dihalosubstituted 
pyridine 50 and the stannane 5194-96 provides terpyridine in good to high yields. Similarly, the 
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reaction of the 2,6-bis(trimethylstannyl)pyridine 53 with the 2-bromopyridine 54 proved to be 
efficient.97 Negishi coupling reaction between the organozinc derivative 55 and the 2,6-
dihalosubstituted pyridine 5 also leads to various terpy derivatives in acceptable yields and 
facile purification.98,99 
Many other synthetic strategies are reported and reviewed in more detail 
elsewhere.85,86 
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Chapter 2. Linear Bilateral Extended 2,2′:6′,2′′-Terpyridine Ligands: 
Topological Tridentate Analogs of Bidentate 5,5′-Disubstituted 2,2′-
Bipyridines 
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2.1. Introduction 
 
De novo design and synthesis of functional supramolecular architectures benefit from 
ready access to components with well-defined assembly geometries.1,2 A mainstay 
component3 of supramolecular and materials chemistry, 2,2′:6′,2′′-terpyridine4 (terpy) ligands 
form coordination complexes with various metals and have photophysical and 
electrochemical properties suitable for supramolecular chemistry,5 nanotechnology,6 solar 
cells,7 catalysis,8 antitumor,9 and antibacterial10 research. A vast range of accessible terpy 
derivatives incorporate into geometrically well-defined supramolecular assemblies;4,11 and, 
multi-component terpy assemblies, such as metal-organic frameworks (MOFs)12 and metal-
organic polyhedra (MOPs),13 reveal properties not found in the simple sum of the parts. As 
such, there is a clear need for building blocks to address under-represented design geometries. 
Specifically, this chapter addresses the synthesis and characterization of terpy derivatives 
mimicking the linear geometry of 5,5′-functionalized 2,2′-bipyridine (bipy in which sites for 
skeletal substitution are perpendicular to the metal coordination vector (Figure 2.1, example 
a)).14 Such ligands would allow the introduction of terpy into “linear” molecular assemblies – 
a complement to the “stub”, “W”, “V”, and “C” motifs stemming from substituents at 
positions 4′, 4/4′′, 5/5′′, and 6/6′′ with angles relative to the coordination vector of 180°, 120°, 
60°, and 0°, respectively (Figure 1, example b).  
 
Figure 2.1. Substitution sites for a) 2,2&-bipyridine, and b) 2,2&:6&,2&&-terpyridine. c) Linear 
bilateral sites (red arrows)15 for 2,2&:6&,2&&-terpyridine fused to five-membered rings. 
 
Terpy based ligands form kinetically stable 2:1 ligand-to-metal complexes with Ru2+, 
Os2+, and Co3+, which can easily be modified chemically and purified chromatographically. 
Several examples include synthesis of Borromean link precursors,16 metal-organic 
dendrimers17 and molecular grids.18 On the other hand, terpy based ligands can also form 
kinetically labile complexes suitable for the construction of thermodynamically-driven 
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assemblies. Introduction of tridentate and bidentate structural units into one ligand has 
resulted in bifunctional molecular strings where terpy and 1,10-phenanthroline, connected 
with a flexible linker, have been used in rotoxane-based molecular machines, switches and 
muscles;19 however, linear rigid-rod analogs with parallel-aligned coordination vectors for 
terpy and bipy would offer desirable design alternatives. 
 
Figure 2.2. Molecular design of linear bilateral extended terpyridines. 
 
Combination of polygons with different numbers of sides brings new topological 
properties to the molecular systems.20,21 Fusion of a five-membered ring to the six-membered 
flanking rings of terpy modifies the substitution pattern (Figure 2.1, example c), specifically 
addressing the linear bilateral geometry mentioned above. This chapter details the practical 
and versatile synthesis of 2,6-bis(2-substituted-furo[2,3-c]pyridine-5-yl)pyridine-based 
ligands (Figure 2.2), as topological bipy mimics, wherein functional components can be 
introduced via a convergent modular strategy. Complexation of these ligands with 
octahedrally coordinating metal ions (Fe2+, Ru2+, and Zn2+) gives access to terpy-based 
molecular “crossings” and “corners” that are potential building blocks in supramolecular 
chemistry. The structure and properties of these ligands are described. 
 
2.2. Synthesis of Linear Bilateral Extended Terpyridine Ligands 
 
2.2.1. Retrosynthesis 
 
To access terpyridine derivatives 56 with fused five-membered rings at the flanking 
pyridines, one has to consider a reliable synthetic procedure where different substituents can 
be introduced easily. It was decided to follow the retrosynthesis proposed by Jui-Chang Tseng 
(Scheme 2.1). The general structure of linear terpyridine 56 leads to the opening of fused five-
membered rings at a heteroatom Y, giving a disubstituted ethynyl derivative 57. This could be 
N
N
N OO N N
R
NN
R
Tridentate BidentateBidentate
N
N
N OO N N
RR
Tridentate Bidentate
N
N
N OO
R
Tridentate
R
 28 
prepared using Sonogashira coupling22 between dihalide 58 and acetylene 59. Appropriate 
protection of terpyridine 60 with ortho-directing groups at the 5- and 5&&- positions would 
enable ortho-metalation,23 and subsequent addition of a halide electrophile would lead to 
compound 58. 
Scheme 2.1. Retrosynthesis of Linear Terpyridine 56 
 
This strategy suggests an intermediate terpyridine 61 possessing YH substituents in 
the 5- and 5&&- positions. If heteroatom Y represents oxygen, then 61 has to be 5,5&&-hydroxy-
2,2&:6&,2&&-terpyridine, thus leading to 2,6-bis(2-substituted-furo[2,3-c]pyridine-5-yl)pyridines 
as a new class of target ligands. 
 
2.2.2.  Synthesis of the Terpy Core 
 
The pursuit of 2,6-bis(2-substituted-furo[2,3-c]pyridine-5-yl)-pyridine-based ligands 
motivated the development of an efficient chromatography-free synthesis  of the key 
intermediate 4,4&&-diiodo-5,5&&-bis(methoxy-methoxy)-2,2&:6&,2&&-terpyridine (69). It was 
decided to follow the route by Jui-Chang Tseng (Scheme 2.2) which was further upscaled and 
optimized to avoid chromatographic purification. The route to 69 follows a Stille24 cross-
coupling strategy via 63 and 65. Regioselective lithiation25 of commercially available 2,5-
dibromopyridine (62) with n-butyllithium and subsequent addition of 2-methoxy-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane gave 5-borylated pyridine 6326 in good yield. The precursor 
of the central ring, 2,6-bis(trimethylstannyl)pyridine (65), was synthesized in nucleophilic 
stannylation of 2,6-dichloropyridine (64) with freshly prepared NaSnMe3 in good yield.27,28 
Terpy 66 was prepared by Stille coupling between bromide 63 and bisstannane 65 according 
to the procedure reported by Schlüter.26 Oxidation/hydroxydeboronation29 of 66 resulted in 
5,5′′-dihydroxyterpyridine 67 in excellent yield.30 These reactions were performed routinely 
on a 40 g to 90 g scale and have the potential for further scale-up. Subsequent deprotonation 
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of hydroxy groups with NaH and treatment with MOMCl (prepared in situ)31 afforded terpy 
68, with ortho-directing groups at  the 5,5′′-positions. 
Scheme 2.2. Synthesis of 4,4& &-Diiodo-5,5& &-bis(methoxymethoxy)-2,2&:6& ,2& &-terpyridine 
(69) 
 
(a) n-BuLi, Et2O, –78 °C, 3 h, then B-methoxypinacolborane, –78 °C to rt, 12 h, 83%; (b) Na, 
Me3SnCl, DME, –15 °C, then 64, –15 °C to rt, 18 h, 84%; (c) 5 mol% Pd(PPh3)4, toluene, reflux, 24 h, 
56%; (d) 30% H2O2, aq. NaOH, THF, rt, 18 h, 96%; (e) 60% NaH, THF, DMF, 0 °C, then 
MOMCl/MeOAc31, 0 °C to rt, 12 h, 96%; (f) 2.2 eq. n-BuLi, TMEDA, THF, –78 °C, 1 h, then 2.2 eq. 
I2, –78 °C to rt, 50%. 
Regioselective ortho-lithiation32 with n-BuLi in the presence of TMEDA and 
subsequent quenching with iodine gave the desired diiodo-terpy 69. During iodine addition, a 
thick precipitate formed complicating both stirring and appropriate cooling. Therefore, an 
optimal yield was obtained when the reaction was run on a 1–3 g scale per batch. 
Straightforward trituration of crude product with hot ethanol afforded pure 69. 
 
2.2.3.  Synthesis of Acetylenes 
 
Sonogashira coupling of alkynes with 69 introduces substituents in the flanking 
positions of linear terpyridine ligands. Introduction of manisyl groups improves solubility and 
facilitates later homologation,33 dictated the use of 2-ethynyl-5-methoxy-1,3-dimethylbenzene 
73.34 Standard Sonogashira coupling conditions of 4-methoxy-2,6-dimethylbromobenzene 
(70)35 with trimethylsilylacetylene was unsatisfactory; therefore, bromide 70 was converted to 
the iodide 71 by lithiation and subsequent quenching with iodine (Scheme 2.3). Under 
optimized conditions for Sonogashira coupling, 71 reacted smoothly with 
trimethylsilylacetylene to produce silyl-protected acetylene 72. Deprotection with KF in 
methanol gave 73 in high yield. 
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Manisyl substituted 5-ethynylbipyridines 77a and 77b were synthesized from known 
bromopyridines 74a33 and 74b36 (Scheme 2.4). Negishi coupling37 with 2,5-dibromopyridine 
(62) afforded bromobipyridines 75a and 75b,36 which coupled well with 
trimethylsilylacetlylene to give 76a and 76b. Subsequent deprotection with KF formed 
ethynylbipyridines 77a and 77b in good yields over 2 steps. 
Scheme 2.3. Synthesis of Acetylene 73 
 
(g) n-BuLi, THF, –78 °C, 30 min, then I2, –78 °C to rt, overnight, 81%; (h) trimethylsilylacetylene, 
5 mol% Pd(PPh3)2Cl2, 10 mol% CuI, toluene, Et3N, reflux, 18 h, 95%; (i) KF, MeOH, 40 °C, 36 h, 
96%. 
Scheme 2.4. Synthesis of 5-Ethynyl-2,2&-bipyridines 77 
 
(j) 1. n-BuLi, THF, –78 °C, 1 h; 2. ZnCl2, THF, –78 to 0 °C, 1 h; 3. 7, 1.5 mol% Pd(PPh3)4, THF, 
reflux, 18 h, 75a: 31%, 75b: 48%36; (k) trimethylsilylacetylene, 10 mol% Pd(PPh3)2Cl2, 5 mol% CuI, 
Et3N, reflux, 18 h; (l) KF, MeOH, rt, 18 h, over 2 steps 77a: 72%, 77b: 76%. 
 
2.2.4.  Ligand Synthesis 
 
Diiodo-terpy 69 proved to be an efficient building block that allowed the incorporation 
of various substituents in the flanking positions by straightforward cross-coupling 
methodology. Simple symmetric terpy derivatives 78a, 78b, and 78e, as well as a mixed 
variation with bipyridine 78f, were prepared by Sonogashira coupling with an excess amount 
(>2 eq) of corresponding alkynes in good to high yields (Table 2.1, entries 1, 2, 5, and 6). Due 
to the instability of 4-ethynylpyridine,38 78d was prepared in a stepwise fashion. First, 
bisethynyl-terpy 78c was synthesized in two steps by Sonogashira coupling between 69 and 
trimethylsilylacetylene following one-pot deprotection of silyl groups in the presence of KF 
(Table 2.1, entry 3). A subsequent coupling reaction with 4-iodopyridine (80) under standard 
conditions (Table 2.1, entry 4) gave 78d in good yield. 
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To incorporate two different substituents into the 4- and 4&&- positions, Sonogashira 
coupling was performed with 1.05 equivalents of acetylene (Table 2.1, entries 7-9), giving a 
statistical mixture of mono- and bis-coupled products 79a-c and 78f-h, respectively, as well 
as unreacted diiodoterpyridine 69. These mixtures were easily separated by column 
chromatography, and pure monosubstituted intermediates 79a-c were obtained. 
Table 2.1. Synthesis of 78 and 79 by Sonogashira Couplinga 
 
entry R= eqe time (h) 
yield (%) 
disubst. monosubst. 69f 
1  2.5 20 78a 95 - - - 
2  2.5 20 78b 92 - - - 
3  5.0 4.5
b/18c 78c 86 - - - 
4  2.1
d 20 78d 88 - - - 
5  7.8 20 78e 85 - - - 
6  2.08 20 78f 90 - - - 
7  1.05 6 78f 18 79a 40 24 
8  1.05 6 78g 17 79b 39 22 
9 
 
1.05 15 78h 15 79c 38 28 
a Reaction conditions: (m) acetylene 59, 5 mol% Pd(PPh3)2Cl2, 10 mol% CuI, THF, Et3N, reflux; (n) 
b trimethylsilylacetylene, 5 mol% Pd(PPh3)2Cl2, 10 mol% CuI, THF, Et3N, reflux, c then the crude 
mixture was subjected to TMS deprotection with KF, MeOH; (o) 1.0 eq 78c, d 4-iodopyridine (80), 10 
mol% Pd(PPh3)2Cl2, 20 mol% CuI, THF, Et3N, reflux. e Unless otherwise stated, equivalents indicated 
for acetylenes 59. f Recovered 69. 
The non-symmetric terpyridine/bipyridine conjugates 79a and 79b were further 
subjected to coupling with manisyl acetylene 73 to give products 81a and 81b in good yields 
(Scheme 2.5). 
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Scheme 2.5. Synthesis of Non-symmetric Ligand Precursors 81 
 
(p) Acetylene 73, 5 mol% Pd(PPh3)2Cl2, 10 mol% CuI, THF, Et3N, reflux, 17-20 h. 
With the library of 4,4′′-disubstituted terpyridines 78a-h, 81a and 81b in hand, 
developing general cyclization conditions to access the 2-substituted-furo[2,3-c]pyridine 
motif became the focus. 
Table 2.2. One-pot MOM-deprotection/Cycloisomerisation of 78 and 81a 
 
entry SM HCl (eq) solvent base eq 
time 
(h) 
yield 
L (%) 
1b 81a 4 MeOH NaOMec 8 20 L4 0 
2b 81a 20 MeOH NaOMec 40 40 L4 5 
3b 81a 42 EtOH NaOMec 85 24 L4 11 
4b 81a 42 THF Cs2CO3 60 24 L4 19 
5 81a 21 DMF Cs2CO3 43 76 L4 97 
6 81b 21 DMF Cs2CO3 43 48 L5 94 
7 78a 5 DMF Cs2CO3 43 48 L1 92 
8 78b 5 DMF Cs2CO3 43 48 L2 95 
9 78d 5 DMF Cs2CO3 43 48 L3 90 
10 78f 10 DMF Cs2CO3 15 72 L6 73 
a 32% aq. HCl was added to the starting material (SM) in the indicated solvent and heated to 80 °C 
until the deprotection of MOM was complete (followed by LC-MS). Then the base was added, and the 
reaction mixture was heated to 90 °C for the corresponding time, unless otherwise stated. b Heated to 
reflux. c 5.4 M NaOMe in MeOH. 
Conditions for acidic deprotection of the MOM group39, followed by base-assisted 
cycloisomerization were tested on the mixed terpyridine/bipyridine 81a to obtain ligand L4. 
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Various reaction conditions, like varying the acid, base, solvent, and reaction time, 
were tried (Table 2.2, entries 1-5). The use of HCl, Cs2CO3, and DMF resulted in the isolation 
of L4 in high yield (Table 2.2, entry 5). These conditions also led to the isolation of L1-L3, 
L5, and L6 (Table 2.2, entries 6-10) in good to high yields. 
 
2.3. Synthesis of Molecular “Crossings” and “Corners” by Metal Complexation 
 
A linear bilateral extended conformation of ligands can be acquired by formation of 
complexes with a 2:1 ligand-to-metal ratio (2:1 complexes). Initially, complexation of simple 
symmetric ligands L1-L3 was tested with divalent octahedral metals (Ru2+, Zn2+, and Fe2+) to 
form molecular “crossings” (Table 2.3). Ruthenium(II) complexes [L1-L32Ru](PF6)2 were 
prepared by heating corresponding ligands with RuCl2(DMSO)4 in ethylene glycol at 
120 °C,4d resulting in a high product yields (Table 2.3, entries 1, 4, and 7).  
Table 2.3. Synthesis of Metal Complexes with Simple Symmetric Ligands L1-L3a 
 
entry   ligand R′=R′′= metal source solvent time (h) 
T 
(°C) product 
Yield 
(%) 
1 L1 
 
RuCl2(DMSO)4 
Ethylene  
glycol 18 120 [L12Ru](PF6)2 92 
2  Zn(OTf)2 THF/MeOH 18 rt [L12Zn](PF6)2 94 
3  Fe(BF4)2•6H2O THF/H2O 18 rt [L12Fe](PF6)2 90 
4 L2 
 
RuCl2(DMSO)4 
Ethylene  
glycol 18 120 [L22Ru](PF6)2 99 
5  Zn(OTf)2 THF/MeOH 18 rt [L22Zn](PF6)2 87 
6  Fe(BF4)2•6H2O THF/H2O 18 rt [L22Fe](PF6)2 90 
7 L3 
 
RuCl2(DMSO)4 
Ethylene  
glycol 18 120 [L32Ru](PF6)2 98 
8  Zn(OTf)2 THF/MeOH 48 50 [L32Zn](PF6)2 94 
9  Fe(BF4)2•6H2O THF/MeCN/H2O 18 rt [L32Fe](PF6)2 80 
a A solution of metal source (0.5 eq) was added to a solution of L1-L3 (1.0 eq) and stirred at the 
indicated temperature. After the stated reaction time, sat. aq. KPF6 was added to induce precipitation 
and the solid was collected by filtration. 
Simple phenyl-substituted ligand L1 and n-hexyl-substituted ligand L2 formed 2:1 
zinc(II) complexes with zinc(II) triflate in a mixture of tetrahydrofuran and methanol at room 
temperature (Table 2.3, entries 2 and 5). As 4-pyridyl-substituted ligand L3 is less soluble, 
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heating at 50 °C was necessary to facilitate complexation, as shown in Table 2.3, entry 8. 
Similarly, Fe2+ complexes were prepared by reacting iron(II) tetrafluoroborate with the 
corresponding ligand in a mixture of tetrahydrofuran and water at room temperature (Table 
2.3, entries 3 and 6), but, in the case of L3, addition of acetonitrile to the reaction mixture was 
necessary to improve solubility and yield (Table 2.3, entry 9). All resulting metal complexes 
were precipitated with aqueous KPF6 and were obtained in good to high yield. The resulting 
complexes were recrystallized with diethyl ether vapor diffusion into acetonitrile or 
dichloromethane solutions. Kinetically stable ruthenium(II) complexes can be additionally 
purified by silica gel column chromatography. 
Analogous to simple ligands L1-L3, mixed terpyridine/bipyridine ligands L4-L6 
reacted with Zn(OTf)2 and Fe(BF4)2⋅6H2O selectively at the terpyridine coordination site 
(Table 2.4), forming either “corner” complexes with L4 and L5, or “crossing” complexes 
with L6 leaving bipyridine coordination site unreacted.  
Table 2.4. Synthesis of Metal Complexes with Mixed Terpyridine/Bipyridine L4-L6 
Ligandsa 
 
entry ligand 
R′= 
R′′= 
metal source solvent time (h) 
T 
(°C) product 
Yield 
(%) 
1 L4 
 
 
Zn(OTf)2 THF/MeOH 18 rt [L42Zn](PF6)2 98 
2  Fe(BF4)2•6H2O THF/H2O 18 rt [L42Fe](PF6)2 97 
3  RuCl2(DMSO)4 
Ethylene 
glycol 48 120 [L42Ru](PF6)2 -
b 
4 L5 
 
 
Zn(OTf)2 THF/H2O 6 rt [L52Zn](PF6)2 99 
5  Fe(BF4)2•6H2O THF/H2O 6 rt [L52Fe](PF6)2 80 
6  RuCl2(DMSO)4 
Ethylene 
glycol 48 120 [L52Ru](PF6)2 -
b 
7 L6 
 
Zn(OTf)2 THF/MeOH 20 rt [L62Zn](PF6)2 92 
8  Fe(BF4)2•6H2O THF/H2O 18 rt [L62Fe](PF6)2 80 
9  RuCl2(DMSO)4 
Ethylene 
glycol 48 120 [L62Ru](PF6)2 -
b 
a A solution of metal source was added to a solution of L4-L6 and stirred at indicated temperature. 
After the stated reaction time, sat. aq. KPF6 was added to induce precipitation and the solid was 
collected by filtration. b Complicated mixture, product could not be isolated. 
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This selectivity can be explained by the kinetic lability of Zn(II) and Fe(II) complexes and the 
thermodynamic stability of the highest order chelate. In contrast, the kinetically inert 
character of Ru(II) led to a complicated mixture of oligomers when L4-L6 were used (Table 
2.4, entries 3, 6, and 9). Isolation of the desired 2:1 complexes was not successful. Therefore, 
an alternative approach towards ruthenium(II) complexes was considered for the mixed ligand 
systems L4-L6. By first introducing ruthenium(II) and then functionalizing the obtained 
complex with bipyridine moieties, the desired “corner” and “crossing” complexes were 
obtained (Scheme 2.6 and 2.7). 
Scheme 2.6. Indirect Synthesis Towards the Ruthenium(II) Complex with Mixed Ligand 
L6 
 
(q) 0.5 eq RuCl2(DMSO)4, ethylene glycol, 120 °C, 48 h, then aq. KPF6; (r) 10 mol% PdCl2(PPh3)2, 
20 mol% CuI, 4.2 eq 77a, DMF, DIPEA, 80 °C, 48 h, then aq. KPF6. 
Diiodoterpyridine 69 was subjected to complexation with 0.5 equivalents of RuCl2(DMSO)4 
by heating in ethylene glycol (Scheme 2.6). Unexpectedly, during the reaction, the MOM 
protecting groups were cleaved, leading to the formation of compound 82. This finding 
obviated harsh acidic conditions39 for MOM-deprotection. Crude complex 82 was used in the 
next step, where Sonogashira cross-coupling with acetylene 77a and in situ ring closure40 
afforded compound [L62Ru](PF6)2 directly; thus, leading to the desired complexes in just two 
steps starting from 69 with a 48% overall yield. 
 The corresponding non-symmetric Ru(II) complexes [L42Ru](PF6)2 and 
[L52Ru](PF6)2 were prepared by a similar synthetic methodology (Scheme 2.7). 
Complexation of manisyl-substituted iodoterpyridine 79c with 0.5 eq of Ru(DMSO)4Cl2 in 
EtOH in one step gave complexed, deprotected, and partially cyclized product 83, which was 
used without further purification in the subsequent reaction. The Sonogashira coupling with 
ethynylbipyridine 77a or 77b and one-pot cyclization gave the desired complexes with 43% 
or 40% isolated yields over two steps, respectively.  
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The 1H NMR spectra of [L42Zn](PF6)2 and [L42Fe](PF6)2 (Figure 2.3, spectra b and 
c) parallel that of [L42Ru](PF6)2 (spectrum d). Given that [L42Ru](PF6)2 is synthesized by 
grafting bipy units on to the preformed terpy ruthenium(II) complex 83, it seems reasonable to 
conclude that Fe(II) and Zn(II) also bind at the terpy unit of L4. 
Scheme 2.7. Indirect Synthesis Towards Ruthenium(II) Complex with Mixed Ligands L4 
and L5 
 
(s) 0.5 eq RuCl2(DMSO)4, EtOH, reflux, 72 h, then aq, KPF6; (t) 5 mol% PdCl2(PPh3)2, 10 mol% 
CuI, 77a or 77b, DMF, Et3N, 90 °C, 24-39 h, then aq. KPF6. 
 
Figure 2.3. 1H NMR (400 MHz, CD2Cl2) for the aromatic regions in L4 and its Zn2+, Fe2+, 
and Ru2+ complexes. 
 
Terpyridine transition metal complexes exhibit characteristic strong upfield shifts of the 
proton o and j signals (d-π* back-donation) and downfield shift for the signal of proton l 
(deshielding due to the conformational change of terpyiridine) compared to the shifts 
N
N NMOMO OMOM
I
79c
O
83
N
N
N OO N N
O
O
N
N
N OO N NO
Ru2+ 2PF6-
[L42Ru](PF6)2 (43% over 2 steps)
N
N NHO
I
N
N N OH
I
Ru2+
2PF6-
O
O
O
O
s
t
[L52Ru](PF6)2 (40% over 2 steps)
R
R
R=
l" b"f"
e,c"
f" b"
e,c,d"
o,j,n,h"
o,j"
n,h,l,m,k"
i"
p"g"
f" b"
g" p"
a,q"
e,c"i" d"
m,k,d"
a,q"
a,q"
p"
o,g,j"n,h,l"
m,k"
i"
[L42Zn](PF6)2"
L4"
[L42Fe](PF6)2"
l,e,c,d"
f"
o,b,j"
p"g"
i"
h,n,m,k"
a,q"
[L42Ru](PF6)2"
a)"
b)"
c)"
d)"
N
N
N OO N N
OO
L4
abc
d
efgh
ij
k
lm
n
o
pq
9.0" 8.5" 8.0" 7.5" 7.0" 6.5"
 37 
observed for the free ligand (Figure 2.3, spectrum a). The proton signals corresponding to the 
bipyridine moiety are less affected. These observations hold true for all Zn2+, Fe2+, and Ru2+ 
complexes in the ligand series L4–L6. 
 
2.4. Structure 
 
Intermediates 78f and 81a give insight into the geometry of the terpyridine core and 
the relationship between its substituents. Single crystals suitable for X-ray crystallography 
were obtained from chloroform-d for non-symmetric terpy 81a (Figure 2.4a) and from a 
mixture of ethyl acetate/hexane for symmetric terpy 78f (Figure 2.4b). In these compounds, 
the terpy core acquires the characteristic transoid-conformation, thus placing 4,4′′-
substituents almost parallel to each other. As usual, the rings of the bipyridyl groups arrange 
themselves such that the N-atoms are on opposite sides of the group axis, thus avoiding short 
H···H contacts within the bipyridyl rings. However, for the symmetric derivative 78f (Figure 
2.4b), the N- and C-atoms in one bipyridyl group are disordered across both possible 
orientations that keep the N-atoms distant from one another. 
a) b)  
Figure 2.4. Molecular structures of a) non-symmetric terpyridine 81a and b) symmetric 
terpyridine 78f (hydrogen atoms removed for clarity). Displacement ellipsoids (50% 
probability level). 
 
Single crystals of the free ligands L1 and L4 suitable for X-ray crystallography were 
obtained by diethyl ether vapor diffusion into a saturated dichloromethane solution. In Figure 
2.5, the molecular structures clearly show the presence of furo[2,3-c]pyridine-5-yl motifs 
linked by the central 2,6-substituted pyridine ring, thus forming the desired ligand architecture. 
The usual conformation of free terpyridine has a “Λ-shaped” structure with the flanking 
substituents placed almost perpendicular to each other, as shown on the example of L1 
(Figure 2.5a). One arm of the mixed ligand L4 consists of furo[2,3-c]pyridine-5-yl, bipyridyl 
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and manisyl groups in a linear disposition and the second arm is the 2-manisyl-furo[2,3-
c]pyridine-5-yl unit (Figure 2.5b). The manisyl rings in L4 adopt a clinal conformation to the 
mean plane of the ligand, in contrast to the periplanar conformation of the simple phenyl 
substituents of L1. This deviation from planarity seen in crystal structure of L4, correlates 
with the much better solubility of the manisyl substituted ligands L4-L6 in common organic 
solvents. 
a) b)  
Figure 2.5. Molecular structures of a) phenyl substituted ligand L1 b) mixed 
bipyridine/terpyridine ligand L4 (hydrogen atoms removed for clarity). Displacement 
ellipsoids (50% probability level). 
 
 
a) b) c)  
Figure 2.6. The switching of L1 conformation from “Λ-shaped” to the “linear bilateral” and 
the molecular structures of a) [L12Zn](PF6)2; b) [L12Ru](PF6)2; c) [L12Fe](PF6)2 (hydrogen 
atoms, PF6- and solvent molecules removed for clarity). Displacement ellipsoids (50% 
probability level). 
 
The complexation of linear terpy ligands with metal ions preferring octahedral 
geometry transforms the overall ligand conformation from “Λ-shaped” to a “linear bilateral” 
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one, as illustrated by the molecular structures of the Fe2+, Ru2+, and Zn2+ complexes with L1 
depicted in Figure 2.6. Crystals for complexes [L12Zn](PF6)2, [L12Ru](PF6)2, and 
[L12Fe](PF6)2 were obtained by diffusion of diethyl ether vapor into the corresponding 
acetonitrile solutions. These crystal structures possess triclinic symmetry and belong to space 
group P-1. In each case, the asymmetric unit consists of one cation, two PF6- anions, and a 
cavity situated about a center of inversion containing disordered solvent molecules. The three 
structures are essentially isostructural except that the contents of the solvent cavities may 
differ. The C(2)-N(2)-C(2) bite angle in these complexes increases in the order Fe2+ < Ru2+ < 
Zn2+ (atom numbers are defined in the sketch in Table 2.5). 
Table 5. Selected Bite Angles and Bond Lengths of L1 Metal Complexes 
  
 [L12Fe](PF6)2 [L12Ru](PF6)2 [L12Zn](PF6)2 
C(2)-N(2)-C(2) (°)a 142.1(3) 146.2(4) 150.1(2) 
N(2)-M-C(2) (°)b 92.8(1) 89.9(2) 87.13(6) 
M-N(1) (Å)b 1.971(3) 2.061(5) 2.183(2) 
M-N(2) (Å)b 1.882(3) 1.983(4) 2.080(2) 
a Average of two such parameters in the molecule. b Average of four such parameters in the 
molecule. 
For an ideally “linear” ligand topology overall, this angle should be ∼160°. The ligand 
in the zinc complex therefore has an almost “linear” topology, while in the iron complex it 
has a slightly more bent character. This trend correlates with the metal-to-nitrogen bond 
lengths, although that is not necessarily intuitive. An increase in the M–N2 distance would 
tend to decrease the bite angle, whereas increases in the M–N1 distances would open it. 
 
2.5. Photophysical Properties 
 
The UV/Vis spectra (Table 2.6 and Figure 2.7) of the phenyl and 4-pyridyl substituted ligands 
L1 and L3 display absorption maximum at ∼300 nm in dichloromethane, while the UV/Vis 
spectrum of the n-hexyl-substituted ligand L2 displays an absorption maximum at 239 nm 
and less pronounced transitions at ∼300 nm. The introduction of bipyridyl groups in L4, L5, 
and L6 leads to a ∼36 nm bathochromic shift in the absorption maxima. These absorptions 
can be attributed to π-π* transitions. The simple symmetric ligands L1 and L2 show 
structured emission bands with maxima at 341 and 338 nm, respectively, and show medium 
quantum yields (∼0.30). The ligands L1 and L2 display relatively short fluorescence lifetimes 
N1
N2
N1 OO M1
2
3
 40 
(2.96 and 1.91 ns, respectively). The emission spectrum of 4-pyridyl derivative L3 is much 
less featured than those of L1 and L2. Its emission maximum, at 374 nm, also shows a 
bathochromic shift relative to L1 and L2. Its quantum yield (0.14) is also significantly lower; 
however, the fluorescence lifetime (4.47 ns) is slightly longer compared to L1 and L2. 
 
Figure 2.7. Emission and absorption spectra of ligands L1-L6 in CH2Cl2 solution. 
 
Table 2.6. Absorption and Emission Maxima, Molar Absorptivity Values (log ε), 
Quantum Yields (φ f), and Lifetimes (τ f) for Free Ligands L1-L6 
 UV/Visa Fluorescence (solution)a,b (powder)c 
 λabs (nm) log ε (log(cm-1 mol-1 L)) λex (nm) λem (nm) φf τf (ns) λem (nm) φf 
L1 261, 300, 318 4.74, 4.84, 4.68 300 341 0.27 2.96 451 0.38 
L2 239, 287, 300 5.12, 4.55, 4.56 287 338 0.30 1.91 350 0.11 
L3 270, 287, 300 4.76, 4.78, 4.82 300 374 0.14 4.47 517 0.42 
L4 260, 338 4.60, 4.73 338 424 0.58 1.53 419 0.29 
L5 258, 336 4.69, 4.71 336 364, 384 0.19 2.58 461 0.13 
L6 264, 338 4.60, 5.07 338 426 0.62 1.53 443 0.09 
a All values were measured in CH2Cl2. Maximum values for λabs, λem and log ε are highlighted with 
bold. b PPO in cyclohexane (φf = 0.94) was used as the standard.43 c All powder samples were 
measured with an integrating sphere. 
The position of a manisyl group relative to the nitrogen atom strongly influences the 
emissive properties of bipy and terpy derivatives.33 This observation is true for the mixed L4, 
L5, and L6 ligands (Table 2.6 and Figure 2.7); when manisyl groups are placed at the β-
position of the bipyridyl groups, as for L4 and L6, broad emission bands at ∼435 nm and high 
quantum yields (∼0.60) are observed, while α-substituted analogue L5 has structured 
emission band with maximum at 384 nm and relatively low quantum yield (0.19). The 
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compounds L4, L5, and L6 display short lifetimes (1.53 ns, 2.58 ns, and 1.53 ns, 
respectively). 
The solid-state (powder) emission spectra and quantum yields for ligands L1-L6 are 
broad and featureless. Ligands L1 and L3 exhibit significantly higher quantum yields in the 
solid state (Table 2.6) than in solution (an increase of 0.27 to 0.38 and an increase of 0.14 to 
0.42, respectively), as well as significantly red-shifted emission spectra (Δ110 nm and Δ143 
nm, respectively). This suggests possible J-aggregate formation in the powder, with the 
fluorescence arising from exciton transitions. In contrast, the emission maximum of L2 in 
powder is red-shifted only by 12 nm compared to the solution emission maximum, and the 
quantum yield decreases from 0.30 to 0.11. The mixed ligand L5 shows a large bathochromic 
shift (Δ77 nm) but a lower quantum yield compared to that measured in solution. The solid-
state quantum yields are decreased for the mixed ligands L4 and L6 as well, but emission 
maxima are less affected. 
The absorption spectra of zinc(II), iron(II), and ruthenium(II) complexes with L1-L6 
(Table 2.7, Figures 2.8 and 2.9) display ligand centered (LC) transitions that are red-shifted 
by ∼10-20 nm and of higher molar extinction coefficients relative to the parent ligands (Table 
2.6). A sharp, intense band at ∼330 nm appears for the metal complexes compared to the free 
ligands (Figures 2.8 and 2.9). Complexes with iron(II) and ruthenium(II) show characteristic 
lower energy bands from 360 to 600 nm and can be attributed to MLCT transitions.41 
The MLCT bands of the iron(II) and ruthenium(II) complexes with L1-L6 are non-
luminescent at room temperature. However, excitation at the LC bands shows weak but 
detectable fluorescence (Table 2.7), possibly arising from an intraligand charge transfer state 
(ILCT).42 The zinc(II) complexes exhibit a fluorescence comparable to that of parent ligands 
(Table 2.6 and 2.7), except the Zn(II) complex of n-hexyl-substituted L2. This complex has 
much higher quantum yield (0.63) than the free ligand (0.30). 
The emission maxima of Zn(II), Fe(II), and Ru(II) complexes with L1, L2, and L4-L6 
ligands are red-shifted relative to those of the free ligands (Figures 2.8 and 2.9). However, 
metal complexes of 4-pyridyl-substituted L3 show hypsochromic shift of emission maxima 
by ∼20 nm, with respect to that of free ligand (Figure 2.8c). 
The fluorescence lifetimes of the L1-L4 metal complexes are in the range of 1.06 to 
2.94 ns. The L5 complexes with Zn(II) and Fe(II), and L6 complex with Fe(II) display two 
lifetime values (Table 2.7). 
The iron(II) and ruthenium(II) complexes of L1-L6 do not show any detectible 
luminescence in the solid state (powder). However, zinc(II) complexes are slightly emissive, 
with quantum yields ranging from 0.06 to 0.17, that are significantly lower than those in 
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solution (Table 2.7). The only exception is zinc(II) complex of L3, which shows a slight 
increase in the quantum yield in the solid state compared to that in solution (from 0.11 to 
0.16). This Zn(II) complex also exhibits a significant bathochromic shift (Δ99 nm) in the 
emission spectra of its powder compared to the solution. 
Table 2.7. Absorption and Emission Maxima, Molar Absorptivity Values (log ε), 
Quantum Yields (φ f), and Lifetimes (τ f) for Metal Complexes [L2M](PF6)2 
 UV/Visa Fluorescence (solution)a (powder)e 
L M λabs (nm) 
log ε (log(cm-1 mol-1 
L)) 
λex 
(nm) 
λem 
(nm) φf τf (ns) 
λem 
(nm) φf 
L1
 
Ru 264, 341, 388, 465 4.90, 5.13, 4.60, 4.30 341 368 0.007b 1.74 - - 
Zn 261, 318, 335, 349 4.99, 5.10, 5.09, 5.06 318 385 0.296c 1.85 423 0.10 
Fe 265, 316, 329, 346, 419, 535 
5.00, 5.05, 5.05, 5.12, 4.43, 
4.10 346 365 0.017
b 1.97 - - 
L2
 Ru 250, 329, 369, 462 5.09, 5.05, 4.26, 4.26 329 348, 366 0.001
d 1.37 - - 
Zn 249, 330, 343 5.18, 4.73, 4.80 330 352, 365 0.630b 1.63 374 0.11 
Fe 252, 336, 391, 532 5.14, 4.97, 4.11, 4.11 336 348, 370 0.011b 1.82 - - 
L3
 
Ru 290, 325, 339, 394, 464 4.88, 4.77, 4.97, 4.39, 4.20 325 349, 363 0.005b 1.06 - - 
Zn 261, 300, 331, 346 4.99, 5.06, 4.82, 4.92 300 354, 368 0.110c 1.10 453 0.16 
Fe 262, 297, 328, 344, 424, 533 
4.95, 5.03, 4.79, 5.08, 4.28, 
4.06 328 351, 363 0.007
c 1.29 - - 
L4
 
Ru 254, 346, 388, 463 4.94, 5.16, 4.74, 4.37 346 465 0.003c 2.42 - - 
Zn 243, 339 5.01, 5.18 339 487 0.573b 2.94 483 0.17 
Fe 253, 346, 412, 533 4.96, 5.19, 4.43, 4.13 346 441 0.007b 1.75 - - 
L5
 
Ru 252, 339, 388, 465 4.93, 5.12, 4.65, 4.32 339 443 0.001d 2.89 - - 
Zn 248, 349 4.95, 5.17 349 497 0.097d 3.34 (42%), 8.03 (58%) ∼500 0.05 
Fe 245, 345, 411, 534 4.81, 5.00, 4.25, 3.97 345 433 0.002d 2.37 (75%), 7.60 (25%) - - 
L6
 
Ru 260, 354, 396, 470 5.02, 5.33, 4.96, 4.54 354 449 0.009d 2.18 - - 
Zn 260, 353 4.60, 5.07 353 494 0.577d 2.06 (59%), 3.54 (41%) 501 0.06 
Fe 263, 359, 430, 536 4.94, 5.35, 4.64, 4.21 359 452 0.004d 2.25 - - 
a All values were measured in CH2Cl2. Maximum values for λabs, λem and log ε are highlighted with 
bold. b PPO in cyclohexane (φf = 0.94); c DPA in cyclohexane (φf = 1.00); d POPOP in cyclohexane (φf 
=  0.97) were used as the standard. 43 e All powder samples were measured with an integrating sphere. 
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C   
Figure 2.8. Emission and absorption spectra of ligands L1, L2, L3 and their corresponding 
Zn2+, Fe2+, Ru2+ complexes in CH2Cl2 solution. 
 
 
 
Figure 2.9. Emission and absorption spectra of ligands L4, L5, L6 and their corresponding 
Zn2+, Fe2+, Ru2+ complexes in CH2Cl2 solution. 
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2.6. Thixotropic Metal-Organic Gel Based on Ru(II) Complex of L4 
 
Gels are classified as either physical or chemical according to the nature of the 
interactions involved in their formation. Supramolecular gels are typically induced by 
aggregation of highly anisotropic 3D structures in solution which are assembled through non-
covalent interactions such as hydrogen bonds, van der Waals, π-π stacking and ionic 
interactions. The design of metallogelators and incorporation of metals into supramolecular 
gels have received growing attention44; however, to our knowledge, no metal-organic gels 
containing ruthenium have been reported to date. 
In our pursuit towards chiral resolution of the C2 symmetric Ru(II) complex 
[L42Ru](PF6)2, a counter ion metathesis was performed, where achiral PF6- was exchanged 
with an enantiopure D3 symmetric (Δ-TRISPHAT)- anion45 (Figure 2.10). The comparison of 
1H NMR spectra (Figure 2.11) supports the formation of the [L42Ru](Δ-TRISPHAT)2 
diastereomeric ion-pairs. Two sets of NMR signals can be observed in the proton spectrum of 
the Ru(II) complex Δ-TRISPHAT salt if compared to the corresponding PF6- salt. So far, 
separation of both diastereometrs was not successful.  
 
Figure 2.10. Synthesis of Ru(II) complex [L42Ru](Δ-TRISPHAT)2. 
 
However, attempts to separate diastereomers from dichloromethane by recrystallization 
resulted in an unexpected formation of a metal-organic gel (MOG), which exhibits thixotropic 
properties – it undergoes a reversible change from a gel into a liquid by mechanical stress 
(Figure 2.12). This ruthenium complex turned out to be an efficient metalogellator with 
critical gelation concentration 1.13 wt% (4.8 mM) at room temperature (Figure 2.13). At 
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higher concentrations (above 3.7 wt% (16.0 mM)) the gel forms in less than one minute, still 
retaining its thixotropic properties. 
 
Figure 2.11. Comparison of aromatic regions in 1H NMR spectra (400 MHz, CD2Cl2) of L4, 
[L42Ru](PF6)2 and [L42Ru](Δ-TRISPHAT)2. 
 
Figure 2.12. Gelation and thixotropic behaviour of [L42Ru](Δ-TRISPHAT)2 in CH2Cl2. 
 
wt% conc. mM time, min 
3.76 16.1 0.5 
2.93 12.5 3 
1.73 7.4 10 
1.38 5.9 35 
1.15 4.9 1080 
1.13 4.8 2880 
Figure 2.13. Time required for a gel formation vs. [L42Ru](Δ-TRISPHAT)2 conentration 
(wt%) in CH2Cl2 at room temperature. 
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A  B  
Figure 2.14. Cryo-SEM images of [L42Ru](Δ-TRISPHAT)2 in CH2Cl2 (3.76 wt%, 16.1 
mM). A. Sample was applied on a carrier and immediately plunge frozen in liquid ethane; B. 
Sample was applied on a carrier, kept for ~30 sec and then frozen. 
 
Gel morphology was determined by cryo-SEM microscopy (Figure 2.14). A 3D cross-linked 
fibrous structure (diameter of fibers ~30-40 nm) was observed when the gel was shaken to 
form a liquid, then applied on a sample carrier and immediately plunge frozen in liquid ethane. 
However, when the sample was kept on the carrier for gelation time and only then plunge 
frozen, 3D cross-linked surfaces were identified. 
To gain a deeper insight into the structure of the gel and molecular interactions 
associated with its thixotropic properties, small and wide angle X-ray scattering (SAXS and 
WAXS) measurements were performed. However, this Ru(II) complex at gelation 
concentrations strongly absorbs X-ray photons, and it turned out to be opaque to the 
conventional X-ray source. A stronger X-ray source like synchrotron should be considered to 
study these systems. 
Valuable photophysical properties of ruthenium, which have been used in photonics 
and light energy conversion devices7, in combination with the ability to form a metal-organic 
gel and its mechanical stress responsive behavior is a promising combination of properties 
with huge potential in material science.  
 
2.7. Conclusions 
 
The concept of a linear bilateral extended terpyridine was developed by fusing five-
membered rings to the flanking pyridine rings of the terpy ligand, thus mimicking the linear 
geometry of 5,5′-functionalized 2,2′-bipyridine. It was realized synthetically by developing a 
modular synthesis of 2,6-bis(2-substituted-furo[2,3-c]pyridine-5-yl)pyridine based ligands. 
This modular synthesis allowed for the introduction of alkyl, aryl, and heteroaryl 
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functionalities in the flanking positions of these ligands. The molecular “crossings” were 
synthesized by coordinating simple symmetric ligands to divalent metal cations (Fe2+, 
Ru2+and Zn2+) forming 2:1 complexes. In the case of mixed bipyridine/terpyridine ligands, 
zinc(II) and iron(II) selectively form complexes at the terpyridine coordination site. The 
corresponding ruthenium(II) complexes were prepared through an indirect methodology. First, 
unfunctionalized ruthenium(II) terpyridine 2:1 complexes were prepared, then bipyridyl 
groups were introduced through a one-pot Sonogashira coupling with an in situ furan ring 
formation. In this way, the terpy and bipy moieties arrange themselves in a linear rod motif. 
These complexes resemble molecular “crossings” and “corners”, depending on whether 
symmetric or non-symmetric starting materials were used in the reaction. X-ray crystal 
structures of symmetric phenyl substituted analogues showed that a proper “linear bilateral” 
conformation of terpy ligands is acquired by complexation with metal ions, so that flanking 
substituents are spanned relative to each other with an obtuse angle. This angle increases in 
the sequence of Fe2+<Ru2+<Zn2+. The free ligands show high to medium fluorescence 
quantum yields that are significantly quenched by complexation with Fe2+ and Ru2+ ions. The 
zinc(II) complexes still retain a fluorescence efficiency similar to that of their parent ligands. 
The free ligands and their zinc(II) complexes exhibit solid-state emission with moderate to 
medium quantum yields, so could find an application as optoelectronic materials. The Ru(II) 
complex of non-symmetric bipyridine/terpyridine ligand L4 in combination with Δ-
TRISPHAT- counterion forms unusual thixotropic metal-organic gel in dichloromethane. 
This molecular design has potential in supramolecular chemistry giving new 
topological features to terpyridine, which now mimics the linear geometry of 5,5′-
disubstituted 2,2′-bipyridine. Terpyridine based fundamental building blocks with “crossing” 
and “corner” character are new tools in the hands of chemists and could inspire the creation of 
new designed molecular architectures. 
 
 48 
2.8. Experimental Section 
 
2.8.1. Materials and Methods 
 
All reagents and solvents used for reactions were reagent grade and used without further 
purification unless otherwise noted. Anhydrous THF and toluene was supplied from an 
Mbraun solvent purification system. Analytical thin-layer chromatography was performed 
with Macherey–Nagel POLYGRAM SIL N-HR/UV254 or ALOX N/UV254. Flash silica gel 
column chromatography was performed with Merck silica gel 60 (particle size 0.040–0.063 
mm). Flash alumina column chromatography was performed with deactivated (5% water) 
Fluka alumina (particle size 0.05–0.15 mm, pH 7.0±0.5). Melting points were recorded on a 
Büchi B-540 melting point apparatus. For characterization purposes, proton nuclear magnetic 
resonance (1H-NMR) spectra were all recorded on Bruker instruments (AV-300 and ARX-
300 at 300 MHz, AV2- 400 at 400 MHz, and AV-500 at 500 MHz). Chemical shifts are 
reported in ppm relative to CHCl3 (δ 7.26), CD2Cl2 (δ 5.31), CD3CN (δ 1.94) or DMSO-d6 
(2.50). Multiplicity and shape are indicated by one or more of the following abbreviations: s 
(singlet); d (doublet); t (triplet); q (quartet); dd (doublet of doublets); td (triplet of doublets); 
m (multiplet); br (broad). Carbon-13 nuclear magnetic resonance (13C- NMR) spectra were 
recorded on Bruker instruments (ARX-300 at 75 MHz, AV2-400 at 100 MHz, and AV-500 at 
125 MHz). Chemical shifts are reported relative to CDCl3 (δ 77.2), CD2Cl2 (δ 53.8), CD3CN 
(δ 1.3) or DMSO-d6 (δ 39.5). Infrared spectroscopic data were recorded on NaCl plates as 
thin films, as KBr pellets or neat sample on a Perkin Elmer Spectrum One (PE) or Jasco 
FT/IR-4100 spectrophotometer. The intensities are given as follows: s = strong, m = medium, 
and w = weak. An Agilent 8453 UV/Vis spectrophotometer was used to record all UV/Vis 
spectra. Emission spectra and lifetimes (ns) were recorded on an Edinburgh Instruments 
FLS920 spectrometer. Solid-state quantum yields were measured using an integrating sphere 
accessory for FLS920 spectrometer. X-ray structures were carried out by the Laboratorium 
für Computerchemie und Röntgenstructuranalyse of the Institute of Organic Chemistry of the 
University of Zurich using a Nonius KappaCCD diffractometer with MoKα radiation (λ = 
0.71037 Å). 
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2.8.2. Experimental Procedures 
 
2.8.2.1. Synthesis of Terpy Core (69) 
 
2-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (63)26 
 
To a solution of 2,5-dibromopyridine (62) (22.46 g, 94.80 mmol) in Et2O (800 mL) was 
added dropwise a solution of n-BuLi (2.50 M in hexane, 39.80 mL, 99.50 mmol) at –78 °C 
under N2 atmosphere. After addition, the mixture was stirred at –78 °C for 3 h, then a solution 
of 2-methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (15.88 g, 100.5 mmol) in Et2O (20 
mL) was introduced dropwise to the reaction mixture at –78 °C. The reaction was gradually 
warmed up to room temperature and stirred for 12 h, then the solvent was removed under 
reduced pressure. The residue was dissolved in 10% NaOH solution (200 mL) and washed 
with CH2Cl2 (100 mL × 2). The organic layers were discarded and the aqueous phase was 
acidified carefully to pH 1~2 with 32% HCl, then extracted with CH2Cl2 (200 mL × 3). The 
combined organic extracts were dried over MgSO4, filtered and concentrated reduced pressure 
to afford boronic ester 63 (23.66 g, 83%) as a pale white solid. 
Mp 94–95.5 °C (lit. mp 94 °C)26 
1H NMR (400 MHz, CDCl3, δ): 8.67 (dd, J = 0.7, 2.0 Hz, 1H), 7.87 (dd, J = 2.0, 7.9 Hz, 1H), 
7.47 (dd, J = 0.7, 7.9 Hz, 1H), 1.34 (s, 12H). 
13C NMR (100 MHz, CDCl3, δ): 156.1 (d), 145.6 (s), 144.5 (d), 127.7 (d), 84.6 (s), 25.0 (q) 
C-Bpin was not observed in 13C NMR due to line broadening of the short relaxation time and 
the quadrupole moment of 11B (I = 3/2). 
IR (film on NaCl, cm–1): 2978m, 1578s, 1546m, 1455m, 1385s, 1357vs, 1142m, 1103s, 1015m, 
857m, 823m, 742m, 662m. 
MS (ESI) m/z: 284.1 ([M + H]+); 306.1 ([M + Na]+). 
HRMS (ESI) m/z: [M + Na]+ calcd for C11H15NO2BrBNa: 306.0291; found: 306.0284.  
 
2,6-Bis(trimethylstannyl)pyridine (65)28 
 
To a suspension of fresh finely chopped sodium (32.3 g, 1.40 mol, 7.38 eq) in anhydrous 
DME (200 mL) a solution of Me3SnCl (94.5 g, 0.474 mol, 2.50 eq ) in anhydrous DME (100 
mL) was slowly added at –15 °C under N2 atmosphere. After stirring for 3 h at –15 °C, the 
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pistachio green suspension of NaSnMe3 in DME was introduced in 30 min., via a cannula, to 
a solution of 2,6-dichloropyridine (64) (28.07 g, 0.1897 mol, 1.00 eq) in anhydrous DME 
(200 mL) at –15 °C under N2 atmosphere. The dark brown reaction mixture was stirred at –
15 °C for 1 h, then gradually warmed up to room temperature and stirred for 18 h. The solvent 
was removed under reduced pressure, and the residue was treated with Et2O (350 mL). The 
insoluble inorganic salts were filtered off through a plug of Celite (3 cm) and the cake was 
washed with Et2O (300 mL). The combined filtrates were concentrated under reduced 
pressure to afford the crude product as dark brown oil. The crude residue was purified by 
vacuum distillation (0.05 mbar, 80-82 °C) to give 2,6-bis(trimethylstannyl)pyridine (65) 
(64.39 g, 84%) as colorless oil. 
1H NMR (400 MHz, CD2Cl2, δ): 7.38-7.25 (m, 3H), 0.30 (s, with Sn satellites, 2JHSn = 
55.8/53.4 Hz, 18H). 
13C NMR (75 MHz, CD2Cl2, δ): 174.4 (s), 131.5 (d), 130.3 (d), -9.7 (q, with Sn satallites, 
1JCSn=346.9/331.6 Hz). 
 
5,5′′-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,2′:6′,2′′-terpyridine (66)26 
 
To a degassed mixture of boronic ester 63 (99.6 g, 342 mmol, 2.15 eq) and Pd(PPh3)4 (8.97 g, 
7.76 mmol, 4.87 mol%) in toluene (600 mL) a solution of bisstannyl pyridine 65 (64.5 g, 159 
mmol, 1.00 eq) in degassed toluene (250 mL) was added under N2 atmosphere. The reaction 
mixture was heated to reflux for 24 h. The mixture was cooled to 5 °C and the resulting 
precipitate was collected by filtration. The solid was dissolved in CH2Cl2 (600 mL) and 
washed with 10% aqueous KF solution (500 mL × 2). The aqueous phases were extracted 
with CH2Cl2 (200 ml × 2). The combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure to give diboronic ester 66 (42.26 g, 56%) as an off-white 
solid.  
Mp 259.5–260.5 °C (lit. mp 251 °C)26. 
1H NMR (400 MHz, CDCl3, δ): 9.03 (dd, J = 0.9, 1.7 Hz, 2H), 8.59 (dd, J = 0.9, 7.9 Hz, 2H), 
8.51 (d, J = 7.8 Hz, 2H), 8.23 (dd, J = 1.7, 7.9 Hz, 2H), 7.96 (t, J = 7.8 Hz, 1H), 1.39 (s, 24H). 
13C NMR (125 MHz, CDCl3, δ): 158.3 (s) 155.6 (s), 155.2 (d), 143.3 (d), 138.0 (d), 121.9 (d), 
120.4 (d), 84.3 (s), 25.0 (q) C-Bpin was not observed in 13C NMR due to line broadening of 
the short relaxation time and the quadrupole moment of 11B (I = 3/2). 
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IR (film on NaCl, cm–1): 2977m, 1593s, 1547m, 1359vs, 1316m, 1142m, 1107m, 1022m, 
857m, 820m, 765m, 666m.  
MS (ESI) m/z: 486.3 ([M + H]+); 508.3 ([M + Na]+). 
HRMS (ESI) m/z: [M + Na]+ calcd for C27H33N3O4B2Na: 508.2567; found: 508.2561. 
 
5,5′′-Dihydroxy-2,2′:6′,2′′-terpyridine (67)30 
 
Prepared according to the modified procedure of Jui-Chang Tseng. 
 
To a solution of diboronic ester 66 (42.16 g, 86.89 mmol, 1.000 eq) in THF (1.5 L) an 
aqueous solution of NaOH (6.0 M, 41.7 mL, 260 mmol, 3.00 eq) was added. After stirring the 
mixture for 10 min at room temperature, white precipitate formed. Then, to the resulting 
suspension an aqueous solution of H2O2 (30%, 23.6 mL, 226 mmol, 2.60 eq) was added 
dropwise in ∼ 10 min by cooling the mixture with ice-water bath. The reaction mixture was 
allowed to stir at room temperature for 18 h and quenched with 10% Na2S2O3 aqueous 
solution (250 mL). After complete removal of volatile organic solvents under reduced 
pressure, the aqueous layer was acidified with 10% HCl to pH 6–7. The resulting yellow 
precipitate was filtered, washed with H2O (400 mL) and dried under high vacuum at 40 °C for 
24 h to afford the dihydroxy terpyridine 67 (22.19 g, 96%) as a yellowish orange solid. 
Mp 153–154 °C. 
1H NMR (500 MHz; DMSO-d6, δ): 10.26 (s, 2H), 8.45 (d, J = 8.6 Hz, 2H), 8.25 (d, J = 2.7 Hz, 
2H), 8.20 (d, J = 7.8 Hz, 2H), 7.95 (t, J = 7.8 Hz, 1H), 7.34 (dd, J = 8.6, 2.8 Hz, 2H). 
13C NMR (125 MHz, DMSO-d6, δ): 154.8 (s), 154.4 (s), 146.6 (s), 137.9 (d), 137.4 (d), 122.9 
(d), 121.5 (d), 118.4 (d). 
IR (film on NaCl, cm–1): 3093br, 1705m, 1565s, 1537s, 1490m, 1440vs, 1361m, 1283s, 
1221m, 853m, 807m. 
MS (ESI) m/z: 288.1 ([M + Na]+). 
HRMS (ESI) m/z: [M + Na]+ calcd for C15H11N3O2Na: 288.0749; found: 288.0746. 
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5,5′′-Bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (68) 
 
Prepared according to the modified procedure of Jui-Chang Tseng. 
 
To a suspension of NaH (60% in oil, 3.80 g, 99.1 mmol, 3.00 eq) in anhydrous THF (120 mL) 
was added dropwise a solution of dihydroxy terpyridine 67 (8.76 g, 33.0 mmol, 1.00 eq) in 
DMF (40 mL) at 0 °C under N2 atmosphere. After addition, the mixture was allowed to warm 
up and stirred at room temperature for 30 min, then cooled down to 0 °C. To this mixture was 
added slowly a freshly prepared solution of MOMCl in MeOAc, obtained as described in the 
literature from ZnBr2 (3.9 mg, 1.8 mmol, 0.018 mol%) catalyzed reaction of AcCl (8.21 mL, 
115.6 mmol, 3.50 eq) and (MeO)2CH2 (10.23 mL, 115.6 mmol, 3.50 eq)31, at 0 °C under N2 
atmosphere. The reaction mixture was then warmed up to room temperature and stirred for 12 
h. After slowly quenched with H2O (200 mL) at 0 °C, the mixture was extracted with CH2Cl2 
(200 mL × 3). The combined organic layers were dried over MgSO4, filtered and concentrated 
under reduced pressure. The crude product was treated with hexane and collected by filtration. 
The residue was filtered through a short pad of silica gel eluating with hexane/EtOAc/MeOH 
(25:25:1) to afford terpyridine 68 (11.2 g, 96%) as a white solid. 
Mp 75.5–76.5 °C. 
1H NMR (500 MHz, CDCl3, δ): 8.53 (dd, J = 8.8, 0.6 Hz, 2H), 8.47 (dd, J = 2.9, 0.6 Hz, 2H), 
8.31 (d, J = 7.8 Hz, 2H), 7.88 (t, J = 7.8 Hz, 1H), 7.51 (dd, J = 8.7, 2.9 Hz, 2H), 5.26 (s, 4H), 
3.52 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 155.1 (s), 154.0 (s), 150.3 (s), 138.7 (d), 137.8 (d), 123.7 (d), 
121.8 (d), 119.9 (d), 94.8 (t), 56.4 (q). 
IR (film on NaCl, cm–1): 2951w, 2908w, 1562s, 1486m, 1448m, 1283m, 1207m, 1154m, 
1141m, 1077m, 961vs, 933m, 808s, 753m, 636m. 
MS (ESI) m/z: 376.2 ([M + Na]+). 
HRMS (ESI) m/z: [M + Na]+ calcd for C19H19N3O4Na: 376.1273; found: 376.1272. 
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4,4′′-Diiodo-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (69) 
 
Prepared according to the modified procedure of Jui-Chang Tseng. 
 
To a mixture of terpyridine 68 (1.10 g, 3.12 mmol, 1.00 eq) and TMEDA (0.94 mL, 6.24 
mmol, 2.00 eq) in THF (70 mL) was added dropwise a solution of n-BuLi (2.50 M in hexane, 
2.74 mL, 6.85 mmol, 2.20 eq) at –78 °C under N2 atmosphere. The resulting deep blue 
mixture was allowed to stir at –78 °C for 1 h. To the mixture a solution of I2 (1.74 g, 6.86 
mmol, 2.20 eq) in THF (10 mL) was added dropwise in 20 min at –78 °C. The reaction 
mixture was allowed to warm to room temperature, stirred for 18 h and quenched with 
aqueous Na2S2O3 (10%, 50 mL). The organic layer was separated and the aqueous phase was 
extracted with CH2Cl2 (100 mL × 3). The combined organic layers were washed with brine 
and dried over MgSO4, filtered and evaporated under reduced pressure. The residue was 
suspended in EtOH (60 mL), heated to reflux and allowed to cool to room temperature. The 
resulting solid was collected by filtration and washed with EtOH (8 mL × 2) to give diiodo 
terpyridine 69 (0.94 g, 50%) as an off-white solid. 
Mp 212–213 °C. 
1H NMR (500 MHz, CDCl3, δ): 8.98 (s, 2H), 8.38 (s, 2H), 8.32 (d, J = 7.8 Hz, 2H), 7.89 (t, J 
= 7.8 Hz, 1H), 5.36 (s, 4H), 3.58 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 154.0 (s), 153.7 (s), 150.8 (s), 138.1 (d), 135.8 (d), 132.2 (d), 
120.8 (d), 99.5 (s), 95.7 (t), 56.9 (q). 
IR (film on NaCl, cm–1): 2946w, 2905w, 1563m, 1480s, 1443s, 1351m, 1301m, 1265s, 1238m, 
1202m, 1160s, 1037m, 985vs, 899m, 821m. 
MS (ESI) m/z: 627.9 ([M + Na]+). 
HRMS (ESI) m/z: [M + Na]+ calcd for C19H17N3O4I2Na: 627.9206; found: 627.9203. 
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2.8.2.2. Synthesis of Acetylenes 73, 77a and 77b 
 
2-Iodo-5-methoxy-1,3-dimethylbenzene (71) 
 
To a solution of 2-bromo-5-methoxy-1,3-dimethylbenzene (70) (1.00 g, 4.64 mmol, 1.00 eq) 
in anhydrous THF (15 mL) a solution of n-BuLi (2.50 M in hexane, 1.95 mL, 4.87 mmol, 
1.05 eq) was added dropwise under N2 atmosphere at -78 °C over 10 min. The resulting white 
suspension was stirred for 30 min. at -78 °C, then a solution of iodine (1.29 g, 5.10 mmol, 
1.10 eq) in anhydrous THF was added dropwise at -78 °C over 15 min. The reaction mixture 
was allowed to warm up to room temperature and stirred overnight. The solvent was 
evaporated under reduced pressure and the residue was dissolved in CH2Cl2 (50 mL), washed 
with 10% Na2S2O3 aqueous solution (50 mL), water and brine. The organic phase was dried 
over Mg2SO4, filtered and evaporated under reduced pressure. The residue was purified by 
silica gel column chromatography with hexane/ethyl acetate (99:1) to give 2-iodo-5-methoxy-
1,3-dimethylbenzene (71)46 (0.98 g, 81%) as a yellow oil. 
1H NMR (300 MHz, CDCl3, δ): 6.67 (s, 2H), 3.77 (s, 3H), 2.45 (s, 6H). 
13C NMR (75 MHz, CDCl3, δ): 159.3 (s), 143.0 (s), 113.0 (d), 97.2 (s), 55.4 (q), 29.9 (q). 
IR (film on NaCl, cm–1): 2996w, 2952m, 2836m, 1586s, 1464s, 1402w, 1377w, 1317s, 1275w, 
1195m, 1163s, 1075m, 1030w, 1005m, 933w, 853m, 833m, 690w, 609w. 
HRMS (EI) m/z: [M]+ calcd for C9H11O1I: 261.9854; found: 261.9854. 
 
[(4-Methoxy-2,6-dimethylphenyl)ethynyl]trimethylsilane (72) 
 
To a degassed mixture of 2-iodo-5-methoxy-1,3-dimethylbenzene (71) (2.00 g, 7.63 mmol, 
1.00 eq), Pd(PPh3)2Cl2 (267 mg, 0.380 mmol, 5 mol%) and CuI (145 mg, 0.760 mmol, 10 
mol%) in toluene (40 mL) and triethylamine (20 mL) was added a solution of 
trimethylsilylacetylene (1.52 mL, 10.7 mmol, 1.40 eq) in toluene (20 mL) and triethylamine 
(20 mL) at 80 °C. The reaction mixture was heated to reflux for 18 h, allowed to cool to room 
temperature and diluted with CH2Cl2 (100 mL). The mixture was washed with 10% aqueous 
NH4OH, water and brine. The organic phase was dried over MgSO4, filtered and evaporated 
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under reduced pressure. The residue was purified by silica gel column chromatography with 
hexane/ethyl acetate (50:1) to give [(4-methoxy-2,6-dimethylphenyl)ethynyl]trimethylsilane 
(72) (1.68 g, 95%) as a pale yellow oil. 
1H NMR (300 MHz, CDCl3, δ):  6.57 (s, 2H), 3.77 (s, 3H), 2.41 (s, 6H), 0.25 (s, 9H). 
13C NMR (75 MHz, CDCl3, δ): 159.2 (s), 142.6 (s), 115.6 (s), 112.4 (d), 103.1 (s), 101.0 (s), 
55.3 (q), 21.4 (q), 0.4 (q). 
IR (film on NaCl, cm–1): 3000w, 2959s, 2840w, 2147s, 1606s, 1575w, 1481m, 1470m, 1377w, 
1321s, 1284w, 1250m, 1222m, 1194m, 1152s, 1064m, 943w, 862s, 786w, 760m, 698w, 625w. 
HRMS (ESI) m/z: [M + H]+ calcd for C14H21OSi: 233.13562; found: 233.13522. 
 
2-Ethynyl-5-methoxy-1,3-dimethylbenzene (73) 
 
To a solution of [(4-methoxy-2,6-dimethylphenyl)ethynyl]trimethylsilane (72) (1.31 g, 5.64 
mmol, 1.00 eq) in methanol (140 mL) KF (3.27 g, 56.4 mmol, 10.0 eq) was added. The 
reaction mixture was heated to 40 °C for 18 h (followed by GC/MS). After evaporation of 
solvent under reduced pressure, the residue was filtered through a pad of Celite eluting with 
diethyl ether (100 mL). The filtrate was evaporated under reduced pressure and the crude 
product was purified by silica gel column chromatography with hexane/ethyl acetate (95:5) to 
give 2-ethynyl-5-methoxy-1,3-dimethylbenzene (73)34 as a white waxy solid (0.866 g, 96%). 
Mp 42–44 °C. 
1H NMR (300 MHz, CDCl3, δ): 6.59 (s, 2H), 3.78 (s, 3H), 3.42 (s, 1H), 2.43 (s, 6H). 
13C NMR (75 MHz, CDCl3, δ): 159.3 (s) 142.8 (s), 114.5 (s), 112.5 (d), 83.9 (d), 81.5 (s), 
55.3 (q), 21.4 (q). 
IR (film on NaCl, cm–1): 3310s, 3290s, 3001w, 2957m, 2919m, 2840w, 2144w, 2097m, 1606s, 
1582m, 1481m, 1470m, 1443m, 1377w, 1320s, 1206m, 1196m, 1147s, 1062m, 858m, 840m, 
725w, 680w. 
HRMS (ESI) m/z: [M + H]+ calcd for C11H13O: 161.09609; found: 161.09607. 
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5-Bromo-5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridine (75a) 
 
To a solution of 2-bromo-5-(4-methoxy-2,6-dimethylphenyl)pyridine (74a)33 (7.20 g, 24.6 
mmol, 1.00 eq) in anhydrous THF (150 mL) a solution of n-BuLi (2.50 M in hexane, 10.8 mL, 
27.1 mmol, 1.10 eq) was added dropwise under N2 at –78 °C over 15 min. The reaction 
mixture was allowed to stir for 1 h at –78 °C and then a solution of dry ZnCl2 (3.70 g, 27.1 
mmol, 1.10 eq) in anhydrous THF (50 mL) was added via cannula. Upon warming to room 
temperature, the resulting aryl zincate solution was cannulated into a solution of 2,5-
dibromopyridine (62) (6.13 g, 25.9 mmol, 1.05 eq.) and Pd(PPh3)4 (427 mg, 0.370 mmol, 1.5 
mol%) in anhydrous THF (100 mL). The reaction mixture was heated to reflux for 18 h and 
allowed to cool to room temperature. The resulting white precipitate was filtered off, washed 
with THF, and dried under reduced pressure. The dry precipitate was then suspended in a 
mixture of CH2Cl2 and a basic aqueous solution EDTA (basified using an aqueous solution of 
NaHCO3) and stirred until all precipitate dissolve. The organic phase was separated, washed 
with water and brine, dried over MgSO4, and evaporated under reduced pressure to give 5-
bromo-5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridine (75a) (2.84 g, 31%) as a white 
solid.  
Mp 132–134 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.74 (d, J = 2.1 Hz, 1H) 8.47 (s, 1H), 8.44 (d, J = 8.1 Hz, 1H), 
8.36 (d, J = 8.5 Hz, 1H), 7.96 (dd, J = 8.5, 2.3 Hz, 1H), 7.63 (dd, J = 8.1, 2.1 Hz, 1H), 6.71 (s, 
2H), 3.83 (s, 3H), 2.06 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 159.1 (s), 154.7 (s), 153.6 (s), 150.4 (d), 150.2 (d), 139.6 (d), 
138.6 (d), 137.9 (s), 137.2 (s), 130.3 (s), 122.4 (d), 121.2 (s), 120.8 (d), 113.2 (d), 55.3 (q), 
21.3 (q). 
IR (film on NaCl, cm–1): 2954w, 2836w, 1607m, 1539w, 1453vs, 1359w, 1318s, 1275w, 
1193w, 1155s, 1092w, 1075w, 1056w, 1005m, 837m, 738w. 
HRMS (ESI) m/z: [M + H]+ calcd for C19H18BrN2O: 369.05970; found: 369.05953. 
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5-Ethynyl-5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridine (77a) 
 
To a mixture of 5-bromo-5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridine (75a) (2.79 g, 
7.56 mmol, 1.00 eq), CuI (72 mg, 0.38 mmol, 5 mol%) and PdCl2(PPh3)2 (0.530 g, 0.756 
mmol, 10 mol%) in degassed Et3N (150 mL) was added trimethylsilylacetylene (2.12 mL, 
15.1 mmol, 2.00 eq) under N2 atmosphere at 80 °C. The reaction mixture was heated to reflux 
for 19 h, allowed to cool to room temperature and evaporated to dryness under reduced 
pressure. The residue was redissolved in CH2Cl2 (100 mL), washed with 10% aqueous 
NH4OH, water and brine. The organic phase was dried over MgSO4, filtered and evaporated 
under reduces pressure. The crude residue was dissolved in MeOH (100 mL), and to the 
resulting mixture KF (1.32 g, 22.8 mmol, 3.00 eq) was added. The reaction mixture was 
stirred at room temperature for 18 h. The solvent was evaporated under reduced pressure, and 
the residue was filtered through a pad of Celite eluting with CH2Cl2 (100 mL). After 
evaporation of solvent, the crude product was purified by silica gel column chromatography 
with hexane/ethyl acetate (3:1) to give 5-ethynyl-5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridine (77a) (1.72 g, 72%) as an off-white solid. 
Mp 137.5–138.5 °C. 
1H NMR (500 MHz, CDCl3, δ): 8.80 (dd, J = 2.1, 0.8 Hz, 1H), 8.49 (dd, J = 2.2, 0.8 Hz, 1H), 
8.47 (dd, J = 8.1, 0.8 Hz, 1H), 8.43 (dd, J = 8.2, 0.8 Hz, 1H), 7.92 (dd, J = 8.2, 2.1 Hz, 1H), 
7.64 (dd, J = 8.1, 2.2 Hz, 1H), 6.71 (s, 2H), 3.84 (s, 3H), 3.30 (s, 1H), 2.08 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 159.1 (s), 155.5 (s), 153.8 (s), 152.4 (d), 150.3 (d), 140.1 (d), 
138.5 (d), 137.9 (s), 137.2 (s), 130.3 (s), 121.2 (d), 120.3 (d), 119.1 (s), 113.1 (d), 81.4 (d), 
80.9 (s), 55.3 (q), 21.4 (q). 
IR (film on NaCl, cm–1): 3287m, 2955w, 2836w, 2105vw, 1605m, 1589m, 1461vs, 1318s, 
1192m, 1155s, 1074m, 1056m, 844m, 746m. 
MS (ESI) m/z: 315.3 ([M + H]+), 337.3 ([M + Na]+). HRMS (ESI) m/z: [M + Na]+ calcd for 
C21H18N2ONa: 337.1317; found: 337.1317. 
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5-Ethynyl-6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridine (77b) 
 
To a mixture of 5-bromo-6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridine (75b)36 (7.00 g, 
19.0 mmol, 1.00 eq), CuI (0.181 g, 0.948 mmol, 5 mol%) and PdCl2(PPh3)2 (1.33 g, 1.89 
mmol, 10 mol%) in degassed Et3N (150 mL) was added trimethylsilylacetylene (5.33 mL, 
38.0 mmol) under N2 atmosphere at 80 °C. The reaction mixture was heated to reflux for 18 h, 
allowed to cool to room temperature and evaporated to dryness under reduced pressure. The 
residue was redissolved in CH2Cl2 (200 mL), washed with aqueous 10% NH4OH, water and 
brine. The organic phase was dried over MgSO4, filtered and evaporated under reduces 
pressure. The crude residue was dissolved in MeOH (250 mL), and to the resulting mixture 
KF (3.50 g, 22.8 mmol, 3.23 eq) was added. The reaction mixture was stirred at room 
temperature for 18 h. The solvent was evaporated under reduced pressure, and the residue was 
filtered through a pad of Celite eluting with CH2Cl2 (250 mL). After evaporation of solvent, 
the crude product was purified by silica gel column chromatography with hexane/ethyl acetate 
(3:1) to give 5-ethynyl-6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridine (77b) (4.65 g, 
78%) as an off-white solid. 
Mp 123.5–125 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.78 (dd, J = 2.1, 0.8 Hz, 1H) 8.43 (dd, J = 8.2, 0.8 Hz, 1H), 
8.37 (dd, J = 7.6, 1.0 Hz, 1H), 7.87 (t, J = 7.6 Hz, 1H), 7.84 (dd, J = 8.2, 2.1 Hz, 1H), 7.24 
(dd, J = 7.6, 1.1 Hz, 1H), 6.70 (s, 2H), 3.84 (s, 3H), 3.28 (s, 1H), 2.11 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 159.3 (s), 159.1 (s), 155.8 (s), 155.2 (s), 152.2 (d), 140.0 (d), 
137.6 (s), 137.2 (d), 133.6 (s), 125.6 (d), 120.8 (d), 119.2 (d), 119.1 (s), 113.2 (d), 81.3 (d), 
80.9 (s), 55.3 (q), 20.9 (q). 
IR (film on NaCl, cm–1): 3288m, 2954w, 2836w, 2105w, 1606m, 1585m, 1450s, 1321m, 
1192m, 1157vs, 1070m, 858m, 819m, 751m. 
MS (ESI) m/z: 337.2 ([M + Na]+). HRMS (ESI) m/z: [M + Na]+ calcd for C21H18N2ONa: 
337.1317; found: 337.1315. 
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2.8.2.3. Synthesis of Bis(ethynyl)terpyridines 78a-h, 79a-c and 81a,b 
 
5,5′′-Bis(methoxymethoxy)-4,4′′-bis(phenylethynyl)-2,2′:6′,2′′-terpyridine (78a) 
 
To a mixture of diiodoterpyridine 69 (300 mg, 0.496 mmol, 1.00 eq), CuI (9.4 mg, 0.050 
mmol, 10 mol%) and PdCl2(PPh3)2 (17.4 mg, 0.0248 mmol, 5 mol%) in degassed THF/Et3N 
(10 mL/10 mL) was added ethynylbenzene (0.126 mL, 1.24 mmol, 2.50 eq) under N2 
atmosphere at 80 °C. The reaction mixture was heated to reflux for 20 h, allowed to cool to 
room temperature and evaporated to dryness under reduced pressure. The residue was 
redissolved in CH2Cl2 (30 mL), washed with 10% aqueous NH4OH, water and brine. The 
organic phase was dried over MgSO4, filtered and evaporated under reduces pressure. The 
residue was purified by neutral alumina (Brockman III) column chromatography with 
hexane/ethyl acetate (3:1) to give 5,5′′-bis(methoxymethoxy)-4,4′′-bis(phenylethynyl)-
2,2′:6′,2′′-terpyridine (78a) (261 mg, 95 %) as an off-white solid. 
Mp 149–151 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.72 (s, 2H), 8.60 (s, 2H), 8.36 (d, J = 7.8 Hz, 2H), 7.92 (t, J 
= 7.8 Hz, 1H), 7.63 (dd, J = 7.6, 1.7 Hz, 4H), 7.41-7.34 (m, 6H), 5.40 (s, 4H), 3.61 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 154.8 (s), 153.6 (s), 150.3 (s), 137.9 (d), 137.5 (d), 132.0 (d), 
129.1 (d), 128.5 (d), 124.6 (d), 122.7 (s), 120.3 (d), 97.7 (s), 95.9 (t), 83.9 (s), 56.7 (q). 
IR (film on NaCl, cm–1): 2957w, 2906w, 2219w, 1600w, 1573m, 1544w, 1494m, 1484s, 
1457m, 1379m, 1308w, 1268m, 1232w, 1200m, 1155s, 1077m, 982s, 921w, 823w, 757m, 
690w. 
MS (ESI) m/z: 554.3 ([M + H]+); HRMS (ESI) m/z: [M+Na]+ calcd for C35H27N3NaO4: 
576.18938; found: 576.18905. 
 
4,4′′-Bis(1-octynyl-1-yl)-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (78b) 
 
To a mixture of diiodoterpyridine 69 (300 mg, 0.496 mmol, 1.00 eq), CuI (9.4 mg, 0.050 
mmol, 10 mol%) and PdCl2(PPh3)2 (17.4 mg, 0.0248 mmol, 5 mol%) in degassed THF/Et3N 
(10 mL/10 mL) was added 1-octyne (0.182 mL, 1.24 mmol, 2.50 eq) under N2 atmosphere at 
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80 °C. The reaction mixture was heated to reflux for 20 h, allowed to cool to room 
temperature and evaporated to dryness under reduced pressure. The residue was redissolved 
in CH2Cl2 (30 mL), washed with 10% aqueous NH4OH, water and brine. The organic phase 
was dried over MgSO4, filtered and evaporated under reduces pressure. The residue was 
purified by neutral alumina (Brockman III) column chromatography with hexane/ethyl acetate 
(3:1) to give 4,4′′-bis(1-octynyl-1-yl)-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (78b) 
(261 mg, 92 %) as an off-white solid. 
Mp 73–74 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.54 (s, 2H), 8.52 (s, 2H), 8.31 (d, J = 7.8 Hz, 2H), 7.88 (t, J 
= 7.8 Hz, 1H), 5.34 (s, 4H), 3.57 (s, 6H), 2.54 (t, J = 7.1 Hz, 4H), 1.69 (quintet, J = 7.4 Hz, 
4H), 1.51 (quintet, J = 7.0 Hz, 4H), 1.39-1.31 (m, 8H), 0.91 (t, J = 6.8 Hz, 6H). 
13C NMR (100 MHz, CDCl3, δ): 154.8 (s), 153.8 (s), 150.3 (s), 137.8 (d), 137.4 (d), 124.8 (d), 
123.5 (s), 120.3 (d), 99.9 (s), 95.8 (t), 75.2 (s), 56.6 (q), 31.4 (t), 28.7 (t), 28.6 (t), 22.7 (t), 
20.0 (t), 14.2 (q). 
IR (film on NaCl, cm–1): 2931s, 2955s, 2857m, 2235w, 1576m, 1543w, 1485s, 1456s, 1376m, 
1278m, 1193m, 1154s, 1082m, 984s, 924w, 823w. 
MS (ESI) m/z: 570.5 ([M + H]+). HRMS (ESI) m/z: [M+Na]+ calcd for C35H43N3NaO4: 
592.31458; found: 592.31377. 
 
4,4′′-Diethynyl-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (78c) 
 
To a mixture of diiodoterpyridine 69 (908 mg, 1.50 mmol, 1.00 eq), PdCl2(PPh3)2 (53 mg, 
0.075 mmol, 5 mol%) and CuI (18 mg, 0.15 mmol, 10 mol%) in degassed THF/Et3N (35 
mL/30 mL) was added trimethylsilylacetylene (1.1 mL, 7.5 mmol, 5.0 eq) under N2 
atmosphere. The reaction mixture was heated to 80 °C for 4.5 h, filtered through Celite and 
the filter was washed with CH2Cl2 (150 ml). The filtrate was washed with 10% aqueous 
NH4OH, water and brine. The organic phase was dried over MgSO4, filtered and evaporated 
under reduces pressure. The crude residue was dissolved in CH2Cl2/MeOH (40 mL/40 mL) 
and to the resulting mixture KF (348.6 mg, 6.00 mmol) was added. The reaction mixture was 
stirred at room temperature for 18 h. After evaporation of solvents, the residue was treated 
with CH2Cl2 (100 mL) and filtered through a Celite plug (1 cm). The cake was washed with 
CH2Cl2 (100 mL) and the combined organic phase was concentrated in vacuo. The residue 
was purified by neutral alumina (Brockman III) column chromatography with hexane/ethyl 
N
N
N OMOMMOMO
 61 
acetate (3:1) to give 4,4′′-diethynyl-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (78c) 
(516 mg, 86%) as a white solid.  
Mp 167.5–169 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.64 (s, 2H), 8.60 (s, 2H), 8.33 (d, J = 7.8 Hz, 2H), 7.90 (t, J 
= 7.8 Hz, 1H), 5.38 (s, 4H), 3.58 (s, 6H), 3.55 (s, 2H). 
13C NMR (100 MHz, CDCl3, δ): 154.6 (s), 154.2 (s), 150.1 (s), 138.0 (d), 137.1 (d), 125.1 (d), 
121.2 (s), 120.4 (d), 95.6 (t), 85.6 (s), 78.1 (d), 56.7 (q). 
IR (film on NaCl, cm–1): 3179m, 2966w, 2939w, 2909w, 2105m, 1570m, 1488m, 1457m, 
1369m, 1271m, 1204m, 1157m, 1079m, 979vs, 921m, 824m, 614m. 
MS (ESI) m/z: 402.3 ([M + H]+); 424.2 ([M + Na]+). HRMS (ESI) m/z: [M + Na]+ calcd for 
C23H19N3O4Na: 424.1273; found: 424.1273. 
 
5,5′′-Bis(methoxymethoxy)-4,4′′-bis[2-(pyridine-4-yl)ethynyl]-2,2′:6′,2′′-terpyridine 
(78d) 
 
A mixture of bis-ethynyl terpyridine 78c (401 mg, 1.00 mmol, 1.00 eq), 4-iodopyridine (80) 
(431 mg, 2.10 mmol, 2.10 eq), PdCl2(PPh3)2 (70.2 mg, 0.100 mmol, 10 mol%) and CuI (38.2 
mg, 0.200 mmol, 20 mol%) in degassed THF/ Et3N (20 mL/20 mL) was heated to 80 °C for 
20 h under N2 atmosphere. After evaporation of solvents, the residue was redissolved in 
CH2Cl2 (100 mL), washed with 10% aqueous NH4OH, water and brine. The organic phase 
was dried over MgSO4, filtered and evaporated under reduces pressure. The crude product 
was purified by silica gel column chromatography with CH2Cl2/MeOH (gradient 99:1 to 9:1) 
to give 5,5′′-bis(methoxymethoxy)-4,4′′-bis[2-(pyridine-4-yl)ethynyl]-2,2′:6′,2′′-terpyridine 
(78d) (489 mg, 88%) as a white solid.  
Mp 174–175 °C dec. 
1H NMR (500 MHz, CDCl3, δ): 8.68 (d, J = 0.6 Hz, 2H), 8.66-8.64 (m, 6H), 8.36 (d, J = 7.8 
Hz, 2H), 7.94 (t, J = 7.8 Hz, 1H), 7.47-7.46 (m, 4H), 5.40 (s, 4H), 3.60 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 154.5 (s), 153.6 (s), 150.1 (s), 149.8 (d), 137.8 (d), 137.1 (d), 
130.6 (s), 125.6 (d), 124.3 (d), 120.9 (s), 120.4 (d), 95.5 (t), 94.1 (s), 88.0 (s), 56.6 (q). 
IR (film on NaCl, cm–1): 2957w, 2831w, 2219w, 1591s, 1483m, 1456m, 1379m, 1309m, 
1269m, 1201m, 1154s, 1076m, 974vs, 902m, 819s, 753w. 
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MS (ESI) m/z: 556.3 ([M + H]+), 578.3 ([M + Na]+). HRMS (ESI) m/z: [M + Na]+ calcd for 
C33H25N5O4Na: 578.1804; found: 578.1801. 
 
5,5′′-Bis(methoxymethoxy)-4,4′′-bis[2-(pyridine-3-yl)ethynyl]-2,2′:6′,2′′-terpyridine 
(78e) 
 
A mixture of diiodoterpyridine 69 (242 mg, 0.400 mmol, 1.00 eq), 3-ethynylpyridine (981 mg, 
3.12 mmol, 7.80 eq), PdCl2(PPh3)2 (14 mg, 0.040 mmol, 5 mol%) and CuI (7.6 mg, 0.080 
mmol, 10 mol%) in degassed THF/Et3N (40 mL/40 mL) was heated to 80 °C for 20 h under 
N2 atmosphere. After evaporation of solvents, the residue was redissolved in CH2Cl2 (200 
mL), washed with 10% NH4OH aqueous solution, water and brine. The organic phase was 
dried over MgSO4, filtered and evaporated under reduces pressure. The crude product was 
purified by silica gel column chromatography with CH2Cl2/MeOH (gradient 99:1 to 9:1) to 
give 5,5′′-bis(methoxymethoxy)-4,4′′-bis[2-(pyridine-3-yl)ethynyl]-2,2′:6′,2′′-terpyridine 
(78e) (189 mg, 85%) as a white solid. 
Mp 164–165 °C dec. 
1H NMR (400 MHz, CDCl3, δ): 8.86 (d, J = 1.2 Hz, 2H), 8.69 (s, 2H), 8.63 (s, 2H), 8.61 (dd, 
J = 4.9, 1.6 Hz, 2H), 8.36 (d, J = 7.8 Hz, 2H), 7.93 (t, J = 7.9 Hz, 1H), 7.90 (dt, J = 7.9, 1.9 
Hz, 2H), 7.34 (ddd, J = 7.9, 4.9, 0.7 Hz, 2H), 5.40 (s, 4H), 3.60 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 154.7 (s), 153.7 (s), 152.4 (d), 150.2 (s), 149.3 (d), 139.0 (d), 
138.0 (d), 137.2 (d), 124.5 (d), 123.4 (d), 121.7 (s), 120.6 (d), 119.9 (s), 95.7 (t), 94.0 (s), 87.0 
(s), 56.8 (q). 
IR (film on NaCl, cm–1): 2958w, 2831w, 2220w, 1570.8m, 1545.9w, 1486.0s, 1456.5m, 
1408.9w, 1378m, 1308w, 1268w, 1234w, 1200m, 1155s, 1076m, 976vs, 923w, 821w, 703w. 
HRMS (ESI) m/z: [M + H]+ calcd for C33H26N5O4: 556.19793; found: 556.19697. 
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4-Iodo-4′′-{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-5,5′′-
bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (79a) 
 
A mixture of diiodoterpyridine 69 (450 mg, 0.744 mmol, 1.00 eq), 5-ethynyl-5′-(4-methoxy-
2,6-dimethylphenyl)-2,2′-bipyridine (77a) (245 mg, 0.781 mmol, 1.05 eq ), PdCl2(PPh3)2 (26 
mg, 0.037 mmol, 5 mol%) and CuI (14 mg, 0.074 mmol, 10 mol%)  in degassed THF/Et3N 
(15 mL/15 mL) was heated to 80 °C for 6 h under N2 atmosphere. The reaction mixture was 
diluted with CH2Cl2 (50 mL), washed with 10% aqueous NH4OH, water and brine. The 
organic phase was dried over MgSO4, filtered and evaporated under reduces pressure. The 
crude residue was separated by silica gel column chromatography with hexane/ethyl acetate 
(3:1) to give monosubstituted 79a (225 mg, 40%), disubstituted 78f (132 mg, 18%) and 
recovered starting diiodoterpyridine 69 (110 mg, 24%). 
Yellowish amorphous solid, Mp 108–110 °C. 
1H NMR (400 MHz, CDCl3, δ): 9.04 (s, 1H), 8.95 (d, J = 1.3 Hz, 1H), 8.69 (s, 1H), 8.64 (s, 
1H), 8.52 (d, J = 8.2 Hz, 2H), 8.51 (s, 1H), 8.39 (s, 1H), 8.37 (dd, J = 7.9, 0.8 Hz, 1H), 8.34 
(dd, J = 7.8, 0.8 Hz, 1H), 8.08 (dd, J = 8.2, 2.1 Hz, 1H), 7.92 (t, J = 7.8 Hz, 1H), 7.66 (dd, J = 
7.9, 2.2 Hz, 1H), 6.72 (s, 2H), 5.43 (s, 2H), 5.36 (s, 2H), 3.84 (s, 3H), 3.63 (s, 3H), 3.58 (s, 
3H), 2.08 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 159.2 (s), 155.6 (s), 154.8 (s), 154.0 (s), 153.7 (s), 153.7 (s), 
152.2 (d), 150.9 (s), 150.3 (d), 150.2 (s), 139.9 (d), 138.7 (d), 138.0 (d), 137.9 (s), 137.4 (d), 
137.3 (s), 135.8 (d), 132.2 (d), 130.3 (s), 124.5 (d), 121.9 (s), 121.3 (d), 120.7 (d), 120.6 (d), 
120.4 (d), 119.7 (s), 113.2 (d), 99.5 (s), 95.8 (t), 95.7 (t), 94.5 (s), 87.9 (s), 56.9 (q), 56.8 (q), 
55.4 (q), 21.4 (q). 
IR (film on NaCl, cm–1): 2956w, 2832w, 2220w, 1606w, 1569m, 1540m, 1482m, 1463s, 1451s, 
1354w, 1317m, 1267m, 1235s, 1200m, 1155vs, 1084m, 976s, 922w, 845w, 821w, 733m. 
MS (ESI) m/z: 792.3 ([M + H]+); HRMS (ESI) m/z: [M]+ calcd for C40H34IN5O5: 792.16707; 
found: 792.16774. 
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4,4′′-Bis{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-5,5′′-
bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (78f) 
 
A mixture of diiodoterpyridine 69 (908 mg, 1.50 mmol, 1.00 eq), 5-ethynyl-5′-(4-methoxy-
2,6-dimethylphenyl)-2,2′-bipyridine (77a) (981 mg, 3.12 mmol, 2.08 eq), PdCl2(PPh3)2 (53 
mg, 0.075 mmol, 5 mol%) and CuI (29 mg, 0.15 mmol, 10 mol%)  in degassed THF/Et3N (30 
mL/30 mL) was heated to 80 °C for 20 h under N2 atmosphere. The reaction mixture was 
diluted with CH2Cl2 (150 mL), washed with 10% aqueous NH4OH, water and brine. The 
organic phase was dried over MgSO4, filtered and evaporated under reduces pressure. The 
crude residue was separated by silica gel column chromatography with hexane/ethyl acetate 
(2:1) to give 4,4′′-bis{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-
5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (78f) (1.325 g, 90%) as a white solid. 
White crystalline solid, Mp 237–238.5 °C dec. 
1H NMR (400 MHz, CDCl3, δ): 8.95 (d, J = 2.1 Hz, 2H), 8.74 (s, 2H), 8.65 (s, 2H), 8.54 (d, J 
= 8.2 Hz, 2H), 8.53 (d, J = 8.1 Hz, 2H), 8.47 (d, J = 2.2 Hz, 2H), 8.38 (d, J = 7.8 Hz, 2H), 
8.08 (dd, J = 2.1, 8.2 Hz, 2H), 7.94 (t, J = 7.8 Hz, 1H), 7.61 (dd, J = 2.2, 8.1 Hz, 2H), 6.69 (s, 
4H), 5.44 (s, 4H), 3.84 (s, 6H), 3.64 (s, 6H), 2.02 (s, 12H). 
13C NMR (125 MHz, CDCl3, δ): 159.1 (s), 155.7 (s), 154.9 (s), 153.8 (s), 153.7 (s), 152.1 (d), 
150.4 (s), 150.3 (d), 139.9 (d), 138.6 (d), 138.0 (d), 137.9 (s), 137.5 (d), 137.2 (s), 130.3 (s), 
124.4 (d), 121.9 (s), 121.4 (d), 120.6 (d), 120.5 (d), 119.6 (s), 113.1 (d), 95.8 (t), 94.6 (s), 87.8 
(s), 56.8 (q), 55.3 (q), 21.3 (q). 
IR (film on NaCl, cm–1): 2955w, 2833w, 2215vw, 1606m, 1573m, 1482m, 1461vs, 1378m, 
1316m, 1268m, 1195m, 1155vs, 1075m, 976m, 843m, 746m. 
MS (ESI) m/z: 1000.7 ([M + Na]+); HRMS (ESI) m/z: [M + Na]+ calcd for C61H51N7O6Na: 
1000.3799; found: 1000.3798. 
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4-Iodo-4′′-{2-[6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-5,5′′-
bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (79b) 
 
A mixture of diiodoterpyridine 69 (450 mg, 0.744 mmol, 1.00 eq), 5-ethynyl-6′-(4-methoxy-
2,6-dimethylphenyl)-2,2′-bipyridine (77b) (245 mg, 0.781 mmol, 1.05 eq ), PdCl2(PPh3)2 (26 
mg, 0.037 mmol, 5 mol%) and CuI (14 mg, 0.074 mmol, 10 mol%) in degassed THF/Et3N 
(15 mL/15 mL) was heated to 80 °C for 6 h under N2 atmosphere. The reaction mixture was 
diluted with CH2Cl2 (50 mL), washed with 10% aqueous NH4OH, water and brine. The 
organic phase was dried over MgSO4, filtered and evaporated under reduces pressure. The 
crude residue was separated by silica gel column chromatography with hexane/ethyl acetate 
(3:1) to give monosubstituted 79b (230 mg, 39%), disubstituted 78g (126 mg, 17%) and 
recovered starting diiodoterpyridine 69 (100 mg, 22%). 
 
4-iodo-4′′-{2-[6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-5,5′′-
bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (79b) 
White crystalline solid, Mp 166–169 °C. 
1H NMR (400 MHz, CDCl3, δ): 9.04 (s, 1H), 8.93 (dd, J = 2.0, 0.6 Hz, 1H), 8.68 (s, 1H), 8.63 
(s, 1H), 8.51 (dd, J = 8.3, 0.6 Hz, 1H), 8.41 (dd, J = 7.9, 0.9 Hz, 1H), 8.39 (s, 1H), 8.37 (dd, J 
= 7.8, 0.8 Hz, 1H), 8.34 (dd, J = 7.8, 0.9 Hz, 1H), 8.00 (dd, J = 8.3, 2.0 Hz, 1H), 7.92 (t, J = 
7.9 Hz, 1H), 7.89 (t, J = 7.8 Hz, 1H), 7.26 (dd, J = 7.9, 0.9 Hz, 1H), 6.71 (s, 2H), 5.42 (s, 2H), 
5.36 (s, 2H), 3.84 (s, 3H), 3.62 (s, 3H), 3.58 (s, 3H), 2.13 (s, 6H).  
13C NMR (100 MHz, CDCl3, δ): 159.4 (s), 159.1 (s), 156.0 (s), 155.2 (s), 154.7 (s), 154.0 (s), 
153.7 (s), 152.0 (d), 150.9 (s), 150.2 (s), 139.8 (d), 138.1 (d), 137.7 (s), 137.4 (d), 137.2 (d), 
135.8 (d), 133.6 (s), 132.2 (d), 125.7 (d), 124.6 (d), 122.1 (s), 121.0 (d), 120.8 (d), 120.6 (d), 
119.6 (s), 119.4 (d), 113.3 (d), 99.6 (s), 95.9 (t), 95.7 (t), 94.8 (s), 87.7 (s), 56.9 (q), 56.8 (q), 
55.4 (q), 20.9 (q). 
IR (film on NaCl, cm–1): 2957w, 2831w, 2221vw, 1607m, 1568m, 1542m, 1482m, 1451s, 
1387w, 1354w, 1312m, 1266m, 1236w, 1200m, 1156vs, 1084m, 976s, 908m, 820m, 732m. 
HRMS (ESI) m/z: [M + H]+ calcd for C40H35IN5O5: 792.16774 ; found: 792.16789. 
4,4′′-bis{2-[6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-5,5′′-
bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (78g) 
White crystalline solid, Mp 248–249.5 °C dec. 
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1H NMR (400 MHz, CDCl3, δ): 8.92 (d, J = 2.1 Hz, 2H), 8.69 (s, 2H), 8.64 (s, 2H), 8.48 (d, J 
= 8.3 Hz, 2H), 8.38 (d, J = 7.9 Hz, 2H), 8.36 (d, J = 7.8 Hz, 2H), 7.98 (dd, J = 8.3, 2.1 Hz, 
2H), 7.94 (t, J = 7.9 Hz, 1H), 7.82 (t, J = 7.8 Hz, 2H), 7.22 (d, J = 7.6 Hz, 2H), 6.69 (s, 4H), 
5.42 (s, 4H), 3.83 (s, 6H), 3.62 (s, 6H), 2.10 (s, 12H). 
13C NMR (125 MHz, CDCl3, δ): 159.3 (s), 159.1 (s), 156.0 (s), 155.3 (s), 155.0 (s), 153.8 (s), 
152.0 (d), 150.5 (s), 139.6 (d), 138.0 (d), 137.7 (s), 137.5 (d), 137.2 (d), 133.6 (s), 125.6 (d), 
124.4 (d), 122.0 (s), 120.9 (d), 120.6 (d), 119.6 (s), 119.4 (d), 113.2 (d), 95.9 (t), 94.8 (s), 87.6 
(s), 56.8 (q), 55.3 (q), 20.9 (q). 
IR (film on NaCl, cm–1): 2955w, 2831w, 2215vw, 1606m, 1567m, 1490m, 1452s, 1378m, 
1311m, 1266m, 1195m, 1156vs, 1072m, 976m, 819m, 752w. 
MS (ESI) m/z: 1000.5 ([M + Na]+). HRMS (ESI) m/z: [M + Na]+ calcd for C61H51N7O6Na: 
1000.3799; found: 1000.3803. 
 
4-Iodo-4′′-[2-(4-methoxy-2,6-dimethylphenyl)-ethynyl]-5,5′′-bis(methoxymethoxy)-
2,2′:6′,2′′-terpyridine (79c) 
 
To a mixture of diiodoterpyridine 69 (450 mg, 0.744 mmol, 1.00 eq), CuI (14 mg, 0.074 
mmol, 10 mol%) and Pd(PPh3)2Cl2 (26 mg, 0.037 mmol, 5 mol%) in anhydrous THF (15 mL) 
was added a solution of 2-ethynyl-5-methoxy-1,3-dimethylbenzene (73) (125 mg, 0.781 
mmol, 1.05 eq) in degassed Et3N (15 mL) under N2 atmosphere at 80 °C. The reaction 
mixture was heated to reflux for 15 h, allowed to cool to room temperature and diluted with 
CH2Cl2 (100 mL). The mixture was washed with 10% aqueous NH4OH, water and brine. The 
organic phase was dried over MgSO4, filtered and evaporated under reduces pressure. The 
residue was purified by silica gel column chromatography with hexane/ethyl acetate/MTBE 
(2:2:1) to give monosubstituted 79c (179 mg, 38%), disubstituted 78h (81 mg, 15%) and 
recovered starting diiodoterpyridine 69 (126 mg, 28%). 
 
4-iodo-4′′-[2-(4-methoxy-2,6-dimethylphenyl)-ethynyl]-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-
terpyridine (79c) 
White solid, Mp 146.5–147.5 °C. 
N
N NMOMO OMOM
I
O
 67 
1H NMR (400 MHz, CDCl3, δ): 9.06 (s, 1H), 8.65 (s, 1H), 8.55 (s, 1H), 8.37 (s, 1H), 8.35 (d, 
J = 7.8 Hz, 1H), 8.31 (d, J = 7.8 Hz, 1H), 7.90 (t, J = 7.8 Hz, 1H), 6.67 (s, 2H), 5.39 (s, 2H), 
5.35 (s, 2H), 3.82 (s, 3H), 3.58 (s, 3H), 3.57 (s, 3H), 2.60 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 160.0 (s), 154.7 (s), 153.8 (s), 153.7 (s), 153.2 (s), 150.9 (s), 
150.0 (s), 142.9 (s), 138.1 (d), 137.1 (s), 135.8 (d), 132.4 (d), 124.2 (d), 123.7 (s), 120.4 (d), 
114.9 (s), 112.8 (d), 99.4 (s), 96.5 (s), 95.7 (t), 95.6 (t), 90.8 (s), 56.8 (q), 56.7 (q), 55.3 (q), 
21.5 (q). 
IR (film on NaCl, cm–1): 2956w, 2838w, 2208w, 1605m, 1581m, 1569m, 1539m, 1482s, 
1453s, 1354w, 1321s, 1287m, 1269m, 1236w, 1199m, 1156vs, 1083m, 979s, 820m, 738w. 
HRMS (ESI) m/z: [M + H]+ calcd for C30H29IN3O5: 638.11464; found: 638.11406. 
 
4,4′′-bis[2-(4-methoxy-2,6-dimethylphenyl)-ethynyl]-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-
terpyridine (78h) 
White solid, Mp 181.5–182.5 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.65 (s, 2H), 8.57 (s, 2H), 8.38  (d, J = 7.9 Hz, 2H), 7.94 (t, J 
= 7.9 Hz, 1H), 6.62 (s, 4H), 5.39 (s, 4H), 3.82 (s, 6H), 3.58 (s, 6H), 2.53 (s, 12H). 
13C NMR (100 MHz, CDCl3, δ): 159.9 (s), 154.7 (s), 153.3 (s), 150.1 (s), 142.9 (s), 138.1 (d), 
136.9 (d), 124.2 (d), 123.8 (s), 120.5 (d), 115.0 (s), 112.7 (d), 96.6 (s), 95.6 (t), 90.7 (s), 56.7 
(q), 55.3 (q), 21.4 (q). 
IR (film on NaCl, cm–1): 2954w, 2839w, 2206m, 1605m, 1575s, 1539w, 1485m, 1456m, 
1377m, 1321s, 1287m, 1266w, 1196m, 1158vs, 1121w, 1076m, 1059w, 985s, 922w 822m, 
732w. 
HRMS (ESI) m/z: [M + H]+ calcd for C41H40N3O6: 670.29116; found: 670.29092. 
 
4-{2-[5′-(4-Methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-4′′-[2-(4-methoxy-
2,6-dimethylphenyl)-ethynyl]-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (81a) 
 
To a mixture of iodoterpyridine 69 (257 mg, 0.325 mmol, 1.00 eq), Pd(PPh3)2Cl2 (11.4 mg, 
0.016 mmol, 5 mol%) and CuI (6.2 mg, 0.032 mmol, 10 mol%) in degassed THF/Et3N (3 
mL/3 mL) was added a solution of 2-ethynyl-5-methoxy-1,3-dimethylbenzene (73) (57 mg, 
0.36 mmol, 1.1 eq ) in degassed THF/Et3N (3 mL/3 mL) under N2 atmosphere at 75 °C. The 
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reaction mixture was heated to reflux for 20 h, allowed to cool to room temperature and 
diluted with CH2Cl2 (25 mL). The mixture was washed with 10% NH4OH aqueous solution, 
water and brine. The organic phase was dried over MgSO4, filtered and evaporated under 
reduces pressure. The residue was purified by neutral alumina (Brockman III) column 
chromatography with hexane/ethyl acetate (3:1) to give desired product 81a (232 mg, 87%) as 
an off-white solid. 
Mp 177–178.5 °C.  
1H NMR (400 MHz, CDCl3, δ): 8.92 (s, 1H), 8.75 (s, 1H), 8.69 (s, 1H), 8.64 (s, 1H), 8.57 (s, 
1H), 8.55-8.51 (m, 3H), 8.37 (d, J = 7.8 Hz, 2H), 8.04 (d, J = 8.2 Hz, 1H), 7.93 (t, J = 7.8 Hz, 
1H), 7.67 (d, J = 8.1 Hz, 1H), 6.73 (s, 2H), 6.61 (s, 2H), 5.43 (s, 2H), 5.39 (s, 2H), 3.84 (s, 
3H), 3.75 (s, 3H), 3.63 (s, 3H), 3.58 (s, 3H), 2.56 (s, 6H), 2.09 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 159.9 (s), 159.2 (s), 155.6 (s), 154.9 (s), 154.6 (s), 153.8 (s), 
153.6 (s), 153.2 (s), 152.1 (d), 150.4 (d), 150.3 (s), 150.2 (s), 142.8 (s), 139.8 (d), 138.6 (d), 
138.0 (d), 137.9 (s), 137.4 (d), 137.3 (d), 137.1 (s), 130.3 (s), 124.7 (d), 124.1 (d), 123.6 (s), 
121.8 (s), 121.3 (d), 120.4 (d), 120.4 (d), 120.2 (d), 119.7 (s), 114.9 (s), 113.2 (d), 112.8 (d), 
112.7 (s), 96.5 (s), 95.8 (t), 95.5 (t), 94.2 (s), 90.8 (s), 87.9 (s), 56.8 (q), 56.7 (q), 55.4 (q), 
55.3 (q), 21.5 (q), 21.4 (q). 
IR (film on NaCl, cm–1): 2957m, 2837w, 2208w, 1606m, 1575s, 1539w, 1486s, 1463s, 1456s, 
1378m, 1320s, 1270m, 1231w, 1196m, 1157s, 1076m, 1057w, 982s, 924m, 907m, 845m, 
822m, 734m. 
HRMS (ESI) m/z: [M + H]+ calcd for C51H46N5O6: 824.34426; found: 824.34373. 
 
4-{2-[6′-(4-Methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]ethynyl}-4′′-[2-(4-methoxy-
2,6-dimethylphenyl)-ethynyl]-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (81b) 
 
 
To a mixture of iodoterpyridine 69 (131 mg, 0.165 mmol, 1.00 eq), Pd(PPh3)2Cl2 (5.8 mg, 
0.0083 mmol, 5 mol%) and CuI (3.2 mg, 0.017 mmol, 10 mol%) in degassed THF/Et3N (2.5 
mL/2.5 mL) was added a solution of 2-ethynyl-5-methoxy-1,3-dimethylbenzene (73) (34 mg, 
0.22 mmol, 1.3 eq) in degassed THF/Et3N (2.5 mL/2.5 mL) under N2 atmosphere at 75 °C. 
The reaction mixture was heated to reflux for 17 h, allowed to cool to room temperature and 
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diluted with CH2Cl2 (15 mL). The mixture was washed with 10% NH4OH aqueous solution, 
water and brine. The organic phase was dried over MgSO4, filtered and evaporated under 
reduces pressure. The residue was purified by neutral alumina (Brockman III) column 
chromatography with hexane/ethyl acetate (3:1) to give desired product 81b (107 mg, 79%) as 
a white solid. 
Mp 164–166 °C.  
1H NMR (400 MHz, CDCl3, δ): 8.91 (s, 1H), 8.73 (s, 1H), 8.68 (s, 1H), 8.63 (s, 1H), 8.57 (s, 
1H), 8.50 (d, J = 8.2 Hz, 1H), 8.43 (d, J = 8.2 Hz, 1H), 8.37 (d, J = 7.7 Hz, 1H), 7.99-7.87 (m, 
3H), 7.29-7.25 (d, J = 7.1 Hz, 1H), 6.72 (s, 2H), 6.59 (s, 2H), 5.42 (s, 2H), 5.39 (s, 2H), 3.85 
(s, 3H), 3.71 (s, 2H), 3.62 (s, 3H), 3.58 (s, 3H), 2.56 (s, 6H), 2.14 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 159.9 (s), 159.3 (s), 159.1 (s), 155.9 (s), 155.2 (s), 154.7 (s), 
154.6 (s), 153.6 (s), 153.2 (s), 152.0 (d), 150.3 (s), 150.1 (s), 142.8 (s), 139.5 (d), 138.1 (s), 
138.0 (d), 137.6 (s), 137.4 (d), 137.2 (d), 136.9 (d), 133.6 (s), 125.7 (d), 124.6 (d), 124.1 (d), 
123.6 (s), 121.9 (s), 120.8 (d), 120.4 (d), 120.3 (d), 119.6 (s), 119.3 (d), 114.8 (s), 113.2 (d), 
112.8 (d), 96.6 (s), 95.8 (t), 95.5 (t), 94.3 (s), 90.7 (s), 87.7 (s), 56.8 (q), 56.6 (q), 55.3 (q), 
55.2 (q), 21.4 (q), 20.9 (q). 
IR (film on NaCl, cm–1): 2956m, 2837w, 2207w, 1605m, 1575s, 1546w, 1485m, 1455s, 
1377m, 1321s, 1268m, 1233w, 1196m, 1157vs, 1075m, 982s, 925w, 821m, 737w. 
HRMS (ESI) m/z: [M + H]+ calcd for C51H46N5O6: 824.34426; found: 824.34402. 
 
2.8.2.4. Synthesis of Ligands L1-L6 
 
2,6-Bis[2-(phenyl)furo[2,3-c]pyridin-5-yl]pyridine (L1) 
 
To a solution of 5,5′′-bis(methoxymethoxy)-4,4′′-bis(phenylethynyl)-2,2′:6′,2′′-terpyridine 
(78a) (217 mg, 0.391 mmol, 1.00 eq) in DMF (10 mL) was added 32%  aq. HCl (0.19 mL, 2.0 
mmol, 5.0 eq). The reaction mixture was heated to 80 °C for 2 h, then Cs2CO3 (5.47 g, 16.8 
mmol, 43.0 eq) was added portion-wise. The resulting mixture was heated to 90 °C for 48 h. 
Evaporation of DMF resulted in residue that was treated with water (100 ml) and the mixture 
was extracted with CH2Cl2 (100 mL × 4). The combined organic fractions were washed with 
water and brine, dried over MgSO4, filtered and evaporated under reduced pressure. The 
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resulting solid was treated with hexane (20 ml), collected by filtration and washed with Et2O 
(10 ml) to give desired ligand L1 (168 mg, 92%) as an off-white solid. 
Mp 294–295 °C dec.  
1H NMR (400 MHz, CDCl3, δ): 9.02 (s, 2H), 8.98 (s, 2H), 8.48 (d, J = 7.8 Hz, 2H), 7.98 (t, J 
= 7.8 Hz, 1H), 7.97-7.95 (m, 4H), 7.54-7.45 (m, 6H), 7.23 (s, 2H). 
13C NMR (125 MHz, CDCl3, δ): 160.2 (s), 155.3 (s), 152.4 (s), 149.8 (s), 138.2 (d), 137.3 (s), 
132.2 (d), 130.2 (d), 129.4 (s), 129.2 (d), 125.9 (d), 120.8 (d), 113.8 (d), 101.2 (d). 
IR (KBr, cm–1): 2919w, 1606w, 1586m, 1567m, 1448vs, 1424w, 1399m, 1306w, 1154w, 
1019w, 913w, 903w, 894m, 894m, 821m, 767s, 756w, 691m. 
HRMS (ESI) m/z: [M + Na]+ calcd for C31H19N3NaO2: 488.13695; found: 488.13659. 
 
2,6-Bis[2-(hexyl)furo[2,3-c]pyridin-5-yl]pyridine (L2) 
 
To a solution of 4,4′′-bis(1-octynyl-1-yl)-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine 
(78b) (244 mg, 0.429 mmol, 1.00 eq) in DMF (10 mL) was added 32%  aq. HCl (0.21 mL, 
2.0 mmol, 5.0 eq). The reaction mixture was heated to 80 °C for 2 h, then Cs2CO3 (5.99 g, 
18.4 mmol, 43 eq) was added portion-wise. The reaction mixture was heated to 90 °C for 48 h. 
Evaporation of DMF resulted in residue that was treated with water (100 ml) and the mixture 
was extracted with CH2Cl2 (50 mL × 3). The combined organic fractions were washed with 
water and brine, dried over MgSO4, filtered and evaporated under reduced pressure. The 
crude product was purified by neutral alumina (Brockman III) column chromatography with 
hexane/ethyl acetate (3:1) to give desired ligand L2 (196 mg, 95%) as a white solid. 
Mp 86–87 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.82 (s, 2H), 8.78 (s, 2H), 8.40 (d, J = 7.8 Hz, 2H), 7.91 (t, J 
= 7.8 Hz, 1H), 6.52 (s, 2H), 2.82 (t, J = 7.6 Hz, 4H), 1.78 (quintet, J = 7.5 Hz, 4H), 1.43-1.31 
(m, 12H), 0.92-0.88 (m, 6H). 
13C NMR (100 MHz, CDCl3, δ): 164.3 (s), 155.8 (s), 152.5 (s), 149.9 (s), 137.8 (d), 136.9 (s), 
131.8 (d), 120.4 (d), 113.2 (d), 102.2 (d), 31.6 (t), 29.0 (t), 28.7 (t), 27.5 (t), 22.7 (t), 14.2 (q). 
IR (film on NaCl, cm–1): 2933s, 2859m, 1595s, 1567s, 1455s, 1424m, 1399m, 1304s, 1285m, 
1149m, 1072w, 1035w, 949w, 933w, 915m, 897m, 823s, 793w, 744w, 734w, 660m.  
HRMS (ESI) m/z: [M + H]+ calcd for C31H36N3O2: 482.28020; found: 482.28030. 
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2,6-Bis[2-(pyridin-4-yl)furo[2,3-c]pyridin-5-yl]pyridine (L3) 
 
To a solution of 5,5′′-bis(methoxymethoxy)-4,4′′-bis[2-(pyridine-4-yl)ethynyl]-2,2′:6′,2′′-
terpyridine (78d) (117 mg, 0.211 mmol, 1.00 eq) in DMF (6 mL) was added 32%  aq. HCl 
(0.10 mL, 3.2 mmol, 5.0 eq). The reaction mixture was heated to 80 °C for 2 h, then Cs2CO3 
(2.94 g, 9.05 mmol, 43.0 eq) was added portion-wise. The reaction mixture was heated to 
90 °C for 72 h. Evaporation of DMF resulted in residue that was treated with water (40 ml). 
The resulting precipitate was collected by filtration, washed with pentane (15 ml) and Et2O 
(15 ml) to give desired ligand L3 (88 mg, 90%) as an off-white solid. 
Mp 335–336 °C dec. 
1H NMR (500 MHz, CDCl3, δ): 9.04 (s, 2H), 8.95 (d, J = 0.8 Hz, 2H), 8.79 (dd, J = 4.5, 1.6 
Hz, 4H), 8.48 (d, J = 7.8 Hz, 2H), 7.99 (t, J = 7.8 Hz, 1H), 7.81 (dd, J = 4.5, 1.6 Hz, 4H), 7.40 
(d, J = 0.5 Hz, 2H).  
13C NMR (125 MHz, CDCl3, δ): 156.7 (s), 155.6 (s), 152.7 (s), 150.8 (d), 150.7 (s), 138.2 (d), 
136.6 (s), 136.0 (s), 133.3 (d), 120.9 (d), 119.5 (d), 113.9 (d), 104.5 (d). 
IR (KBr, cm–1): 3038w, 2919w, 2853w, 1635w, 1604m, 1568s, 1448s, 1401s, 13101w, 1296w, 
1223w, 1210w, 1156w, 1037w, 993w, 916w, 905m, 895m, 821vs, 810w, 742w, 690w, 650w. 
MS (ESI) m/z: 468.2 ([M + H]+); 490.2 ([M + Na]+); HRMS (ESI) m/z: [M + Na]+ calcd for 
C29H17N5NaO2: 490.12745; found: 490.12704. 
 
2-(4-Methoxy-2,6-dimethylphenyl)-5-(6-{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine (L4) 
 
To a solution of terpyridine 81a (231 mg, 0.281 mmol, 1.00 eq) in DMF (10 mL) was added 
32% aq. HCl (0.58 mL, 5.9 mmol, 21 eq). The reaction mixture was heated to 80 °C for 5 h, 
then Cs2CO3 (3.93 g, 12.1 mmol, 43 eq) was added portion-wise. The reaction mixture was 
heated to 90 °C for 76 h. Evaporation of DMF resulted in residue that was treated with water 
(50 ml) and the mixture was extracted with CH2Cl2 (15 mL × 4). The combined organic 
fractions were washed with water and brine, dried over MgSO4, filtered and evaporated under 
reduced pressure. The crude product was purified by neutral alumina (Brockman III) column 
chromatography with hexane/CH2Cl2/MeOH (50:50:1) to give desired product L4 (200 mg, 
97%) as a white solid.  
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Mp 304–305 °C dec.  
1H NMR (500 MHz, CDCl3, δ): 9.28 (d, J = 2.3 Hz, 1H), 9.03 (s, 1H), 9.01 (s, 1H), 8.97 (s, 
1H), 8.94 (s, 1H), 8.62 (d, J = 8.3 Hz, 1H), 8.56 (d, J = 8.3 Hz, 1H), 8.53 (d, J = 2.2 Hz, 1H), 
8.49 (d, J = 7.8 Hz, 1H), 8.48 (d, J = 7.8 Hz, 1H), 8.37 (dd, J = 8.3, 2.3 Hz, 1H), 7.99 (t, J = 
7.8 Hz, 1H), 7.68 (dd, J = 8.0, 2.2 Hz, 1H), 7.35 (s, 1H), 6.84 (s, 1H), 6.73 (s, 2H), 6.73 (s, 
2H), 3.86 (s, 3H), 3.85 (s, 3H), 2.29 (s, 6H), 2.09 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 160.5 (s), 159.8 (s), 159.1 (s), 156.9 (s), 156.8 (s), 155.7 (s), 
155.6 (s), 153.7 (s), 152.7 (s), 152.4 (s), 150.6 (s), 150.4 (d), 149.8 (s), 146.7 (d), 140.3 (s), 
138.6 (d), 138.1 (d), 138.0 (s), 137.3 (s), 136.8 (s), 136.5 (s), 133.7 (d), 132.8 (d), 132.3 (d), 
130.3 (s), 125.4 (s), 122.1 (s), 121.3 (d), 121.1 (d), 120.7 (d), 120.6 (d), 113.7 (d), 113.6 (d), 
113.3 (d), 113.1 (d), 106.5 (d), 102.7 (d), 55.4 (q), 55.3 (q), 21.4 (q), 21.0 (q). 
IR (KBr, cm–1): 2923w, 1607s, 1570m, 1447s, 1460s, 1402m, 1319m, 1193w, 1154vs, 1063w, 
1012w, 826w, 653w. 
HRMS (ESI) m/z: [M + H]+ calcd for C47H37N5O4: 736.29183; found: 736.29141. 
 
2-(4-Methoxy-2,6-dimethylphenyl)-5-(6-{2-[6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine (L5) 
 
To a solution of terpyridine 81b (51.6 mg, 0.0604 mmol, 1.00 eq) in DMF (2 mL) was added 
32% aq. HCl (0.069 mL, 0.22 mmol, 21 eq). The reaction mixture was heated to 80 °C for 4 h, 
then Cs2CO3 (844 mg, 2.60 mmol, 43.0 eq) was added portion-wise. The reaction mixture was 
heated to 90 °C for 48 h. Evaporation of DMF resulted in residue that was treated with water 
(20 ml) and the mixture was extracted with CH2Cl2 (15 mL × 4). The combined organic 
fractions were washed with water and brine, dried over MgSO4, filtered and evaporated under 
reduced pressure. The crude product was purified by neutral alumina (Brockman III) column 
chromatography with hexane/CH2Cl2/MeOH (50:50:1) to give desired product L5 (43.3 mg, 
94%) as a white solid.  
Mp 300–301 °C dec. 
1H NMR (400 MHz, CDCl3, δ): 9.23 (s, 1H), 8.99 (s, 1H), 8.94 (s, 1H), 8.93 (s, 2H), 8.59 (d, 
J = 8.3 Hz, 1H), 8.47 (s, 1H), 8.47-8.41 (m, 2H), 8.24 (d, J = 8.4 Hz, 1H), 7.96 (t, J = 7.8 Hz, 
1H), 7.89 (t, J = 7.7 Hz, 1H), 7.28-7.26 (m, 2H), 6.82 (s, 1H), 6.72 (s, 4H), 3.85 (s, 3H), 3.85 
(s, 3H), 2.28 (s, 6H), 2.14 (s, 6H). 
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13C NMR (100 MHz, CDCl3, δ): 160.5 (s), 159.4 (s), 159.1 (s), 157.2 (s), 156.9 (s), 156.0 (s), 
155.6 (s), 155.2 (s), 152.7 (s), 152.5 (s), 150.7 (s), 150.2 (s), 146.5 (d), 140.3 (s), 137.9 (d), 
137.7 (s), 137.2 (d), 136.5 (s), 136.4 (s), 133.6 (s), 133.5 (d), 132.8 (d), 132.5 (d), 125.7 (d), 
125.4 (s), 122.3 (s), 121.5 (d), 120.7 (d), 120.5 (d), 119.2 (d), 113.6 (d), 113.5 (d), 113.3 (d), 
113.2 (d), 106.4 (d), 102.5 (d), 55.4 (q), 55.3 (q), 21.0 (q), 20.9 (q). 
IR (KBr, cm–1): 2925w, 1606s, 1568m, 1448vs, 1401w, 1319m, 1195w, 1154s, 1071w, 821w, 
651w. 
HRMS (ESI) m/z: [M + H]+ calcd for C47H37N5O4: 736.29183; found: 736.29186. 
 
2,6-Bis{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]furo[2,3-c]pyridin-5-
yl}pyridine (L6) 
 
To a solution of terpyridine 78f (185 mg, 0.190 mmol, 1.00 eq) in DMF (10 mL) was added 
32% aq. HCl (0.19 mL, 1.9 mmol, 10 eq). The reaction mixture was heated to 80 °C for 4 h, 
then Cs2CO3 (926 mg, 2.84 mmol, 15.0 eq) was added portion-wise. The reaction mixture was 
heated to 90 °C for 72 h. Evaporation of DMF resulted in residue that was treated with water 
(20 ml) and the mixture was extracted with CH2Cl2 (20 mL × 4). The combined organic 
fractions were washed with water and brine, dried over MgSO4, filtered and evaporated under 
reduced pressure. The crude product was treated with acetone and collected by filtration to 
give desired product L6 (123 mg, 73%) as a yellow solid.  
Mp >330 °C dec.  
1H NMR (400 MHz, CDCl3, δ): 9.26 (dd, J = 2.2, 0.7 Hz, 2H), 9.00 (s, 2H), 8.93 (s, 2H), 8.61 
(dd, J = 8.3, 0.7 Hz, 2H), 8.55 (dd, J = 8.0, 0.8 Hz, 2H), 8.53 (dd, J = 2.2, 0.8 Hz, 2H), 8.46 (d, 
J = 7.8 Hz, 2H), 8.34 (dd, J = 8.3, 2.2 Hz, 2H), 7.97 (t, J = 7.8 Hz, 1H), 7.68 (dd, J = 8.0, 2.2 
Hz, 2H), 7.32 (s, 2H), 6.73 (s, 4H), 3.85 (s, 6H), 2.09 (s, 12H). 
13C NMR (125 MHz, CDCl3, δ): 159.2 (s), 156.9 (s), 156.8 (s), 155.6 (s), 153.7 (s), 152.7 (s), 
150.6 (s), 150.4 (d), 146.7 (d), 138.6 (d), 138.1 (d), 138.0 (s), 137.3 (s), 136.4 (s), 133.7 (d) 
132.9 (d), 130.3 (s), 125.4 (s), 121.2 (d), 121.1 (d), 120.7 (d), 113.6 (d), 113.1 (d), 102.6 (d), 
55.3 (q), 21.4 (q). 
IR (film on NaCl, cm–1): 2921w, 1605s, 1570m, 1460vs, 1448s, 1316m, 1274w, 1193w, 
1155vs, 1078w, 1061w, 1012w, 998w, 905w, 844w, 820m, 733w, 648w.  
HRMS (ESI) m/z: [M + 2H]2+ calcd for C57H45N7O4: 445.67610; found: 445.67560. 
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2.8.2.5. Preparation of Zn2+, Fe2+ and Ru2+ Complexes of Ligands L1-L6 
 
Zn[2,6-bis(2-phenylfuro[2,3-c]pyridin-5-yl)pyridine]-2PF6 ([L12Zn](PF6)2) 
 
To a solution of ligand L1 (25.0 mg, 0.0537 mmol, 1.00 eq) in THF (12 mL) a solution of 
Zn(OTf)2 (9.78 mg, 0.0264 mmol, 0.50 eq) in MeOH (2.2 mL) was added dropwise in 5 
minutes at room temperature. The reaction mixture was stirred for 18 h at room temperature. 
To the mixture saturated aq. KPF6 was added and the resulting yellow precipitate was filtered 
over Celite, washed with water, Et2O, hexane and redissolved with acetonitrile. The solvent 
was evaporated to give desired Zn complex ([L12Zn](PF6)2) (32.3 mg, 94%) as a yellow solid. 
Single crystals suitable for X-ray diffraction analysis were obtained by slow vapor diffusion 
of Et2O into an acetonitrile solution of ([L12Zn](PF6)2). 
Mp >370 °C dec.  
1H NMR (500 MHz, CD3CN, δ): 8.84 (s, 2H), 8.81-8.76 (m, 3H), 8.02 (s, 2H), 7.87-7.82 (m, 
4H), 7.48-7.44 (m, 6H), 7.37 (s, 2H). 
13C NMR (125 MHz, CD3CN, δ): 163.7 (s), 153.5 (s), 151.0 (s), 144.9 (d), 142.5 (s), 140.4 (s), 
132.1 (d), 131.7 (d), 129.9 (d), 128.6 (s), 126.6 (d), 123.0 (d), 116.3 (d), 102.0 (d). 
IR (KBr, cm–1): 3116w, 3065w, 1616m, 1583w, 1478w, 1454s, 1425w, 1324m, 1177w, 1021w, 
959w, 842vs, 767w, 687w, 558s. 
HRMS (ESI) m/z: [M]2+ calcd for C62H38N6O4Zn: 497.11175; found: 497.11197. 
 
Fe[2,6-bis(2-phenylfuro[2,3-c]pyridin-5-yl)pyridine]-2PF6 ([L12Fe](PF6)2) 
 
To a solution of ligand L1 (25.0 mg, 0.0537 mmol, 1.00 eq) in THF (12 mL) a solution of 
Fe(BF4)2⋅6H2O (9.06 mg, 0.0269 mmol, 0.500 eq) in water (2.2 mL) was added dropwise in 5 
minutes at room temperature. The dark purple reaction mixture was stirred for 18 h at room 
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temperature. To the mixture saturated aq. KPF6 was added and the resulting dark purple 
precipitate was filtered over Celite, washed with water, Et2O, hexane and redissolved with 
acetonitrile. The solvent was evaporated to give desired Fe complex [L12Fe](PF6)2 (30.8 mg, 
90 %) as a dark purple solid. Single crystals suitable for X-ray diffraction analysis were 
obtained by slow vapor diffusion of Et2O into an acetonitrile solution of [L12Fe](PF6)2. 
Mp >370 °C dec.  
1H NMR (500 MHz, CD3CN, δ): 8.96 (d, J = 8.1 Hz, 2H), 8.80 (t, J = 8.1 Hz, 1H), 8.78 (s, 
2H), 7.78-7.75 (m, 4H), 7.45-7.41 (m, 6H), 7.34 (s, 2H), 7.24 (s, 2H). 
13C NMR (125 MHz, CD3CN, δ): 162.52 (s) 161.1 (s), 152.6 (s), 151.6 (s), 138.8 (d), 138.5 
(s), 136.7 (d), 131.5 (d), 129.6 (d), 128.2 (s), 126.4 (d), 122.6 (d), 116.9 (d), 101.7 (d).  
IR (KBr, cm–1): 3116w, 3086w, 1622m, 1585w, 1564w, 1459s, 1449s, 1320m, 1278w, 1252w, 
1174w, 1020w, 841vs, 766m, 746w, 687m, 558s.  
HRMS (ESI) m/z: [M]2+ calcd for C62H38N6O4Fe: 493.11473; found: 493.11390. 
 
Ru[2,6-bis(2-phenylfuro[2,3-c]pyridin-5-yl)pyridine]-2PF6 ([L12Ru](PF6)2) 
 
A suspension of ligand L1 (25.0 mg, 0.0537 mmol, 1.00 eq) and Ru(DMSO)4Cl2 (13.0 mg, 
0.0269 mmol, 0.500 eq) in ethylene glycol (15 ml) was heated to 120 °C for 18 h. The 
reaction mixture was allowed to cool to room temperature and a saturated aq. KPF6 solution 
was added. The resulting red precipitate was filtered over Celite, washed with water, Et2O, 
hexane and redissolved with acetonitrile. The solvent was evaporated and the residue was 
purified by silica gel column chromatography with acetonitrile/H2O/aq. KPF6 (97:3:0.3), 
reprecipitated with a saturated aq. KPF6 solution and collected by filtration. The red solid was 
washed with water and Et2O to give desired complex [L12Ru](PF6)2 (32.5 mg, 92%) as a 
dark red solid. Single crystals suitable for X-ray diffraction analysis were obtained by slow 
vapor diffusion of Et2O into an acetonitrile solution of [L12Ru](PF6)2. 
Mp >350 °C dec.  
1H NMR (500 MHz, CD3CN, δ): 8.82 (s, 2H), 8.80 (d, J = 8.2 Hz, 2H), 8.50 (t, J = 8.2 Hz, 
1H), 7.83-7.80 (m, 4H), 7.68 (s, 2H), 7.48-7.46 (m, 6H), 7.34 (s, 2H). 
13C NMR (125 MHz, CD3CN, δ): 163.1 (s), 156.8 (s), 152.9 (s), 152.8 (s), 137.9 (s), 137.0 (d), 
136.8 (d), 131.9 (d), 130.2 (d), 128.9 (s), 126.9 (d), 123.2 (d), 117.9 (d), 102.4 (d). 
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IR (KBr, cm–1): 3116w, 3069w, 1621m, 1585w, 1567w, 1485w, 1459s, 1447s, 1385w, 1313w, 
1278w, 1176w, 1020w, 842vs, 767w, 687w, 558s. 
HRMS (ESI) m/z: [M]2+ calcd for C62H38N6O4Ru: 516.10018; found: 516.09979. 
 
Zn[2,6-bis(2-hexylfuro[2,3-c]pyridin-5-yl)pyridine]-PF6 ([L22Zn](PF6)2) 
 
To a solution of ligand L2 (15.0 mg, 0.0311 mmol, 1.00 eq) in THF (3 mL) a solution of 
Zn(OTf)2 (5.66 mg, 0.0156 mmol, 0.500 eq) in MeOH (1.3 mL) was added dropwise in 5 
minutes at room temperature. The reaction mixture was stirred for 18 h at room temperature. 
To the mixture saturated aq. KPF6 was added and the resulting yellow precipitate was filtered 
over Celite, washed with water, Et2O, hexane and redissolved with acetonitrile. The solvent 
was evaporated to give desired Zn complex ([L22Zn](PF6)2) (17.8 mg, 87%) as a yellow solid. 
Recrystallization by slow vapor diffusion of Et2O into a CH2Cl2 solution of ([L22Zn](PF6)2) 
gives yellow needles.  
Mp 257–258 °C dec. 
1H NMR (500 MHz, CD2Cl2, δ): 8.75-8.71 (m, 3H), 8.68 (s, 2H), 7.75 (s, 2H), 6.70 (s, 2H), 
2.74 (t, J = 7.6 Hz, 4H), 1.64 (quintet, J = 7.4 Hz, 4H), 1.29-1.20 (m, 12H), 0.81 (t, J = 6.8 Hz, 
6H). 
13C NMR (125 MHz, CD2Cl2, δ): 169.46 (s), 153.2 (s), 150.6 (s), 144.9 (d), 141.5 (s), 140.3 
(s), 130.7 (d), 122.3 (d), 115.5 (d), 103.2 (d), 31.6 (t), 29.0 (t), 28.9 (t), 27.4 (t), 22.7 (t), 14.1 
(q). 
IR (film on NaCl, cm–1): 3125w, 2931m, 2859w, 1620w, 1587m, 1485w, 1456s, 1429w, 1324s, 
1257w, 1182w, 1158w, 959w, 900w, 841vs, 740w, 665w, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C62H70N6O4Zn: 513.23695; found: 513.23769. 
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Fe[2,6-bis(2-hexylfuro[2,3-c]pyridin-5-yl)pyridine]-PF6 ([L22Fe](PF6)2) 
 
To a solution of ligand L2 (15.0 mg, 0.0311 mmol, 1.00 eq) in THF (3 mL) a solution of 
Fe(BF4)2⋅6H2O (5.26 mg, 0.0156 mmol, 0.500 eq) in water (1.3 mL) was added dropwise in 5 
minutes at room temperature. The dark purple reaction mixture was stirred for 18 h at room 
temperature. To the mixture saturated aq. KPF6 was added and the resulting dark purple 
precipitate was filtered over Celite, washed with water, Et2O, hexane and redissolved with 
acetonitrile. The solvent was evaporated to give desired Fe complex [L22Fe](PF6)2 (18.4 mg, 
90 %) as a dark purple solid. Recrystallization by slow vapor diffusion of Et2O into a CH2Cl2 
solution of [L22Fe](PF6)2 gives dark purple blocks. 
Mp 299–300 °C dec. 
1H NMR (500 MHz, CD2Cl2, δ): 8.87 (d, J = 7.9 Hz, 2H) 8.74 (t, J = 8.0 Hz, 1H), 8.64 (s, 2H), 
7.11 (s, 2H), 6.61 (s, 2H), 2.68 (t, J = 7.6 Hz, 4H), 1.62-1.52 (m, 4H), 1.27-1.17 (m, 12H), 
0.80 (t, J = 6.9 Hz, 6H). 
13C NMR (125 MHz, CD2Cl2, δ):168.3 (s), 161.1 (s), 152.6 (s), 150.8 (s), 138.6 (s), 138.5 (d), 
135.5 (d), 122.0 (d), 116.4 (d), 103.1 (d), 31.6 (t), 28.9 (t), 28.6 (t), 27.4 (t), 22.7 (t), 14.0 (q). 
IR (film on NaCl, cm–1): 3123w, 2931m, 2860w, 1624w, 1585m, 1456s, 1320m, 1259w, 
1157w, 904w, 841vs, 749w, 674w, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C62H70FeN6O4: 509.23993; found: 509.23943. 
 
Ru[2,6-bis(2-hexylfuro[2,3-c]pyridin-5-yl)pyridine]-PF6 ([L22Ru](PF6)2) 
 
A suspension of ligand L2 (25.0 mg, 0.0519 mmol, 1.00 eq) and Ru(DMSO)4Cl2 (12.6 mg, 
0.0260 mmol, 0.500 eq) in ethylene glycol (15 ml) was heated to 120 °C for 18 h. The 
reaction mixture was allowed to cool to room temperature and a saturated aq. KPF6 solution 
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was added. The resulting red precipitate was filtered over Celite, washed with water, Et2O, 
hexane and redissolved with acetonitrile. The solvent was evaporated to give desired Ru 
complex ([L22Ru](PF6)2) (34.8 mg, 99%) as a dark red solid. 
Mp >320 °C dec.  
1H NMR (500 MHz, CD2Cl2, δ): 8.68 (d, J = 8.2 Hz, 2H) 8.63 (s, 2H), 8.45 (t, J = 8.2 Hz, 1H), 
7.38 (s, 2H), 6.64 (d, J = 0.7 Hz, 2H), 2.70 (t, J = 7.5 Hz, 4H), 1.59 (quintet, J = 7.5 Hz, 4H), 
1.28-1.18 (m, 12H), 0.80 (t, J = 6.9 Hz, 6H). 
13C NMR (125 MHz, CD2Cl2, δ): 168.6 (s), 156.1 (s), 152.4 (s), 151.2 (s), 137.6 (s), 136.5 (d), 
135.0 (d), 122.1 (d), 117.0 (d), 103.1 (d), 31.6 (t), 28.9 (t), 28.7 (t), 27.4 (t), 22.7 (t), 14.1 (q). 
IR (film on NaCl, cm–1): 3125w, 2931m, 2859w, 1623w, 1584m, 1493w, 1455s, 1314m, 
1259w, 1156w, 903w, 840vs, 740w, 557m. 
HRMS (ESI) m/z: [M]2+ calcd for C62H70RuN6O4: 532.22539; found: 532.22467. 
 
Zn[2,6-bis(2-(pyridin-4-yl)furo[2,3-c]pyridin-5-yl)pyridine]-PF6 ([L32Zn](PF6)2) 
 
To a solution of ligand L3 (12.0 mg, 0.0257 mmol, 1.00 eq) in THF (12 mL) a solution of 
Zn(OTf)2 (4.67 mg, 0.0156 mmol, 0.500 eq) in MeOH (1.1 mL) was added dropwise in 5 
minutes at room temperature. The reaction mixture was stirred for 48 h at room temperature. 
To the mixture saturated aq. KPF6 was added and the resulting yellow precipitate was filtered 
over Celite, washed with water, Et2O, hexane and redissolved with acetonitrile. The solvent 
was evaporated to give desired Zn complex [L32Zn](PF6)2 (15.5 mg, 94%) as a yellow solid. 
Recrystallization by slow vapor diffusion of Et2O into an acetonitrile solution of 
[L32Zn](PF6)2 gives yellow block. 
Mp >350 °C dec.  
1H NMR (500 MHz, CD3CN, δ) 8.93 (d, J = 0.9 Hz, 2H), 8.85-8.83 (m, 2H), 8.80-8.76 (m, 
1H), 8.69-8.68 (m, 4H), 8.12 (d, J = 0.8 Hz, 2H), 7.73-7.71 (m, 4H), 7.63 (d, J = 0.7 Hz, 2H). 
13C NMR (125 MHz, CD3CN, δ): 161.1 (s), 154.0 (s), 151.8 (d), 151.2 (s), 145.2 (d), 143.2 (s), 
139.9 (s), 136.0 (s), 133.5 (d), 123.6 (d), 120.5 (d), 117.3 (d), 105.7 (d). 
IR (KBr, cm–1): 2921w, 1611m, 1582w, 1599w, 1452m, 1414w, 1384w, 1325m, 1179w, 
1046w, 835vs, 690w, 558s. 
HRMS (ESI) m/z: [M]2+ calcd for C58H34N10O4Zn: 499.10225; found: 499.10186. 
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Fe[2,6-bis(2-(pyridin-4-yl)furo[2,3-c]pyridin-5-yl)pyridine]-PF6 ([L32Fe](PF6)2) 
 
To a suspension of ligand L3 (100 mg, 0.214 mmol, 1.00 eq) in a mixture of THF (21 mL) 
and MeCN (2 mL) under N2 atmosphere a solution of Fe(BF4)2⋅6H2O (36.1 mg, 0.107 mmol, 
0.500 eq) in water (9 mL) was added dropwise in 5 minutes at room temperature. The dark 
purple reaction mixture was stirred for 18 h at room temperature. To the mixture saturated aq. 
KPF6 was added and the resulting dark purple precipitate was filtered over Celite, washed 
with water, Et2O, hexane and redissolved with acetonitrile. The solvent was evaporated to give 
a dark purple solid. Recrystallization by slow vapor diffusion of Et2O into an acetonitrile 
solution of crude product afforded dark purple blocks of [L32Fe](PF6)2 that were collected by 
filtration (0.109 mg, 80%). 
Mp >350 °C dec.  
1H NMR (500 MHz, CD3CN, δ): 8.99 (d, J = 8.1 Hz, 2H), 8.86 (s, 2H), 8.81 (t, J = 8.1 Hz, 
1H), 8.64 (d, J = 5.8 Hz, 4H), 7.64 (d, J = 6.0 Hz, 4H), 7.53 (s, 2H), 7.47 (s, 2H). 
13C NMR (125 MHz, CD3CN, δ): 161.5 (s), 159.8 (s), 153.2 (s), 152.6 (s), 151.7 (d), 139.3 (d), 
138.6 (d), 138.1 (s), 135.8 (s), 123.5 (d), 120.3 (d), 117.9 (d), 105.6 (d). 
IR (KBr, cm–1): 2923w, 1611m, 1577w, 1455m, 1414w, 1384w, 1321w, 1174w, 1043w, 844vs, 
690w, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C58H34N10O4Fe: 495.10522; found: 495.10475. 
 
Ru[2,6-bis(2-(pyridin-4-yl)furo[2,3-c]pyridin-5-yl)pyridine]-PF6 ([L32Ru](PF6)2) 
 
 
A suspension of ligand L3 (12.0 mg, 0.0257 mmol, 1.00 eq) and Ru(DMSO)4Cl2 (6.22 mg, 
0.0129 mmol, 0.500 eq) in ethylene glycol (10 ml) was heated to 120 °C for 18 h. The 
reaction mixture was allowed to cool to room temperature and a saturated aq. KPF6 solution 
was added. The resulting red precipitate was filtered over Celite, washed with water, Et2O, 
hexane and redissolved with acetonitrile. The solvent was evaporated to give desired Ru 
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complex [L32Ru](PF6)2 (16.7 mg, 98%) as a dark red solid. Recrystallization by slow vapor 
diffusion of Et2O into an acetonitrile solution of [L32Ru](PF6)2 gives dark red blocks. 
Mp >350 °C dec. 
1H NMR (400 MHz, CD3CN, δ): 8.88 (d, J = 0.7 Hz, 2H), 8.82 (d, J = 8.2 Hz, 2H), 8.68-8.66 
(m, 4H), 8.53 (t, J = 8.2 Hz, 1H), 7.76 (s, 2H), 7.68-7.67 (m, 4H), 7.57 (d, J = 0.7 Hz, 2H). 
13C NMR (125 MHz, CD3CN, δ): 160.1 (s), 156.7 (s), 153.1 (s), 153.0 (s), 151.6 (d), 138.0 (d), 
137.2 (s), 137.2 (d), 136.0 (s), 123.5 (d), 120.4 (d), 118.6 (d), 105.8 (d). 
IR (KBr, cm–1): 2922w, 1609m, 1576w, 1455s, 1414w, 1313w, 1177w, 1042w, 990w, 845vs, 
690w, 558w. 
HRMS (ESI) m/z: [M]2+ calcd for C58H34N10O4Ru: 518.09061; found: 518.09079. 
 
Zn[2-(4-methoxy-2,6-dimethylphenyl)-5-(6-{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine]2-2PF6 
([L42Zn](PF6)2) 
 
To a solution of ligand L4 (24.0 mg, 0.0326 mmol, 1.00 eq) in THF (6 mL) a solution of 
Zn(OTf)2 (5.93 mg, 0.0163 mmol, 0.500 eq) in MeOH (2 mL) was added dropwise in 5 
minutes at room temperature. The reaction mixture was stirred for 18 h at room temperature. 
To the mixture saturated aq. KPF6 was added and the resulting yellow precipitate was filtered 
over Celite, washed with water, Et2O, hexane and redissolved with acetonitrile. The solvent 
was evaporated to give desired Zn complex [L42Zn](PF6)2 (29.3 mg, 98%) as a yellow solid. 
Recrystallization by slow vapor diffusion of Et2O into an acetonitrile solution of 
[L42Zn](PF6)2 gives yellow precipitate. 
Mp 286–289 °C dec. 
1H NMR (400 MHz, CD2Cl2, δ): 9.12 (d, J = 1.6 Hz, 2H), 8.88 (d, J = 0.5 Hz, 2H), 8.85-8.78 
(m, 8H), 8.55 (d, J = 8.5 Hz, 2H), 8.48 (d, J = 8.1 Hz, 2H), 8.43 (d, J = 1.4 Hz, 2H), 8.23 (dd, 
J = 8.4, 2.3 Hz, 2H), 8.01 (s, 2H), 7.97 (s, 2H), 7.61 (dd, J = 8.1, 2.2 Hz, 2H), 7.45 (d, J = 0.5 
Hz, 2H), 6.96 (d, J = 0.7 Hz, 2H), 6.68 (s, 4H), 6.62 (s, 4H), 3.79 (s, 6H), 3.76 (s, 6H), 2.08 (s, 
12H), 2.01 (s, 12H). 
13C NMR (100 MHz, CD2Cl2, δ): 164.4 (s), 161.4 (s), 161.3 (s), 159.4 (s), 158.3 (s), 153.5 (s), 
153.5 (s), 153.3 (s), 150.8 (s), 150.7 (d), 150.6 (s), 147.2 (d), 145.2 (d), 142.3 (s), 141.7 (s), 
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140.5 (s), 140.1 (s), 140.1 (s), 138.8 (d), 138.1 (s), 137.9 (s), 134.5 (d), 131.7 (d), 131.5 (d), 
130.5 (s), 124.1 (s), 122.8 (d), 122.7 (d), 121.4 (d), 121.2 (d), 120.7 (s), 116.4 (d), 116.1 (d), 
113.7 (d), 113.3 (d), 107.5 (d), 103.0 (d), 55.6 (q), 55.5 (q), 21.3 (q), 20.9 (q). 
IR (film on NaCl, cm–1): 2919w, 1603s, 1455vs, 1321s, 1283w, 1193w, 1155m, 1063w, 959w, 
842vs, 558w. 
HRMS (ESI) m/z: [M]2+ calcd for C94H74N10O8Zn: 767.24858; found: 767.24808. 
 
Fe[2-(4-methoxy-2,6-dimethylphenyl)-5-(6-{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine]2-2PF6 
([L42Fe](PF6)2) 
 
To a solution of ligand L4 (24.0 mg, 0.0326 mmol, 1.00 eq) in THF (6 mL) a solution of 
Fe(BF4)2⋅6H2O (5.50 mg, 0.0163 mmol, 0.500 eq) in water (2 mL) was added dropwise in 5 
minutes at room temperature. The dark purple reaction mixture was stirred for 48 h at room 
temperature. To the mixture saturated aq. KPF6 was added and the resulting dark purple 
precipitate was filtered over Celite, washed with water, Et2O, hexane and redissolved with 
acetonitrile. The solvent was evaporated to give desired Fe complex [L42Fe](PF6)2 (28.3 mg, 
97%) as a dark purple solid. Recrystallization by slow vapor diffusion of Et2O into an 
acetonitrile solution of [L42Fe](PF6)2 gives dark purple blocks. 
Mp >330 °C dec.  
1H NMR (400 MHz, CD2Cl2, δ): 9.06 (d, J = 1.6 Hz, 2H), 9.01-8.98 (m, 4H), 8.87-8.78 (m, 
6H), 8.52 (d, J = 8.4 Hz, 2H), 8.45 (d, J = 8.1 Hz, 2H), 8.42 (d, J = 1.6 Hz, 2H), 8.17 (dd, J = 
8.4, 2.0 Hz, 2H), 7.60 (dd, J = 8.1, 2.0 Hz, 2H), 7.39 (s, 2H), 7.37 (s, 2H), 7.32 (s, 2H), 6.87 
(s, 2H), 6.68 (s, 4H), 6.60 (s, 4H), 3.79 (s, 6H), 3.75 (s, 6H), 2.02 (s, 12H), 2.01 (s, 12H). 
13C NMR (100 MHz, CD2Cl2, δ): 163.3 (s), 161.7 (s), 161.3 (s), 161.2 (s), 161.0 (s), 160.4 (s), 
159.4 (s), 158.2 (s), 153.4 (s), 152.9 (s), 152.7 (s), 151.7 (s), 151.0 (s), 150.7 (d), 147.2 (d), 
140.5 (s), 139.1 (d), 138.8 (d), 138.4 (s), 138.1 (s), 137.9 (s), 136.6 (d), 136.2 (d), 134.4 (d), 
130.5 (s), 123.9 (s), 122.5 (d), 122.5 (d), 121.4 (d), 121.2 (d), 120.4 (s), 117.1 (d), 116.9 (d), 
113.7 (d), 113.3 (d), 107.3 (d), 102.8 (d), 55.6 (q), 55.5 (q), 21.3 (q), 20.8 (q). 
IR (film on NaCl, cm–1): 2919w, 1603s, 1455vs, 1318s, 1281w, 1193w, 1154s, 1063w, 841vs, 
558w.  
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HRMS (ESI) m/z: [M]2+ calcd for C94H74N10O8Fe: 763.25153; found: 763.25054. 
 
Ru[4-iodo-6′-(2-(4-methoxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)-2,2′-bipyridin-
5-ol]2-2PF6 (83) 
 
A suspension of 4-iodo-4′′-[2-(4-methoxy-2,6-dimethylphenyl)-ethynyl]-5,5′′-
bis(methoxymethoxy)-2,2′:6′,2′′-terpyridine (79c) (148 mg, 0.232 mmol, 1.00 eq) and 
Ru(DMSO)4Cl2 (56.3 mg, 0.116 mmol, 0.500 eq) in ethanol (44 ml) was heated to reflux for 
72 h. The reaction mixture was allowed to cool to room temperature and a saturated aq. KPF6 
solution was added. The resulting red precipitate was filtered over Celite, washed with water, 
Et2O, hexane and redissolved with acetonitrile. The solvent was evaporated to give Ru 
complex 83 (171 mg, crude yield 99%) as a dark red solid that was used without further 
purification in the subsequent reaction. 
Mp >350 °C dec. 
1H NMR (500 MHz, CD3CN, δ): 8.71 (br. s, 1H), 8.68 (br. s, 1H), 8.57-8.47 (m, 2H), 8.29-
8.21 (m, 1H), 7.29 (br. s, 1H), 6.92 (s, 1H), 6.68 (br. s, 2H), 6.44 (br. s, 1H), 3.76 (s, 3H), 
2.02 (s, 6H). 
13C NMR (125 MHz, CD3CN, δ):162.0 (s), 160.9 (s), 155.4 (s), 154.3 (s), 151.9 (s), 151.4 (s), 
140.2 (s), 138.0 (d), 136.4 (s), 135.5 (d), 134.0 (d), 121.8 (d), 120.5 (d), 116.6 (d), 113.2 (d), 
106.8 (d), 55.0 (q), 19.7 (q). 
IR (film on NaCl, cm–1): 3647w, 3584w, 3440br, 3086w, 2922w, 2844w, 2194w, 1604m, 
1575w, 1455vs, 1381w, 1318s, 1193w, 1154m, 1068w, 842vs, 738w, 623w, 558m. 
HRMS (ESI) m/z: [M-H]+ calcd for C52H39I2N6O6Ru: 1199.00723; found: 1199.00725. 
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Ru[2-(4-methoxy-2,6-dimethylphenyl)-5-(6-{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine]2-2PF6 
([L42Ru](PF6)2) 
 
A mixture of a crude complex 83 (130 mg, 0.0873 mmol, 1.00 eq), 5-ethynyl-5′-(4-methoxy-
2,6-dimethylphenyl)-2,2′-bipyridine (77a) (56.2 mg, 0.179 mmol, 2.05 eq), PdCl2(PPh3)2 (3.1 
mg, 0.0044 mmol, 5 mol%) and CuI (1.7 mg, 0.0087 mmol, 10 mol%)  in degassed 
DMF/Et3N (20 mL/12 mL) was heated to 90 °C for 24 h under N2 atmosphere. The reaction 
mixture was allowed to cool to room temperature and the solvent was evaporated under 
reduced pressure. The residue was redissolved in CH2Cl2, washed with 10% NH4OH aqueous 
solution, water and brine. The organic phase was dried over MgSO4, filtered and evaporated 
under reduces pressure. The crude residue was purified by silica gel column chromatography 
with acetonitrile/CH2Cl2/H2O/aq. KPF6 (140:100:8:3). The first red band was collected and 
the solvent was evaporated under reduced pressure. The residue was redissolved in CH2Cl2 
and filtered through a pad of Celite. The filtrate was evaporated under reduced pressure to 
give desired Ru complex [L42Ru](PF6)2 (70 mg, 43% from 79c over 2 steps) as a dark red 
solid. 
Mp >350 °C dec.  
1H NMR (400 MHz, CD2Cl2, δ): 9.09 (d, J = 1.1 Hz, 2H), 8.85-8.79 (m, 8H), 8.57-8.53 (m, 
4H), 8.47 (d, J = 8.1 Hz, 2H), 8.43 (s, 2H), 8.19 (dd, J = 8.4, 2.1 Hz, 2H), 7.65 (s, 2H), 7.61 
(dd, J = 8.2, 2.0 Hz, 3H), 7.58 (s, 2H), 7.41 (s, 2H), 6.91 (s, 2H), 6.68 (s, 4H), 6.61 (s, 4H), 
3.79 (s, 6H), 3.76 (s, 6H), 2.05 (s, 12H), 2.01 (s, 12H). 
13C NMR (100 MHz, CD2Cl2, δ): 163.6 (s), 161.4 (s), 160.7 (s), 159.4 (s), 158.2 (s), 156.2 (s), 
156.1 (s), 153.5 (s), 152.7 (s), 152.5 (s), 152.1 (s), 151.4 (s), 150.7 (s), 147.1 (d), 140.5 (s), 
138.8 (d), 138.1 (s), 137.9 (s), 137.5 (s), 136.9 (d), 136.0 (d), 135.7 (d), 134.4 (d), 130.5 (s), 
124.0 (s), 122.7 (d), 122.6 (d), 121.4 (d), 121.2 (d), 120.5 (s), 117.8 (d), 117.5 (d), 113.7 (d), 
113.3 (d), 107.4 (d), 102.9 (d), 55.6 (q), 55.5 (q), 21.3 (q), 20.9 (q). 
IR (film on NaCl, cm–1): 2920w, 1603s, 1456vs, 1315s, 1278w, 1192w, 1154s, 1062w, 999w, 
841vs, 557m. 
HRMS (ESI) m/z: [M]2+ calcd for C94H74N10O8Ru: 786.23642; found: 786.23519. 
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Zn[2-(4-methoxy-2,6-dimethylphenyl)-5-(6-{2-[6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine]2-2PF6 
([L52Zn](PF6)2) 
 
To a solution of ligand L5 (5.08 mg, 0.00690 mmol, 1.00 eq) in THF (1 mL) a solution of 
Zn(OTf)2 (1.25 mg, 0.00345 mmol, 0.500 eq) in water (0.4 mL) was added dropwise in 1 
minutes at room temperature. The reaction mixture was stirred for 6 h at room temperature. 
To the mixture saturated aq. KPF6 was added and the resulting yellow precipitate was filtered 
over Celite, washed with water, Et2O, hexane and redissolved with acetonitrile. The solvent 
was evaporated to give desired Zn complex [L52Zn](PF6)2 (6.23 mg, 99%) as a yellow solid. 
Recrystallization by slow vapor diffusion of Et2O into an acetonitrile solution of 
[L52Zn](PF6)2 gives yellow precipitate. 
Mp 270–272 °C dec. 
1H NMR (400 MHz, CD2Cl2, δ): 9.11 (s, 2H), 8.84-8.79 (m, 10H), 8.49 (d, J = 8.6 Hz, 2H), 
8.37 (d, J = 7.5 Hz, 2H), 8.15 (dd, J = 8.4, 2.2 Hz, 2H), 7.98 (s, 2H), 7.95 (s, 2H), 7.87 (t, J = 
7.8 Hz, 3H), 7.42 (s, 2H), 7.26 (dd, J = 7.7, 0.6 Hz, 2H), 6.95 (s, 2H), 6.66 (s, 4H), 6.62 (s, 
4H), 3.80 (s, 6H), 3.76 (s, 5H), 2.08 (s, 12H), 2.04 (s, 12H).  
13C NMR (125 MHz, CD2Cl2, δ): 164.3 (s), 161.4 (s), 161.2 (s), 159.6 (s), 159.3 (s), 158.4 (s), 
154.9 (s), 153.4 (s), 153.2 (s), 150.7 (s), 150.5 (s), 147.0 (d), 145.1 (d), 142.1 (s), 141.6 (s), 
140.4 (s), 140.0 (s), 140.0 (s), 137.8 (s), 137.6 (d), 134.3 (d), 133.6 (s), 131.6 (d), 131.4 (d), 
126.3 (d), 124.1 (s), 122.7 (d), 122.6 (d), 121.4 (d), 120.6 (s), 119.5 (d), 116.3 (d), 116.0 (d), 
113.6 (d), 113.2 (d), 107.4 (d), 102.8 (d), 55.5 (q), 55.5 (q), 20.8 (q), 20.7 (q). 
IR (film on NaCl, cm–1): 2921w, 1603s, 1582m, 1454vs, 1322s, 1284w, 1193w, 1155m, 
1070w, 841vs, 558w. 
HRMS (ESI) m/z: [M]2+ calcd for C94H74N10O8Zn: 767.24858; found: 767.24783. 
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Fe[2-(4-methoxy-2,6-dimethylphenyl)-5-(6-{2-[6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine]2-2PF6 
([L52Fe](PF6)2) 
 
To a solution of ligand L5 (5.18 mg, 0.00704 mmol, 1.00 eq) in THF (3 mL) a solution of 
Fe(BF4)2⋅6H2O (1.88 mg, 0.00352 mmol, 0.500 eq)  in water (0.4 mL) was added dropwise in 
1 minutes at room temperature. The dark purple reaction mixture was stirred for 6 h at room 
temperature. To the mixture saturated aq. KPF6 was added and the resulting dark purple 
precipitate was filtered over Celite, washed with water, Et2O, hexane and redissolved with 
acetonitrile. The solvent was evaporated to give desired Fe complex [L52Fe](PF6)2 (5.11 mg, 
80%) as a dark purple solid. Recrystallization by slow vapor diffusion of Et2O into an 
acetonitrile solution of [L52Fe](PF6)2 gives dark purple precipitate. 
Mp >320 °C dec.  
1H NMR (500 MHz, CD2Cl2, δ): 9.05 (s, 2H), 8.99-8.92 (m, 4H), 8.85-8.74 (m, 6H), 8.47 (d, 
J = 7.6 Hz, 2H), 8.36 (d, J = 7.7 Hz, 2H), 8.10 (d, J = 7.5 Hz, 2H), 7.87 (t, J = 7.5 Hz, 2H), 
7.35 (s, 2H), 7.33 (s, 2H), 7.30 (s, 2H), 7.25 (d, J = 7.6 Hz, 2H), 6.86 (s, 2H), 6.66 (s, 4H), 
6.59 (s, 4H), 3.80 (s, 6H), 3.75 (s, 6H), 2.03 (s, 12H), 2.01 (s, 12H). 
13C NMR (125 MHz, CD2Cl2, δ): 163.2 (s), 161.3 (s), 161.1 (s), 160.9 (s), 160.3 (s), 159.6 (s), 
159.3 (s), 158.4 (s), 154.9 (s), 152.8 (s), 152.6 (s), 151.5 (s), 150.9 (s), 147.0 (d), 140.4 (s), 
139.0 (d), 138.2 (s), 137.8 (s), 137.6 (d), 136.5 (d), 136.1 (d), 134.2 (d), 133.6 (s), 126.3 (d), 
123.9 (s), 122.4 (d), 122.4 (d), 121.4 (d), 120.3 (s), 119.5 (d), 117.0 (d), 116.8 (d), 113.6 (d), 
113.2 (d), 107.2 (d), 102.7 (d), 55.5 (q), 55.5 (q), 20.8 (q), 20.7 (q). 
IR (film on NaCl, cm–1): 2921w, 1604s, 1455vs, 1318s, 1282w, 1193w, 1155m, 1070w, 841vs, 
558w. 
HRMS (ESI) m/z: [M]2+ calcd for C94H74FeN10O8: 763.25153; found: 763.25106. 
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Ru[2-(4-methoxy-2,6-dimethylphenyl)-5-(6-{2-[6′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine]2-2PF6 
([L52Ru](PF6)2) 
 
A mixture of a crude complex 83 (15.7 mg, 0.0105 mmol, 1.00 eq), 5-ethynyl-6′-(4-methoxy-
2,6-dimethylphenyl)-2,2′-bipyridine (77b) (6.79 mg, 0.0216 mmol, 2.05 eq), PdCl2(PPh3)2 
(0.37 mg, 0.00053 mmol, 5 mol%) and CuI (0.20 mg, 0.0011 mmol, 10 mol%)  in degassed 
DMF/Et3N (2 mL/2 mL) was heated to 90 °C for 39 h under N2 atmosphere. The reaction 
mixture was allowed to cool to room temperature and the solvent was evaporated under 
reduced pressure. The residue was redissolved in CH2Cl2, washed with 10% NH4OH aqueous 
solution, water and brine. The organic phase was dried over MgSO4, filtered and evaporated 
under reduces pressure. The crude residue was purified by silica gel column chromatography 
with acetonitrile/CH2Cl2/H2O/aq. KPF6 (140:100:8:3). The first red band was collected and 
the solvent was evaporated under reduced pressure. The residue was redissolved in CH2Cl2 
and filtered through a pad of Celite. The filtrate was evaporated under reduced pressure to 
give desired Ru complex [L52Ru](PF6)2 (7.8 mg, 40% from 79c over 2 steps) as a dark red 
solid. 
Mp >350 °C dec.  
1H NMR (400 MHz, CD2Cl2, δ): 9.07 (s, 2H), 8.81-8.74 (m, 8H), 8.53-8.44 (m, 4H), 8.36 (d, 
J = 7.5 Hz, 2H), 8.10 (d, J = 7.3 Hz, 2H), 7.86 (t, J = 7.8 Hz, 2H), 7.63 (s, 2H), 7.57 (s, 2H), 
7.38 (s, 2H), 7.25 (d, J = 7.5 Hz, 2H), 6.91 (s, 2H), 6.67 (s, 4H), 6.60 (s, 4H), 3.81 (s, 6H), 
3.75 (s, 6H), 2.04 (s, 12H), 2.03 (s, 12H). 
13C NMR (125 MHz, CD2Cl2, δ): 163.5 (s), 161.2 (s), 160.5 (s), 159.5 (s), 159.4 (s), 158.1 (s), 
156.1 (s), 155.9 (s), 154.7 (s), 152.6 (s), 152.4 (s), 152.0 (s), 151.3 (s), 147.0 (d), 140.4 (s), 
137.8 (d), 137.4 (s), 137.3 (s), 136.8 (d), 135.9 (d), 135.6 (d), 134.2 (d), 133.4 (s), 126.4 (d), 
124.0 (s), 122.6 (d), 122.5 (d), 121.4 (d), 120.4 (s), 119.6 (d), 117.7 (d), 117.5 (d), 113.6 (d), 
113.2 (d), 107.3 (d), 103.0 (d), 55.5 (q), 55.5 (q), 20.8 (q), 20.7 (q). 
IR (film on NaCl, cm–1): 2921w, 1604s, 1455vs, 1313m, 1291w, 1193w, 1156m, 1070w, 
842vs, 558w. 
HRMS (ESI) m/z: [M]2+ calcd for C94H74N10O8Ru: 786.23642; found: 786.23652. 
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Zn[2,6-bis{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]furo[2,3-c]pyridin-
5-yl}pyridine]-2PF6 ([L62Zn](PF6)2) 
 
To a solution of ligand L6 (15.2 mg, 0.0171 mmol, 1.00 eq) in THF (12 mL) a solution of 
Zn(OTf)2 (3.10 mg, 0.00854 mmol, 0.500 eq) in water (1.4 mL) was added dropwise in 5 
minutes at room temperature. The reaction mixture was stirred for 18 h at room temperature. 
To the mixture saturated aq. KPF6 was added and the resulting yellow precipitate was filtered 
over Celite, washed with water, Et2O, hexane and redissolved with acetonitrile. The solvent 
was evaporated to give desired Zn complex [L62Ru](PF6)2 (16.8 mg, 92%) as a yellow solid. 
Recrystallization by slow vapor diffusion of Et2O into an acetonitrile solution of 
[L62Ru](PF6)2 gives yellow precipitate. 
Mp >350 °C dec.  
1H NMR (400 MHz, CD2Cl2, δ): 9.13 (s, 2H), 8.91-8.84 (m, 5H), 8.57 (d, J = 8.5 Hz, 2H), 
8.48 (d, J = 7.7 Hz, 2H), 8.43 (s, 2H), 8.23 (d, J = 8.5 Hz, 2H), 8.05 (s, 2H), 7.62 (d, J = 7.7 
Hz, 2H), 7.45 (s, 2H), 6.68 (s, 4H), 3.79 (s, 6H), 2.01 (s, 12H). 
13C NMR (125 MHz, CD2Cl2, δ): 161.5 (s), 159.3 (s), 158.2 (s), 153.5 (s), 153.4 (s), 150.6 (d), 
150.6 (s), 147.1 (d), 145.2 (d), 142.2 (s), 140.1 (s), 138.8 (d), 138.0 (s), 137.9 (s), 134.4 (d), 
131.8 (d), 130.4 (s), 124.0 (s), 122.9 (d), 121.3 (d), 121.1 (d), 116.4 (d), 113.2 (d), 102.9 (d), 
55.4 (q), 21.3 (q). 
IR (film on NaCl, cm–1): 2909w, 2841w, 1602m, 1454s, 1430w, 1322m, 1276w, 1192w, 
1155m, 1062w, 1012w, 959w, 842vs, 747w, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C114H86ZnN14O8: 921.30168; found: 921.30007. 
 
Fe[2,6-bis{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]furo[2,3-c]pyridin-
5-yl}pyridine]-2PF6 ([L62Fe](PF6)2) 
 
To a solution of ligand L6 (15.0 mg, 0.0169 mmol, 1.00 eq) in THF (15 mL) a solution of 
Fe(BF4)2⋅6H2O (2.84 mg, 0.00842 mmol, 0.500 eq)  in water (1.1 mL) was added dropwise in 
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5 minutes at room temperature. The dark purple reaction mixture was stirred for 6 h at room 
temperature. To the mixture saturated aq. KPF6 was added and the resulting dark purple 
precipitate was filtered over Celite, washed with water, Et2O, hexane and redissolved with 
acetonitrile. The solvent was evaporated to give desired Fe complex [L62Fe](PF6)2 (14.4 mg, 
80%) as a dark purple solid. Recrystallization by slow vapor diffusion of Et2O into an 
acetonitrile solution of [L62Fe](PF6)2 gives dark purple precipitate. 
Mp >350 °C dec.  
1H NMR (400 MHz, CD2Cl2, δ): 9.08-9.03 (m, 4H), 8.90 (t, J = 7.8 Hz, 1H), 8.86 (s, 2H), 
8.52 (d, J = 8.5 Hz, 2H), 8.45 (d, J = 8.1 Hz, 2H), 8.41 (s, 2H), 8.17 (d, J = 8.5 Hz, 2H), 7.60 
(d, J = 8.1 Hz, 2H), 7.43 (s, 2H), 7.36 (s, 2H), 6.67 (s, 4H), 3.79 (s, 6H), 2.00 (s, 12H). 
13C NMR (100 MHz, CD2Cl2, δ): 161.0 (s), 160.5 (s), 159.4 (s), 158.2 (s), 153.4 (s), 152.9 (s), 
151.6 (s), 150.7 (d), 147.2 (d), 139.2 (s), 138.8 (s), 138.4 (d), 138.1 (s), 137.9 (s), 136.7 (d), 
134.4 (d), 130.5 (s), 123.9 (s), 122.8 (d), 121.4 (d), 121.2 (d), 117.2 (d), 113.3 (d), 102.8 (d), 
55.5 (q), 21.3 (q). 
IR (film on NaCl, cm–1): 2914w, 2841w, 1601m, 1456s, 1318m, 1276w, 1192w, 1155m, 
1062w, 1012w, 840vs, 749w, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C114H86FeN14O8: 917.80621; found: 917.80624. 
 
Ru[5,5′′-dihydroxy-4,4′′-diiodo-2,2′:6′,2′′-terpyridine]-2PF6 (82) 
 
A suspension of diiodoterpyridine 69 (333 mg, 0.550 mmol, 1.00 eq) and Ru(DMSO)4Cl2 (133 
mg, 0.275 mmol, 0.500 eq) in ethylene glycol (60 ml) was heated to 120 °C for 48 h. To the 
hot reaction mixture a saturated aq. KPF6 solution was added till the first precipitate forms. 
The mixture was allowed to cool to room temperature. After dilution with water, the resulting 
orange precipitate was collected by filtration, washed with water, Et2O, ethanol and CH2Cl2. 
Drying under high vacuum resulted in desired Ru complex 82 (319 mg, crude yield 89%) as 
an orange solid, that is insoluble in water and common organic solvents and was used without 
further purification in the subsequent reaction. 
Mp >350 °C dec. 
IR (KBr, cm–1): 3407br, 3077m, 2927m, 1573m, 1551m, 1509m, 1449vs, 1378m, 1299s, 
1228w, 1170w, 1053w, 846s, 689w, 614w, 561m.  
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HRMS (ESI) m/z: [M]2+ calcd for C30H18I4N6O4Ru calcd for: 568.8379; found: 567.82914. 
 
Ru[2,6-bis{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-bipyridin-5-yl]furo[2,3-c]pyridin-
5-yl}pyridine]-2PF6 ([L62Ru](PF6)2) 
 
A mixture of crude 82 (40.0 mg, 0.0308 mmol, 1.00 eq), 5-ethynyl-5′-(4-methoxy-2,6-
dimethylphenyl)-2,2′-bipyridine (77a) (40.7 mg, 0.129 mmol, 4.20 eq), PdCl2(PPh3)2 (2.2 mg, 
0.0031 mmol, 10 mol%) and CuI (1.2 mg, 0.0062 mmol, 20 mol%)  in degassed DMF/DIPEA 
(7 mL/7 mL) was heated to 80 °C for 48 h under N2 atmosphere. The reaction mixture was 
allowed to cool to room temperature and the solvent was evaporated under reduced pressure. 
The residue was treated with EtOAc, collected by filtration and purified by silica gel column 
chromatography with acetonitrile/CH2Cl2/H2O/aq. KPF6 (140:100:8:3). The first red band was 
collected and the solvent was evaporated under reduced pressure. The residue was redissolved 
in CH2Cl2 and filtered through a pad of Celite. The filtrate was evaporated under reduced 
pressure to give desired complex [L62Ru](PF6)2 (36 mg, 48% from 69 over 2 steps) as a dark 
red solid. 
Mp >350 °C dec.  
1H NMR (500 MHz, CD2Cl2, δ): 9.08 (d, J = 2.1 Hz, 2H), 8.94 (s, 2H), 8.93 (d, J = 9.8 Hz, 
2H), 8.62 (t, J = 8.1 Hz, 1H), 8.53 (d, J = 8.5 Hz, 2H), 8.45 (d, J = 8.2 Hz, 2H), 8.41 (d, J = 
1.7 Hz, 2H), 8.18 (dd, J = 8.4, 2.2 Hz, 2H), 7.69 (s, 2H), 7.61 (dd, J = 8.1, 2.1 Hz, 2H), 7.43 
(s, 2H), 6.67 (s, 4H), 3.78 (s, 6H), 2.00 (s, 12H). 
13C NMR (125 MHz, CD2Cl2, δ): 160.8 (s), 159.4 (s), 158.2 (s), 156.0 (s), 153.4 (s), 152.7 (s), 
152.0 (s), 150.7 (d), 147.1 (d), 138.8 (d), 138.1 (s), 137.9 (s), 137.5 (s), 137.1 (d), 136.0 (d), 
134.4 (d), 130.5 (s), 123.9 (s), 122.9 (d), 121.4 (d), 121.2 (d), 117.9 (d), 113.3 (d), 102.9 (d), 
55.5 (q), 21.3 (q). 
IR (film on NaCl, cm–1): 2920w, 2836w, 1600m, 1454vs, 1383w, 1315m, 1276w, 1192w, 
1155m, 1061w, 1011w, 999w, 841vs, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C114H86N14O8Ru: 940.28954; found: 940.28944. 
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Ru[2-(4-methoxy-2,6-dimethylphenyl)-5-(6-{2-[5′-(4-methoxy-2,6-dimethylphenyl)-2,2′-
bipyridin-5-yl]furo[2,3-c]pyridin-5-yl}pyridin-2-yl)furo[2,3-c]pyridine]2-(Δ-
TRISPHAT)2 ([L42Ru](Δ-TRISPHAT)2) 
 
To a solution of [L42Ru](PF6)2 (6.3 mg, 1.0 eq, 0.0034 mmol) in CH2Cl2 (0.5 mL) a solution 
of [cinhonidinium](Δ-TRISPHAT) (7.6 mg, 2.1 eq, 0.0071) in acetone (1.1 mL) was added. 
The mixture was stirred for 10 min. at room temperature. The resulting red suspension was 
evaporated, dissolved in minimum amount of CH2Cl2 applied on the Al2O3 column 
(deactivated with 5wt % H2O) and eluted with eluent gradient (CH2Cl2:MeOH 999:1 to 99:1). 
The collected red bands were evaporated under reduced pressure to give desired 
diastereomeric mixture [L42Ru](Δ-TRISPHAT)2 (8.5 mg, 81%) as a red solid. 
Mp >300 °C dec. 
1H NMR (500 MHz, CD2Cl2, δ): 9.05 (d, J = 2.1 Hz, 2H), 9.03 (d, J = 2.2 Hz, 2H), 8.79 (s, 
2H), 8.71 (d, J = 8.3 Hz, 2H), 8.71 (s, 2H), 8.69 (s, 4H), 8.66 (d, J = 8.3 Hz, 2H), 8.61 (d, J = 
8.0 Hz, 2H), 8.58 (d, J = 8.0 Hz, 2H), 8.55 (dd, J = 1.5, 8.5 Hz, 4H), 8.47 (dd, J = 2.7, 8.1 Hz, 
4H), 8.44 (s, 4H), 8.44-8.40 (m, 4H), 8.14 (dd, J = 2.5, 8.5 Hz, 2H), 8.12 (dd, J = 2.3, 8.4 Hz, 
2H), 7.66-7.60 (m, 12H), 7.24 (s, 2H), 7.14 (s, 2H), 6.89 (s, 2H), 6.85 (s, 2H), 6.69 (s, 8H), 
6.62 (s, 4H), 6.61 (s, 4H), 3.80 (s, 12H), 3.77 (s, 12H), 2.03 (s, 12H), 2.03 (s, 24H), 2.02 (s, 
12H). 
13C NMR (125 MHz, CD2Cl2, δ): 161.6, 161.1, 161.0, 159.6, 158.5, 157.5, 157.4, 156.3, 
156.2, 156.2, 153.5, 152.7, 152.5, 152.0, 151.3, 150.9, 147.2, 142.4, 142.3, 140.6, 139.0, 
138.3, 138.1, 137.6, 137.5, 137.0, 136.9, 135.9, 134.6, 130.6, 123.7, 123.2, 122.7, 122.6, 
122.5, 122.3, 122.2, 121.6, 121.3, 120.3, 118.0, 117.8, 117.6, 117.5, 114.6, 114.5, 113.9, 
113.4, 107.5, 104.0, 102.8, 102.7, 55.8, 55.7, 21.5, 21.1, 21.0. 
IR (film on NaCl, cm–1): 2961m, 2921m, 2852m, 1599m, 1454vs, 1390m, 1314m, 1263w, 
1237w, 1193w, 1155w, 1009w, 992s, 833m, 818m, 719w, 674m, 622w. 
HRMS (ESI) m/z: [M]2+ calcd for C94H74N10O8Ru: 786.2375; found: 786.2363; [M+(Δ-
TRISPHAT)+H]2+ calcd for C112H75Cl12N10O14PRu: 1168.0250; found: 1168.0241. 
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Chapter 3. Three Steps in One-pot: Synthesis of Linear Bilateral 
Extended 2,2′:6′,2′′-Terpyridine Ru(II) Complexes 
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3.1. Introduction 
 
Ability of tridentate 2,2′:6′,2′′-terpyridine (terpy) ligands to form kinetically stable 
complexes with ruthenium(II), and their interesting photophysical and electrochemical 
properties have been extensively utilized in various fields. The characteristic strong metal-
ligand coordinative bonds have been an attractive tool as a design element in supramolecular 
chemistry.1-4 Dye sensitized solar cells developed by Gratzel5 have drawn a special attention 
to polypyridine ruthenium complexes6. In previous chapter the concept of topologically linear 
bilateral extended terpy ligands was introduced as potential building blocks in supramolecular 
chemistry. It has been shown that octahedral metal complexes of tridentate 2,2′:6′,2′′-
terpyridine fused with five-membered furans rings mimic the topology of tetrahedral metal 
complexes of bidentate 5,5′-functionalized 2,2′-bipyridine (bipy) (Figure 3.1). An efficient 
one-pot acidic MOM-deprotection and base assisted cycloisomerization allowed accessing 
alkyl, aryl and heteroaryl substituted linear bilateral extended terpy derivatives. However, 
functional groups labile to the base or acid are incompatible under above described conditions. 
Therefore, a synthetic methodology to obtain these ligands or metal complexes directly under 
the neutral conditions would be of great importance (Figure 3.2). To extend accessibility to 
the linear bilateral terpy ligands, we focused on the available synthetic methodologies for the 
furo[2,3-c]pyridine functionlaity, as this is the key structural element for these systems. 
 
Figure 3.1. Linear bilateral extended 2,2′:6′,2′′-terpyridine mimicking the topology of 
bidentate 5,5′-functionalized 2,2′-bipyridine. 
 
In 1987, Fràter et al showed that furo[2,3-c]pyridine forms as a side product of 
Claisen rearrangement of 2-propynyl(3-pyridiyl)ethers at high temperature.7 Since then many 
other methodologies have been developed8-13. So far the most efficient protocol involves 
palladium catalyzed cross-coupling reaction between 3-hydroxy-4-halopyridine and acetylene 
with in situ cyclization to form fused furan ring, which was first discovered and further 
extended by Marinelli et al.14-16 Although it has been reported that ruthenium 
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(CpRuCl(PPh3)2) catalyzed cycloisomerizations of 2-ethynylpehnols give benzofuranes via 
formation of ruthenium vinlydenes17, to our knowledge, no ruthenium catalyzed synthesis of 
furo[2,3-c]pyridines is known to date. Given the fact that ruthenium is powerful catalyst in 
cycloisomerization reactions18,19 and based on the results described in the previous chapter, it 
was expected that the formation of 2,6-bis-(2-substituted-furo[2,3-c]pyridin-5-yl)pyridine 
scaffold could take place in course of the complexation reaction of 5,5′′-bis-
(methoxymethoxy)-4-(2-substituted-ethynyl)-2,2′:6′,2′′-terpyridine with Ru(DMSO)4Cl2. 
(Figure 3.2). In this chapter, the new methodology is described that provides access to linear 
bilateral extended 2,2′:6′,2′′-terpyridine Ru(II) complexes via one-pot MOM cleavage, 
cycloisomerization and metal complexation of 5,5′′-bis-(methoxymethoxy)-4,4′′-bis-
(substituted-ethynyl)-2,2′:6′,2′′-terpyridines. 
 
Figure 3.2. The one-pot strategy for the synthesis of linear bilateral extended 2,2′:6′,2′′-
terpyridine Ru(II) complexes from 5,5′′-bis-(methoxymethoxy)-4,4′′-bis-(substituted-
ethynyl)-2,2′:6′,2′′-terpyridines. 
 
3.2. Results and Discussion 
 
3.2.1. Synthesis of bisethynyl-substituted terpyridine substrates 78 
 
Initially, several substrates bearing different functional groups were prepared in order to test 
one-pot synthesis of Ru(II) complexes of linear bilateral extended terpyridine ligands. The 
4,4′′-diethynyl 5,5′′-diMOM substituted terpyridines 78 were efficiently prepared from the 
diiodoterpyridine 69. The Sonogashira coupling20 reaction between terpyridine 69 and excess 
of various acetylenes 59 gave disubstituted ethynylterpyridines 78 bearing aryl, haloaryl, 
amide, ester, heteroaryl, nitrile and alkyl groups with good to high yields (Table 3.1). The 
Miyaura borylation21 of dibromo derivative 78j afforded pinacolboronate 78o in a good yield. 
(Scheme 3.1). 
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Table 1. Synthesis of Acetylenes 78 
 
entry R= eq time 
(h) 
product yield 
(%) 
1 
 
2.5 18 78i 83 
2 
 
2.2 18 78j 64 
3 
 
2.4 18 78k 85 
4 
 
2.5 20 78a 95 
5 
 
7.8 20 78e 85 
6 
 
2.4 18 78l 85 
7 
 
2.3 8 78h 91 
8  2.4 18 78n 71 
 
Scheme 1. Synthesis of Pinacol Boronate 78o 
 
 
3.2.2.  One-pot MOM Cleavage, Cyclization and Ru(II) Complexation  
 
Attempts to obtain Ru(II) complex [L72Ru](PF6)2 functionalized with ester groups via 
free ligand 84 with following complexation were not successful (Scheme 3.2). The hydrolysis 
of ester groups during the one-pot acidic MOM deporotection and base assisted 
cycloisomerization of 78i did not give the desired diester 84, instead the ~2:1 mixture of acid 
and monoester was formed. This motivated to test diester 78i as the first substrate for the 
neutral one-pot preparation of complex [L72Ru](PF6)2. 
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Scheme 3.2. Unsuccessful synthesis of [L72Ru](PF6)2 
 
The diethyl ester 78i and 0.5 equivalents of Ru(DMSO)4Cl2  were heated in ethylene 
glycol to 120 °C for 48 hours (Scheme 3.3). According to ESI-MS, the formation of the 2:1 
ligand to Ru(II) complex was observed, in addition, the molecular ion clearly showed that 
MOM protecting groups were cleaved in the course of the reaction. 
Scheme 3.3. Synthesis of bis-[2,6-bis-(2-Substituted-furo[2,3-c]pyridin-5-yl)pyridine] 
Ru(II)-2PF6 Complexes [L2Ru](PF6)2 a 
 
 
a The terpyridine 78 (0.02 mmol) and Ru(DMSO)4Cl2 (0.01 mmol) were heated in ethylene glycol (8 
ml) to 120 °C under N2 for 24 to 48 h. The crude product was precipitated with aq. KPF6 and purified 
by silica gel column chromatography. 
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The crude reaction mixture was subjected to chromatographic separation to isolate the 
red band, which suggested the presence of bis-terpy Ru(II) species. The 1H and 13C NMR 
spectra allowed to distinguish whether the newly formed product remains as a diacetylene or 
performs cyclization to give furo[2,3-c]pyridine moieties. In comparison to the 1H NMR 
spectrum of diacetylene 78i, a new singlet appears at 7.47 ppm in the spectrum of the 
complex [L72Ru](PF6)2, which is characteristic for H at the C3 position of a furo[2,3-
c]pyridine fragment. The characteristic signals for the disubstituted ethynyl group are absent 
in 13C NMR of [L72Ru](PF6)2, but a new CH signal appears at 104.3 ppm (multiplicity 
determined from DEPT90 and DEPT135 experiments), which corresponds to the C3 position 
of the furan ring. Overall, spectral data are compatible with the previously reported Ru(II) 
complexes of linear bilateral extended terpyridines and support the formation of product 
[L72Ru](PF6)2.  
To test the scope of the reaction, various diacetylenes 78 were used for obtaining one-
pot MOM deprotection, furan cyclization and Ru(II) complexation products [L2Ru](PF6)2 
(Scheme 3.3).  
The diacetylenes 78a,e,i-k give the desired products [L1,7-102Ru](PF6)2 in 40-53 % 
yields. Unexpectedly, nitrile groups of 78l underwent solvolysis to give ethylene glycol ester 
[L112Ru](PF6)2. This is an interesting example of the reaction where four transformations 
take place in one-pot. The substrates with electron donating groups give low yields of the 
desired complexes, as shown with the examples of [L122Ru](PF6)2 and [L132Ru](PF6)2. It 
should be noted that pinacol boronate 78o decomposed under the reaction conditions and no 
desired product [L142Ru](PF6)2 was obtained. 
A plausible mechanism for the Ru(II) catalyzed MOM deprotection and 
cycloizomerization is proposed in Scheme 3.4. Initially, Ru(II) species act as Lewis acid 
activating an ether bond of the methoxymethoxy (OMOM) group in order to promote the 
substitution with ethylene glycol A. The formed Ru pyridine-3-olate species B are converted 
to 4-ethynyl-3-hydroxy-pyridyl intermediate C in the presence of previously generated acid. 
Ruthenium coordinates to the acetylene group activating it for the 5-endo-dig cyclization D to 
give a fused furan ring. Further, the organoruthenium intermediate is converted to the desired 
furopyridine motif E. Presumably, after the catalytic cycle Ru(II) species are trapped by terpy 
affording the desired complexes [L2Ru](PF6)2. 
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Scheme 3.4. Proposed Mechanism for Ru(II) Catalyzed MOM Cleavage and 
Cycloisomerization of 78 
 
 
The diethyl ester [L72Ru](PF6)2, prepared by the above-mentioned methodology, can 
be further used to obtain an interesting, water-soluble zwitterionic complex [L152Ru](PF6)2, 
which has four terminal carboxylate groups (Scheme 3.5). Such molecular “crossing” with 
carboxylate groups could be interesting building block for the synthesis of MOFs.  
Scheme 3.5. Synthesis of Zwitterionic Ru(II) Complex [L152Ru](PF6)2 
 
 
3.2.3. Photophysical Properties 
 
The photophysical properties of ruthenium complexes [L2Ru](PF6)2 are summarized 
in Table 3.2. The UV-vis spectra of [L2Ru](PF6)2 display pronounced ligand centered (LC) 
absorptions with maxima at ~330-341 nm and characteristic lower energy MLCT bands (400-
509 nm) (Figure 3.3). The MLCT bands of [L2Ru](PF6)2 are non-luminescent at room 
temperature. However, excitation at the LC bands of [L72Ru](PF6)2, [L12Ru](PF6)2 and [L9-
122Ru](PF6)2 show weak but detectable emission (Figure 3.4). 
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Table 3.2. Absorption and Emission Maxima, Molar Absorptivity Values (log ε), 
Quantum Yields (φ f), and Lifetimes (τ f) for [L2Ru](PF6)2 
 UV/Visa Fluorescence a 
 λabs (nm) log ε (log(cm-1 mol-1 L)) 
λem 
(nm) φf, %
 b τf (ns) 
[L72Ru](PF6)2 
256, 311, 324, 330, 341, 
399, 466, 503 
4.86, 5.10, 5.06, 5.01, 
5.21, 4.59, 4.35, 4.27 383 0.04 4.60 
[L82Ru](PF6)2 
200, 256, 318sh, 330, 376, 
461, 494 
5.11, 5.01, 4.89, 5.09, 
4.37, 4.22, 4.00 -
 c - c - c 
[L92Ru](PF6)2 
218, 256, 312, 325, 340, 
396, 465, 509 
4.61, 4.71, 4.90, 4.89, 
5.02, 4.51, 4.36, 4.30 379, 399  0.01 4.20 
[L12Ru](PF6)2 
258, 291, 307, 324, 338, 
389, 464, 506 
4.90, 5.01, 4.99, 4.98, 
5.16, 4.57, 4.30, 3.73 349 0.06 3.22 
[L102Ru](PF6)2 
256, 291, 306, 323, 337, 
391, 464, 509 
4.89, 4.99, 4.97, 4.90, 
5.11, 4.49, 4.27, 4.12 359 0.17 4.58 
[L112Ru](PF6)2 
256, 311, 324, 341, 400, 
465, 506 
4.75, 5.00, 4.97, 5.09, 
4.50, 4.27, 4.20 380 
<0.01 
d - d 
[L122Ru](PF6)2 
242, 274, 288, 330, 372, 
462, 508 
5.02, 4.86, 4.83, 5.08, 
4.45, 4.22, 3.98 364 
<0.01 
d -
 e 
[L132Ru](PF6)2 247, 326, 366, 461, 499 
4.99, 4.97, 4.23, 4.16, 
3.85 -
 c - c - c 
[L152Ru](PF6)2 f 
258, 297, 313, 326, 341, 
390, 466, 508 
4.52, 4.66, 4.69, 4.70, 
4.79, 4.26, 4.00, 3.90 -
 c - c - c 
a All values measured in MeCN unless otherwise stated. b Measured with an integrating sphere. c 
Nonluminescence at rt. d Below the detection limit. e Due to the low emission cannot be measured 
reliably. f  Measured in the 1:1 mixture of MeCN:H2O. 
 
Figure 3.3. Absorption and emission spectra of complexes [L2Ru](PF6)2 in MeCN 
solution. * Measured in the 1:1 mixture of MeCN:H2O. 
 
The fluorescence quantum yields of these complexes are very low and range from 
0.01% to 0.17%. The emission for [L112Ru](PF6)2 and [L122Ru](PF6)2 can be observed; 
however, quantum yields could not be reliably measured due to the low values. The 
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fluorescence lifetimes for complexes [L12Ru](PF6)2, [L72Ru](PF6)2, and [L9-102Ru](PF6)2 
are in the range of 4.3-4.6 ns. 
 
 
Figure 3.4. Absorption and emission spectra of complexes [L2Ru](PF6)2 in MeCN 
solution. 
 
3.3. Conclusions 
 
In summary, a novel one-pot MOM deprotection, cycloisomerization and complexation 
reaction has been developed, which provided an access to linear bilateral extended 2,2′:6′,2′′-
terpyridine Ru(II) complexes starting form 5,5”-bis-(methoxymethoxy)-4-(2-substituted-
ethynyl)-2,2′:6′,2”-terpyridine. These new reaction conditions broaden the scope to access 
linear bilateral extended terpyridine Ru(II) complexes. Especially, this method provides a 
direct access to Ru(II) complexes bearing such base labile groups like esters. 
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3.4. Experimental Section 
 
3.4.1. Materials and Methods 
 
All reagents and solvents used for reactions were reagent grade and used without further 
purification unless otherwise noted. Commercial chemicals where used as received without 
special purification. Acetylenes 59i22, 59j23, 59k24 and 59l25 were prepared according to the 
literature procedures. Anhydrous THF and toluene was supplied from an Mbraun solvent 
purification system. Analytical thin-layer chromatography was performed with Macherey–
Nagel POLYGRAM SIL N-HR/UV254 or ALOX N/UV254. Flash silica gel column 
chromatography was performed with Merck silica gel 60 (particle size 0.040–0.063 mm). 
Flash alumina column chromatography was performed with deactivated (5% water) Fluka 
alumina (particle size 0.05–0.15 mm, pH 7.0±0.5). Melting points were recorded on a Büchi 
B-540 melting point apparatus. For characterization purposes, proton nuclear magnetic 
resonance (1H-NMR) spectra were all recorded on Bruker instruments (AV-300 and ARX-
300 at 300 MHz, AV2- 400 at 400 MHz, and AV-500 at 500 MHz). Chemical shifts are 
reported in ppm relative to CHCl3 (δ 7.26), CD3CN (δ 1.94) or DMSO-d6 (δ 2.50). 
Multiplicity and shape are indicated by one or more of the following abbreviations: s 
(singlet); d (doublet); t (triplet); q (quartet); dd (doublet of doublets); td (triplet of doublets); 
m (multiplet); br (broad). Carbon-13 nuclear magnetic resonance (13C-NMR) spectra were 
recorded on Bruker instruments (ARX-300 at 75 MHz, AV2-400 at 100 MHz, and AV-500 at 
125 MHz). Chemical shifts are reported relative to CDCl3 (δ 77.2), CD3CN (δ  1.3) or 
DMSO-d6 (δ 39.5). Infrared spectroscopic data was recorded on NaCl plates as thin films or 
as KBr pellets on a Perkin Elmer Spectrum One (PE) and the intensities are given as follows: 
s = strong, m = medium, and w = weak. An Agilent 8453 UV/Vis spectrophotometer was used 
to record all UV/Vis spectra. Emission spectra and lifetimes (ns) were recorded on an 
Edinburgh Instruments FLS920 spectrometer. Quantum yields were measured using an 
integrating sphere accessory for FLS920 spectrometer. ESI-HRMS spectra were recorded at 
the MS Facility of the Institute of Organic Chemistry of the University of Zurich.
 104 
3.4.2. Experimental Procedures 
 
General Procedure for the Synthesis of 78 
To a mixture of diiodoterpyridine 69 (1.0 mmol), CuI (0.1 mmol) and PdCl2(PPh3)2 (0.05 
mmol) in degassed THF/Et3N (10 mL/10 mL) was added acetylene 59 (amount indicated 
below) under N2 atmosphere at 80 °C. The reaction mixture was heated to reflux till 
completion (followed by TLC), allowed to cool to room temperature and evaporated to 
dryness under reduced pressure. The residue was redissolved in CH2Cl2 (30 mL), washed with 
10% aqueous NH4OH, water and brine. The organic phase was dried over MgSO4, filtrated 
and evaporated under reduces pressure. And purified as indicated below.  
 
diethyl 4,4′′-(5,5′′-bis-(methoxymethoxy)-2,2′:6′,2′′-terpyridine-4,4′′-diyl)-bis-(ethyne-2,1-
diyl)-dibenzoate (78i). Ethyl 4-ethynylbenzoate (59i) (2.5 mmol). Purified by neutral Al2O3 
(deact. with 5% w/w H2O) column chromatography with hexane/EtOAc (3:1). 
White solid; 579 mg (yield 83%). 
Mp 159–161 °C.  
IR (film on NaCl, cm–1): 2980w, 2216w, 1718s, 1606m, 1572w, 1484m, 1456m, 1404w, 
1379m, 1308m, 1273vs, 1233m, 1199m, 1158m, 1105m, 1074m, 1020w, 987m, 922w, 905w, 
855w, 820w, 767m, 694w. 
1H NMR (500 MHz, CDCl3, δ): 8.69 (s, 2H), 8.62 (s, 2H), 8.36 (d, J = 7.8 Hz, 2H), 8.05 
(AA′BB′ spin system, 4H), 7.93 (t, J = 7.8 Hz, 1H), 7.68 (AA′BB′ spin system, 4H), 5.41 (s, 
4H), 4.41 (q, J = 7.0 Hz, 4H), 3.61 (s, 6H), 1.42 (t, J = 7.0 Hz, 6H).  
13C NMR (125 MHz, CDCl3, δ): 166.0, 154.6, 153.8, 150.2, 138.1, 137.2, 132.0, 131.0, 129.7, 
127.1, 124.7, 122.4, 120.7, 96.9, 95.9, 86.4, 61.4, 56.8, 14.5. 
HRMS (ESI) m/z [M+H]+ calcd for C41H36N3O8 698.24969, found 698.24925. 
 
5,5′′-bis-(methoxymethoxy)-4,4′′-bis-((4-bromo-2,6-dimethylphenyl)ethynyl)-2,2′:6′,2′′-
terpyridine (78j). 5-Bromo-2-ethynyl-1,3-dimethylbenzene (59j) (2.2 mmol). Purified by 
neutral Al2O3 (deact. with 5% w/w H2O) column chromatography with hexane/EtOAc 
(gradient 3:1 to 1:1). 
A light yellow solid; 491 mg (yield 64%).  
Mp 181–184 °C.  
IR (film on NaCl, cm–1): 2953w, 2919w, 2853w, 2211w, 1572m, 1538w, 1485m, 1454w, 
1376w, 1306w, 1262m, 1202m, 1202w, 1155s, 1086m, 1073m, 991vs, 921w, 902w, 854w, 
838w, 817m, 777w, 724w, 606w. 
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1H NMR (400 MHz, CDCl3, δ): 8.65 (s, 2H), 8.59 (s, 2H), 8.36 (d, J = 7.8 Hz, 2H), 7.93 (t, J 
= 7.8 Hz, 1H), 7.25 (s, 4H), 5.39 (s, 4H), 3.57 (s, 6H), 2.50 (s, 12H).  
13C NMR (100 MHz, CDCl3, δ): 154.8, 153.4, 150.2, 142.7, 138.1, 137.0, 130.1, 124.2, 123.0, 
122.7, 121.6, 120.5, 95.5, 94.7, 92.9, 56.7, 21.0.  
HRMS (ESI) m/z [M+H]+ calcd for C39H34Br2N3O4 766.09106, found 766.09145. 
 
4,4′′-(5,5′′-bis-(methoxymethoxy)-2,2′:6′,2′′-terpyridine-4,4′′-diyl)-bis-(ethyne-2,1-diyl)-
dibenzamide (78k). 4-Ethynylbenzamide (59k) (2.4 mmol). The reaction mixture was 
evaporated to dryness under reduced pressure. The residual solid was treated with 10% 
aqueous NH4OH, filtered and washed with water. The crude product was heated to reflux with 
EtOH/THF (400/40 mL), allowed to cool to room temperature and the solid was collected by 
filtration.  
Off-white solid; 544 mg (yield 85%). Mp >300 °C.  
IR (KBr, cm–1): 3406s, 3190m, 2954w, 2924w, 2849w, 1655s, 1611s, 1573w, 1555w, 1514w, 
1483w, 1457m, 1409m, 1382s, 1304w, 1269w, 1251w, 1120w, 1157m, 1074m, 985m, 923w, 
907w, 853w, 818w, 769w. 
1H NMR (400 MHz, DMSO-d6, δ): 8.70 (s, 2H), 8.68 (s, 2H), 8.35 (d, J =7.8 Hz, 2H), 8.09 (t, 
J =7.8 Hz, 1H), 8.08 (br. s, 2H), 7.97-7.95 (AA′BB′ spin system, 4H), 7.77-7.75 (AA′BB′ spin 
system, 4H), 7.50 (br. s, 2H), 5.51 (s, 4H), 3.53 (s, 6H). 
13C NMR (125 MHz, DMSO-d6, δ): 167.0, 154.2, 153.2, 149.0, 138.5, 137.6, 134.8, 131.6, 
127.9, 124.2, 123.4, 121.0, 120.2, 96.7, 95.3, 85.3, 56.2. 
HRMS (ESI) m/z [M+H]+ calcd for C37H30N5O6: 640.21906; found: 640.21907. 
 
5,5′′-bis-(methoxymethoxy)-4,4′′-bis-(phenylethynyl)-2,2′:6′,2′′-terpyridine (78a). Phenyl 
acetylene (59a) (2.5 mmol). Purified by neutral Al2O3 (deact. with 5% w/w H2O) column 
chromatography. Eluent hexane/EtOAc 3:1. 
Off-white solid; 526 mg (yield 95 %).  
Mp 149–151 °C.  
IR (film on NaCl, cm–1): 2957w, 2906w, 2219w, 1600w, 1573m, 1544w, 1494m, 1484s, 
1457m, 1379m, 1308w, 1268m, 1232w, 1200m, 1155s, 1077m, 982s, 921w, 823w, 757m, 
690w.  
1H NMR (400 MHz, CDCl3, δ): 8.72 (s, 2H), 8.60 (s, 2H), 8.36 (d, J = 7.8 Hz, 2H), 7.92 (t, J 
= 7.8 Hz, 1H), 7.63 (dd, J = 7.6, 1.7 Hz, 4H), 7.41-7.34 (m, 6H), 5.40 (s, 4H), 3.61 (s, 6H). 
13C NMR (100 MHz, CDCl3, δ): 154.8, 153.6, 150.3, 137.9, 137.5, 132.0, 129.1, 128.5, 124.6, 
122.7, 120.3, 97.7, 95.9, 83.9, 56.7.  
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HRMS (ESI) m/z [M+Na]+ calcd for C35H27N3NaO4 576.18938, found 576.18905. 
 
5,5′′-bis(methoxymethoxy)-4,4′′-bis[2-(pyridine-3-yl)ethynyl]-2,2′:6′,2′′-terpyridine (78e). 3-
Ethynylpyridine (59e) (7.8 mmol). Purified by silica gel column chromatography with 
CH2Cl2/MeOH (gradient 99:1 to 9:1).  
White solid; 472 mg (yield 85%). 
 Mp 164–165 °C dec. 
IR (film on NaCl, cm–1): 2958w, 2831w, 2220w, 1571m, 1546w, 1486s, 1457m, 1409w, 
1378m, 1308w, 1268w, 1234w, 1200m, 1155s, 1076m, 976vs, 923w, 821w, 703w. 
 1H NMR (400 MHz, CDCl3, δ): 8.86 (d, J = 1.2 Hz, 2H), 8.69 (s, 2H), 8.63 (s, 2H), 8.61 (dd, 
J = 4.9, 1.6 Hz, 2H), 8.36 (d, J = 7.8 Hz, 2H), 7.93 (t, J = 7.9 Hz, 1H), 7.90 (dt, J = 7.9, 1.9 
Hz, 2H), 7.34 (ddd, J = 7.9, 4.9, 0.7 Hz, 2H), 5.40 (s, 4H), 3.60 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 154.7, 153.7, 152.4, 150.2, 149.3, 139.0, 138.0, 137.2, 124.5, 
123.4, 121.7, 120.6, 119.9, 95.7, 94.0, 87.0, 56.8.  
HRMS (ESI) m/z [M+H]+ calcd for C33H26N5O4: 556.19793; found: 556.19697. 
 
4,4′′-(5,5′′-bis-(methoxymethoxy)-2,2′:6′,2′′-terpyridine-4,4′′-diyl)-bis-(ethyne-2,1-
diyl)dibenzonitrile (78l). 4-Ethynylbenzonitrile (59l) (2.4 eq). Purified by neutral Al2O3 (deact. 
with 5% w/w H2O) column chromatography with hexane/EtOAc (1:1). 
White solid; 513 mg (yield 85%). 
Mp 232–233 °C. 
IR (film on NaCl, cm–1): 2952w, 2916w, 2845w, 2226s, 1605m, 1573m, 1504w, 1482m, 
1457w, 1380m, 1309m, 1270m, 1200w, 1156m, 983s, 900s, 839s. 
1H NMR (500 MHz, CDCl3, δ): 8.64 (s, 2H), 8.63 (s, 2H), 8.35 (d, J = 7.7 Hz, 2H), 7.94 (t, J 
= 7.8 Hz, 1H), 7.71-7.66 (AA′BB′ spin system, 8H), 5.40 (s, 4H), 3.60 (s, 6H). 
13C NMR (125 MHz, CDCl3, δ): 154.9, 153.8, 150.4, 138.1, 137.4, 132.5, 132.3, 127.5, 124.3, 
121.3, 120.7, 118.4, 112.6, 95.8, 95.4, 87.9, 56.8. 
HRMS (ESI) m/z [M+H]+ calcd for C37H26N5O4: 604.19793; found: 604.19798. 
 
4,4′′-bis-[2-(4-methoxy-2,6-dimethylphenyl)-ethynyl]-5,5′′-bis(methoxymethoxy)-2,2′:6′,2′′-
terpyridine (78h). 2-Ethynyl-5-methoxy-1,3-dimethylbenzene (73) (2.3 mmol). Purified by 
silica gel column chromatography with CH2Cl2/MeOH (95:5). 
Off-white solid; 609 mg (yield 91%). Mp 182–183 °C.  
IR (film on NaCl, cm–1): 2952w, 2902w, 2836w, 2190w, 1603m, 1573s, 1484m, 1453m, 
1377m, 1315m, 1303s, 1283m, 1228m, 1194m, 1155s, 1119m, 1086m, 1073m, 1058m, 990s, 
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921m, 897m, 853m, 818m, 732m, 661w, 602m.  
1H NMR (400 MHz, CDCl3, δ): 8.65 (s, 2H), 8.57 (s, 2H), 8.38 (d, J = 7.9 Hz, 2H), 7.94 (t, J 
= 7.9 Hz, 1H), 6.62 (s, 4H), 5.39 (s, 4H), 3.81 (s, 6H), 3.58 (s, 6H), 2.53 (s, 12H).  
13C NMR (125 MHz, CDCl3, δ): 159.9, 154.7, 153.3, 150.1, 142.9, 138.1, 136.9, 124.2, 123.8, 
120.5, 115.0, 112.7, 96.6, 95.6, 90.7, 56.7, 55.3, 21.4.  
HRMS (ESI) m/z [M+H]+ calcd for C41H40N3O6: 670.29116; found: 670.29071. 
 
5,5′′-(5,5′′-bis-(methoxymethoxy)-2,2′:6′,2′′-terpyridine-4,4′′-diyl)dipent-4-yn-1-ol (78n). 
Pent-4-yn-1-ol (59n) (2.4 mmol). Purified by neutral Al2O3 (deact. with 5% w/w H2O) 
column chromatography with CH2Cl2/MeOH (95:5). 
White amorphous solid; 367 mg (71%).  
Mp 144–145 °C.  
IR (film on NaCl, cm–1): 3332br, 2940w, 2919w, 2233w, 1567w, 1544w, 1487m, 1459m, 
1378m, 1276m, 1193m, 1153s, 1083m, 978vs, 924m;  
1H NMR (400 MHz, CDCl3, δ): 8.56 (s, 2H), 8.54 (d, J = 0.5 Hz, 2H), 8.31 (d, J =7.8 Hz, 2H), 
7.89 (t, J = 7.8 Hz, 1H), 5.34 (s, 4H), 3.89 (t, J =6.1 Hz, 4H), 3.57 (s, 6H), 2.68 (t, J =6.8 Hz, 
4H), 2.17 (br. s, 2H), 1.95 (tt, J = 6.1, 6.8 Hz, 4H).  
13C NMR (125 MHz, CDCl3, δ): 154.8, 153.9, 150.3, 137.9, 137.3, 124.8, 122.9, 120.3, 98.7, 
95.7, 77.4, 77.2, 76.9, 75.9, 61.9, 56.7, 31.3, 16.8.  
HRMS (ESI) m/z [M+H]+ calcd for C29H32N3O6: 518.22856; found: 518.22837. 
 
Synthesis of 78o 
 
4,4′′-bis((2,6-dimethyl-4-(3,3,4,4-tetramethylborolan-1-yl)phenyl)ethynyl)-5,5′′-
bis(methoxymethoxy)- 2,2′:6′,2′′-terpyridine (78o). 
Prepared according to the Miyaura borylation21 from (78j) as follows:  
In a dry 50 mL 2 necked flask to a mixture of dibromide 78j (100 mg, 1.0 eq, 0.131 mmol), 
bis(pinacolato)diboron (72.8 mg, 2.2 eq, 0.286 mmol), potassium acetate (51.2 mg, 4.0 eq, 
0.528 mmol) and Pd(dppf)Cl2 (10.7 mg, 10 mol%, 0.0131 mmol) under N2 atmosphere dry 
1,4-dioxane (12 mL) was added. The reaction mixture was heated to reflux for 18 h, allowed 
to cool to room temperature and the solvent was evaporated under reduced pressure. The 
crude mixture was purified by silica gel column chromatography with hexane:EtOAc:CH2Cl2 
(3:1:3). 
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White amorphous solid; 79 mg (yield 70%). Mp 80–86 (waxy solid) °C. IR (film on NaCl, 
cm–1): 2977w, 2919w, 2849w, 2207w, 1607w, 1575w, 1483m, 1455m, 1364vs, 1314w, 1260w, 
1237m, 1199w, 1146s, 1074m, 985s, 853m, 740w, 740w; 1H NMR (400 MHz, CDCl3, δ): 8.63 
(s, 2H), 8.60 (s, 2H), 8.37 (d, J = 7.8 Hz, 2H), 7.93 (t, J = 7.8 Hz, 1H), 7.55 (s, 4H), 5.40 (s, 
4H), 3.58 (s, 6H), 2.57 (s, 12H), 1.37 (s, 24H). 13C NMR (75 MHz, CDCl3, δ): 155.1, 153.5, 
150.3, 140.0, 137.0, 136.9, 133.1, 129.9, 125.3, 123.9, 122.9, 120.5, 95.9, 95.4, 93.0, 84.1, 
56.7, 25.0, 21.0. HRMS (ESI) m/z [M+H]+ calcd for C51H58B2N3O8: 862.44204; found: 
862.44228. 
 
General Procedure for One-pot Synthesis of [L2Ru](PF6)2 
A mixture of diethynyl terpyridine 78 (0.02 mmol) and Ru(DMSO)4Cl2 (0.01 mmol) in 
ethylene glycol (8 mL) was heated to 120 °C under N2 atmosphere for the indicated time. The 
mixture was allowed to cool to room temperature and aqueous KPF6 was added. The resulting 
deep-red precipitate was collected by filtration on Celite, washed with water, Et2O, hexane 
and redissolved with acetonitrile into a clean flask. The solvent was evaporated to give a 
deep-red residue, which was purified by silica gel column chromatography. The combined 
fractions containing product [L2Ru](PF6)2 were evaporated under reduced pressure. 
Dissolved in minimum amount of acetonitrile and reprecipitated with aq. KPF6 solution. A red 
solid was collected by filtration on Celite, washed with water, Et2O and redissolved with 
acetonitrile into a clean flask. Solvent evaporated under reduced pressure to give 
[L2Ru](PF6)2. 
 
Ru[diethyl 4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))dibenzoate]2-2PF6 
([L72Ru](PF6)2). The reaction mixture was heated for 24 h. Eluent acetonitrile/H2O/aq. 
KPF6/CH2Cl2 (97:3:0.3:100). The first red band was collected. 
Dark red solid; 17.0 mg (yield 53%).  
Mp >282 dec °C.  
IR (film on NaCl, cm–1): 2983w, 2918w, 2849w, 1714s, 1613m, 1456s, 1412w, 1368w, 1279s, 
1182w, 1108m, 1016m, 842vs, 773w, 699w, 558m.  
1H NMR (500 MHz, CD3CN, δ): 8.86 (s, 4H), 8.81 (d, J = 8.2 Hz, 4H), 8.52 (t, J = 8.2 Hz, 
2H), 8.07-8.05 (AA′BB′ spin system, 8H), 7.91-7.89 (AA′BB′ spin system, 8H), 7.73 (s, 4H), 
7.47 (s, 4H), 4.32 (q, J = 7.1 Hz, 8H), 1.34 (t, J = 7.1 Hz, 12H).  
13C NMR (125 MHz, CD3CN, δ): 166.4, 161.7, 156.8, 153.2, 153.0, 137.7, 137.5, 137.1, 
133.3, 132.8, 131.0, 126.9, 123.4, 118.3 (overlapping with CD3CN), 104.3, 62.2, 14.5.  
HRMS (ESI) m/z: [M]2+ calcd for C74H54N6O12Ru: 660.14262; found: 660.14224. 
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Ru[2,6-bis(2-(4-bromo-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine]2-2PF6 
([L82Ru](PF6)2). The reaction mixture was heated for 48 h. Eluent gradient 
acetonitrile/H2O/aq. KPF6/CH2Cl2 (97:3:0.3:0 to 97:5:1:100). The first red band was collected.  
Dark red solid; 14.0 mg (yield 40 %).  
Mp >370 dec. °C.  
IR (film on NaCl, cm–1): 2921w, 2853w, 1623w, 1592m, 1452s, 1311w, 1249w, 1148w, 
1001w, 913w, 843vs, 740w, 559m.  
1H NMR (500 MHz, CD3CN, δ): 8.85 (s, 4H), 8.75 (d, J = 8.2 Hz, 4H), 8.44 (t, J = 8.2 Hz, 
2H), 7.72 (s, 4H), 7.35 (s, 8H), 7.06 (s, 4H), 2.04 (s, 24H).  
13C NMR (125 MHz, CD3CN, δ): 161.3, 156.8, 153.0, 152.7, 141.8, 137.7, 137.2, 136.8, 
131.6, 128.4, 125.0, 123.2, 118.1 (overlapping with CD3CN), 108.3, 20.3. 
HRMS (ESI) m/z: [M]2+ calcd for C70H50Br4N6O4Ru: 727.98196; found: 727.98320. 
 
Ru[4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))dibenzamide]2-2PF6 
([L92Ru](PF6)2). The reaction mixture was heated for 48 h. The crude product was dissolved 
in minimum amount of wet acetonitrile and charged on a silica gel column (insoluble in dry 
acetonitrile). Eluent acetonitrile/H2O/aq. KPF6 (90:10:5). The first red band was collected. 
Dark red solid; 12.8 mg (yield 43%).  
Mp >334 dec. °C.  
IR (KBr, cm–1): 3441br, 1667s, 1619m, 1599m, 1555w, 1456m, 1411w, 1384s, 1315w, 1282w, 
1176w, 1014w, 912w, 848vs, 804w, 774w, 558w.  
1H NMR (500 MHz, CD3CN+D2O, δ): 8.87 (s, 4H), 8.82 (d, J = 8.3 Hz, 4H), 8.49 (t, J = 8.3 
Hz, 2H), 8.16-7.99 (m, 8H), 7.87 (s, 16H), 7.71 (s, 4H), 7.47 (s, 4H). 
 13C NMR (125 MHz, CD3CN+D2O, δ): 170.1, 161.8, 156.7, 153.1, 152.9, 137.7, 137.3, 
137.1, 136.1, 131.8, 129.4, 126.9, 123.4, 118.2 (overlapping with CD3CN), 104.02.  
HRMS (ESI) m/z: [M]2+ calcd for C66H42N10O8Ru: 602.11098; found: 602.11118. 
 
Ru[2,6-bis(2-phenylfuro[2,3-c]pyridin-5-yl)pyridine]2-2PF6 ([L12Ru](PF6)2). The reaction 
mixture was heated for 48 h. Eluent acetonitrile/H2O/aq. KPF6 (97:3:0.3). The first red band 
was collected. 
Dark red solid; 10.8 mg (yield 41 %).  
Mp >350 dec °C.  
IR (KBr, cm–1): 3116w, 3069w, 1621m, 1585w, 1567w, 1485w, 1459s, 1447s, 1385w, 1313w, 
1278w, 1176w, 1020w, 842vs, 767w, 687w, 558s. 1H NMR (500 MHz, CD3CN, δ): 8.82 (s, 
2H), 8.80 (d, J = 8.2 Hz, 2H), 8.50 (t, J = 8.2 Hz, 1H), 7.83-7.80 (m, 4H), 7.68 (s, 2H), 7.48-
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7.46 (m, 6H), 7.34 (s, 2H). 13C NMR (125 MHz, CD3CN, δ): 163.1, 156.8, 152.9, 152.8, 
137.9, 137.0, 136.8, 131.9, 130.2, 128.9, 126.9, 123.2, 117.9, 102.4.  
HRMS (ESI) m/z: [M]2+ calcd for C62H38N6O4Ru: 516.10018; found: 516.09979. 
 
Ru[2,6-bis(2-(pyridin-3-yl)furo[2,3-c]pyridin-5-yl)pyridine]2-2PF6 ([L102Ru](PF6)2). The 
reaction mixture was heated for 48 h. Eluent acetonitrile/H2O/aq. KPF6 (90:10:5). The first 
red band was collected. 
Dark red solid; 11.4 mg (yield 43%).  
Mp >278 dec. °C.  
IR (KBr, cm–1): 2921s, 2851m, 1659m, 1632m, 1469w, 1449m, 1407m, 1309w, 1014w, 913m, 
872w, 840s, 798m, 700m, 557m.  
1H NMR (500 MHz, CD3CN, δ): 9.01 (d, J = 1.8 Hz, 4H), 8.86 (s, 4H), 8.81 (d, J = 8.2 Hz, 
4H), 8.61 (dd, J = 1.6, 4.8 Hz, 4H), 8.52 (t, J = 8.2 Hz, 2H), 8.10 (dt, J = 1.9, 8.13 Hz, 4H), 
7.73 (s, 4H), 7.45 (s, 4H), 7.44 (dd, J = 4.8, 7.9 Hz, 4H).  
13C NMR (125 MHz, CD3CN, δ): 160.6, 156.8, 153.1, 153.0, 152.4, 148.0, 137.6, 137.5, 
137.0, 134.0, 125.3, 125.0, 123.4, 118.3 (overlapping with CD3CN), 103.8.  
HRMS (ESI) m/z: [M]2+ calcd for C58H34N10O4Ru: 518.09061; found: 518.09128. 
 
Ru[bis(2-hydroxyethyl) 4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-
diyl))dibenzoate]2-2PF6 ([L112Ru](PF6)2). The reaction mixture was heated for 48 h. Eluent 
acetonitrile/H2O/aq. KPF6/CH2Cl2 (35:2:1:19). The second red band was collected. 
Dark red solid; 12.4 mg (yield 37%).  
Mp >330 dec. °C.  
IR (KBr, cm–1): 3431br, 2923w, 2852w, 1717s, 1620m, 1586w, 1456s, 1411w, 1374w, 1313w, 
1278s, 1182w, 1125w, 1077w, 1015w, 846s, 773w, 558m.  
1H NMR (500 MHz, CD3CN, δ): 8.85 (s, 4H), 8.81 (d, J = 8.2 Hz, 4H), 8.52 (t, J = 8.2 Hz, 
2H), 8.11-8.09 (AA′BB′ spin system, 8H), 7.92-7.91 (AA′BB′ spin system, 8H), 7.73 (s, 4H), 
7.48 (s, 4H), 4.32 (t, J = 4.8 Hz, 8H), 3.78 (t, J = 4.8 Hz, 8H), 2.98 (br. s, 4H).  
13C NMR (125 MHz, CD3CN, δ): 166.4, 161.7, 156.8, 153.2, 153.0, 137.7, 137.5, 137.1, 
133.1, 132.9, 131.1, 126.9, 123.4, 118.3 (overlapping with CD3CN), 104.4, 67.9, 60.8.  
HRMS (ESI) m/z: [M]2+ calcd for C74H54N6O16Ru: 692.13248; found: 692.13168. 
 
Ru[2,6-bis(2-(4-methoxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine]2-2PF6 
([L122Ru](PF6)2). The reaction mixture was heated for 48 h. Eluent acetonitrile/H2O/aq. 
KPF6 (97:3:0.3). The first red band was collected. 
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Dark red solid; 5.6 mg (yield 18%). 
Mp >283 dec. °C.  
IR (film on NaCl, cm–1): 2918w, 1604m, 1455s, 1384w, 1313m, 1291w, 1192w, 1153w, 
1067w, 1003w, 840vs, 809w, 737w, 558w.  
1H NMR (500 MHz, CD3CN, δ): 8.83 (s, 4H), 8.75 (d, J = 8.2 Hz, 4H), 8.43 (t, J = 8.2 Hz, 
2H), 7.69 (s, 4H), 6.98 (s, 4H), 6.70 (s, 8H), 3.77 (s, 12H), 2.04 (s, 24H).  
13C NMR (125 MHz, CD3CN, δ): 163.0, 161.9, 156.9, 153.0, 152.6, 141.2, 137.5, 137.3, 
136.8, 123.1, 121.5, 117.8, 114.3, 107.8, 56.0, 20.7.  
HRMS (ESI) m/z: [M]2+ calcd for C74H62N6O8Ru: 632.18409; found: 632.18350. 
 
Ru[3,3′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))dipropan-1-ol]2-2PF6 
([L132Ru](PF6)2). The reaction mixture was heated for 18 h. Eluent acetonitrile/H2O/aq. 
KPF6/CH2Cl2 (35:2:1:19). The first red band was collected. 
Dark red solid; 5.8 mg (yield 23%). 
 Mp >206 dec. °C.  
IR (film on NaCl, cm–1): 3401br, 2918w, 1623w, 1583m, 1455s, 1313m, 1256m, 1174w, 
1058w, 1028m, 947m, 936m, 897m, 841vs, 808m, 558m.  
1H NMR (500 MHz, CD3CN, δ): 8.68 (d, J = 8.1 Hz, 4H), 8.67 (s, 4H), 8.39 (t, J = 8.1 Hz, 
2H), 7.48 (s, 4H), 6.70 (s, 4H), 3.44 (t, J = 5.2 Hz, 8H), 2.78 (t, J = 7.5 Hz, 8H), 2.58 (br. s, 
4H), 1.76 (quintuplet, J = 6.5 Hz, 8H).  
13C NMR (125 MHz, CD3CN, δ): 168.6, 156.7, 152.9, 152.4, 137.9, 136.5, 136.3, 122.9, 
117.5, 103.6, 61.2, 30.9, 25.5.  
HRMS (ESI) m/z: [M]2+ calcd for C50H46N6O8Ru: 480.12116; found: 480.12126. 
 
Synthesis of [L152Ru](PF6)2 
Ru[Na 4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))dibenzoate]2-2PF6 
([L152Ru](PF6)2). 
To a suspension of [L72Ru](PF6)2 (13.1 mg, 1.0 eq, 0.00813 mmol) in a 1:1 mixuture of 
EtOH/THF (8 mL) was added aqueous 1 M NaOH (81 µL, 10 eq, 0.081 mmol). The reaction 
mixture was heated to reflux for 18 h. The hot reaction mixture was filtered off to collect red 
solid, which was rinsed with few drops of abs. EtOH and dried under vacuum. 
Red solid; 8.6 mg (yield 85 %).  
Mp >200 dec. °C.  
IR (KBr, cm–1): 2927w, 2853w, 1596m, 1574s, 1551m, 1456m, 1385s, 1308w, 1279w, 1092w, 
1013w, 846w, 789w.  
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1H NMR (500 MHz, CD3CN + 5% D2O, δ): 9.07 (s, 4H), 9.02 (d, J = 8.32 Hz, 4H), 8.53 (t, J 
= 8.32 Hz, 2H), 7.88-7.86 (AA′BB′ spin system, 8H), 7.83 (s, 4H), 7.78-7.76 (AA′BB′ spin 
system, 8H), 7.59 (s, 4H).  
13C NMR (125 MHz, CD3CN + 5% D2O) 169.9, 161.9, 158.7, 155.8, 152.4, 152.0, 142.3, 
137.2, 136.3, 130.4, 128.7, 125.8, 123.1, 117.7, 102.7.  
HRMS (ESI) m/z: [M+4H-2Na]2+ calcd for C66H38N6O12Ru: 604.07991; found: 604.07974. 
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Chapter 4. Heterometallic MOFs based on Linear Bilateral Extended 
2,2′:6′,2′′-Terpyridine 
 116 
4.1. Introduction 
 
Rational design and assembly of supramolecular architectures require building blocks 
with defined geometries and topology.1 The pioneering work of Robson in 1990 showed that 
organic ligands and metal centers can act as “spacers and nodes” for constructing extended 
polymeric frameworks.2 Such design principles are successfully applied in the rapidly 
growing field of metal-organic frameworks (MOFs)3-6 with a major focus on creating novel 
porous materials for gas adsorption, storage7-9, and seperation10. However, synthesis and 
investigation of MOFs can also address specific properties required in such fields as 
catalysis11,12, specific recognition13, NLO optical14, luminescent15, spin crossover and 
magnetic materials16-20, and medicine21-23. A rigid and defined framework can be a platform 
for embedding complexity and still maintaining predictable structure.24 The MOFs are mostly 
prepared by solvothermal synthesis, but room temperature synthesis by slow diffusion of 
reactants can also be efficient.25,26 
The inorganic nodes bring rigidity, define topology, and offer geometries unavailable 
when using only organic molecules. However, further success and advance in the field of 
MOFs strongly depend on the development of versatile organic linkers because that is where 
the function, dimensions and properties can be tuned and adjusted most efficiently. 
In the previous chapters, the synthesis and metal complexation of a novel class of 
ligands – linear bilateral extended 2,2′:6′,2′′-terpyridines (terpy) was described. These are 
topological tridentate analogs of bidentate 5,5′-disubstituted 2,2′-bipyridines, which form 
molecular crossings upon complexation with metals preferring octahedral geometry. The 
flanking positions can be used for introducing directional groups that open the doors to 
assembly of extended network structures. This chapter describes assembly of 2D and 3D 
heterometallic MOFs based on 4-pyridyl substituted Fe(II) molecular crossing L3 in the 
presence of metals preferring tetrahedral geometry (Cu(I) and Ag(I)). 
 
4.2.Results and Discussion 
 
4.2.1. Synthesis of 2D and 3D Heterometallic MOFs 
 
A solution of AgPF6 in ethanol was layered over a solution of the 4-pyridyl substituted 
[L32Fe](PF6)2 complex in acetonitrile. A small amount of cyclohexane between the layers 
was used to slow down the diffusion process. In a few days needle-like crystals formed which 
over two weeks transformed into dark purple blocks that were separated by filtration to give 
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[L32FeAg]n(PF6)3n (Scheme 4.1). The structure of the product was elucidated by single 
crystal X-ray analysis.  
Scheme 4.1. Synthesis of 3D MOF [L32FeAg]n(PF6)3n 
 
Similarly, a [Cu(CH3CN)4]PF6 solution was slowly diffused into the acetonitrile 
solution of [L32Fe](PF6)2, using small amount of cyclohexane between the layers. Dark 
purple block-like crystals were obtained over three weeks, and the resulting product 
[L32FeCu(MeCN)]n(PF6)3n was separated by filtration (Scheme 4.2). The X-ray structure 
could be only partially solved due to the insufficient diffraction and crystal quality.  
Scheme 4.2. Synthesis of 2D MOF [L32FeCu(MeCN)]n(PF6)3n 
 
 
 
4.2.2.  Structure 
 
The crystals of [L32FeAg]n(PF6)3n and [L32FeCu(MeCN)]n(PF6)3n used for single 
crystal X-ray analysis where kept in the mother liquor to avoid decomposition, which happens 
due to quick loss of crystallization solvent. 
The X-ray crystal structure of [L32FeAg]n(PF6)3n was elucidated in space group P-1. 
The results of structural analysis are presented in Figures 4.1 and 4.2. The cationic structure 
of [L32FeAg]n(PF6)3n is a three-dimensional interpenetrating polymer.  
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Figure 4.1. ORTEP drawing (50% probability) of the cation in [L32FeAg]n(PF6)n3. (Color 
code: Fe, brown; Ag, silver; N, light blue; O, red; C, dark gray; P, orange; F, light green) 
Hydrogen atoms and PF6- removed for clarity. 
 
Figure 4.2. Packing of [L32FeAg]n(PF6)3n. The cationic structure consists of two 
interpenetrating 3D networks related by inversion symmetry (color defined by symmetry 
operations). Hydrogen atoms, PF6- and disordered solvent molecules removed for clarity. 
 
The symmetry operators connecting the asymmetric unit to adjacent units within the 
polymer all involve unit cell translations. However, the space group also contains inversion 
symmetry, which means that the inversion related version of the polymer has no bonds 
connecting it to the original polymer, but they do interweave with one another. The 
asymmetric unit contains two repeats of the chemically unique portion of the polymeric cation, 
six disordered PF6- anions and a cavity situated about a center of inversion containing 
disordered solvent molecules. The 3D framework structure can be interpreted as consisting of 
layers held together by coordination bonds between 4-pyridyl groups and silver atoms. One 
such layer is shown in Figure 4.3, examples A, B and C. The layer down the c axis is 
represented in example A, where a squeezed honeycomb network can be seen consisting of 6-
membered rings with alternating Ag(I) and Fe(II) nodes. 
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A  B  
C  D  
Figure 4.3. Ball and stick representation of cationic network [L32FeAg]n(PF6)n3. A. One 
layer view down c axis B. One layer view down the edge ao. C. One layer view down b axis. 
D. Three layers view down b axis. 
 
Example C represents one layer from side view (down b axis), whereas example D 
shows three layers stacked on top of each other and connected through N-Ag bonds. When the 
network is observed from the perspective showed in Figure 4.3, example B and Figure 4.2, 
rectangular channels can be seen with alternating silver and iron atoms at the corners. The 
distances Ag(1)-Ag(2) and Fe(1)-Fe(2) are 16.9095(6) and 16.7399(8) Å, respectively. This 
causes significant voids and channels within the structure. Each unit cell contains one 
centrosymmetric cavity which comprises 31.5% of the total volume. 
Topology of the cationic network of [L32FeAg]n(PF6)3n is represented in Figure 4.4. 
The structure of the iron(II) based molecular “crossings” reveal that the furo[2,3-c]pyridine 
arms of the ligand are significantly tilted; therefore, angle between N atoms of both flanking 
4-pyridiyl groups and central ring of terpy N(4)-N(2)-N(5) is 134.43(5)°. This can be 
represented schematically as tetrahedron to define net topology (Figure 4.4). Distorted 
adamantane units within 3D polymeric network can be recognized from the crystal structure. 
The nodes of this framework are tetrahedral silver(I) centers (Figure 4.4, light blue balls) and 
octahedral iron(II) centers (purple balls), where four arms of molecular “crossing” act as 
linkers. The overall topology of the network can be assigned as dia-b net.29,30 The inversion 
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related network is interpenetrated in a characteristic manner for the diamondoid type 
networks.2 
 
 
Figure 4.4. The diamondoid net (dia-b) topology of [L32FeAg]n(PF6)3n and interpenetration. 
 
The schematic representation of the molecular structure of 
[L32FeCu(MeCN)]n(PF6)3n solved in space group P-1 is shown in Figures 4.5 and 4.6. Given 
the poor quality of data, care must be taken when analyzing the structure. 
 
Figure 4.5. Schematic representation of the molecular structure of 
[L32FeCu(MeCN)]n(PF6)3n. Model of the cation drawn as thermal ellipsoids (50% 
probability). Both MeCN molecule bound to the Cu center and the uncoordinated pyridine 
ring are severely disordered. (Color code: Fe, brown; Cu, purple; N, light blue; O, red; C, dark 
gray). Hydrogen atoms and PF6- removed for clarity. 
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Figure 4.6. Space filling representation of [L32FeCu(MeCN)]n(PF6)3n. Two inversion 
symmetry related 2D polymeric layers (color defined by symmetry operations). Hydrogen 
atoms, PF6- and disordered solvent molecules removed for clarity. 
 
The structure could not been definitely solved due to the insufficient diffraction and 
crystal quality. The asymmetric unit should contain 3 PF6- anions; instead, only 2.5 per unit 
could be assigned. Nevertheless, atom connectivity of cationic network can be modeled based 
on X-ray diffraction data. This shows that Fe(II) based molecular “crossings” in the presence 
of Cu(I) assemble into the structure similar to that of [L32FeAg]n(PF6)3n (Figure 4.6). 
However, one coordination site of tetrahedral Cu(I) center is occupied with solvent molecule 
– presumably acetonitrile, but this cannot be definitely assigned from X-ray data. 1H NMR 
spectrum of vacuum dried and re-dissolved crystals in MeCN-d6 supports the presence of 
acetonitrile in the sample but it could also originate from co-crystallized solvent. However, if 
the starting material [Cu(CH3CN)4]PF6 is taken in consideration, it is reasonable to assume 
that one of the four coordination sites of Cu(I) center contains MeCN ligand. This does not 
allow one of four 4-pyridyl groups, which is severely disordered, to be coordinated to the 
copper atom. Therefore, [L32FeCu(MeCN)]n(PF6)3n structure consists of stacked 2D 
polymeric sheets or layers. Two such inversion symmetry related cationic layers are shown in 
Figure 4.6. One individual layer is drawn from different perspectives in Figure 4.7, examples 
A, B, and C. The layer down the a axis is represented in example A, where the honeycomb 
network topology can bee seen with 6-membered rings containing alternating Cu(I) and Fe(II) 
nodes. Figure 4.6 and Figure 4.7, example B, reveal a perspective were rectangular-shaped 
channels can be observed – similar to those of [L32FeAg]n(PF6)3n structure. The comparison 
of one and three layers from side view (down c axis) is shown in the Figure 4.7, example C 
and D. 
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A  B  
C  D  
Figure 4.7. Ball and stick representation of cationic network [L32FeCu(MeCN)]n(PF6)3n. A. 
One layer view down a axis B. One layer view down b axis. C. One layer view down c axis. 
D. Three independent layers view down c axis. 
 
 
Figure 4.8. Schematic representation of 3D structure of [L32FeAg]n(PF6)3n and 2D layered 
structure of [L32FeCu(MeCN)]n(PF6)3n. 
 
The ionic radius for Ag+ is larger than that of Cu+ ion31, which results in longer coordination 
bonds between pyridine nitrogen and silver than those of N-Cu. The N-Ag bonds of 
[L32FeAg]n(PF6)3n joining layers are more elongated than those that are in the plane of layers. 
Taking into consideration similarities between both structures, it can be concluded that one of 
four pyridine rings in [L32FeCu(MeCN)]n(PF6)3n is simply not able to reach enough distance 
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to coordinate to Cu(I) center due to sterical considerations. This is represented schematically 
in Figure 4.8. Therefore, selecting different metal ions one can tailor either fully coordinated 
3D network, or 2D network leaving uncoordinated pyridines. Such heterometallic 2D layers 
with free pyridine arms might be of interest for surface chemistry and assembly of 2D crystals. 
 
4.2.3. Properties 
 
Compounds [L32FeAg]n(PF6)3n and [L32FeCu(MeCN)]n(PF6)3n are insoluble in 
alcohols, Et2O, hydrocarbons, and dichloromethane, whereas they readily dissolve in 
acetonitrile and acetone. The 1H and 13C NMR spectra of vacuum dried and dissolved crystals 
of [L32FeAg]n(PF6)3n and [L32FeCu(MeCN)]n(PF6)3n in acetonitrile-d3 are similar to that of 
[L32Fe](PF6)2. However, proton signals of 4-pyridyl groups are slightly shifted due to the 
presence of Ag(I) or Cu(I) ions. UV-vis spectra of [L32FeAg]n(PF6)3n and 
[L32FeCu(MeCN)]n(PF6)3n for dissolved crystals in acetonitrile are shown in Figures 4.9 and 
4.10. There is no observable difference in absorption spectra of both compounds, and they are 
superimposable with the spectrum of [L32Fe](PF6)3 in acetonitrile. The spectra of 
[L32FeAg]n(PF6)3n and [L32FeCu(MeCN)]n(PF6)3n exhibit strong ligand centered 
absorptions with maxima at 294 nm and weaker absorptions at lower energy that can be 
attributed to MLCT transitions. All the above mentioned observations suggest that the 
corresponding polymeric structures observed in solid state disassociate in acetonitrile solution 
due to the weak coordination of Cu(I) and Ag(I) to the 4-pyridyl groups. This can also be seen 
in the mass spectra (ESI) of the dissolved [L32FeAg]n(PF6)3n and [L32FeCu(MeCN)]n(PF6)3n 
in acetonitrile, where only discrete species, like  [Ag]+, [Ag+MeCN]+ and [L32Fe]2+ for 
[L32FeAg]n(PF6)3n and, similarly, [Cu+MeCN]+, [Cu+2MeCN]+ and [L32Fe]2+ for 
[L32FeCu(MeCN)]n(PF6)3n can be seen (Figure 4.11 and 4.12). Nevertheless, this proves that 
Ag(I) and Cu(I) species were incorporated in both crystalline materials. 
 
Figure 4.9. UV-vis of [L32FeAg]n(PF6)3n in acetonitrile (λmax= 294 nm, log ε = 5.12 cm-
1mol-1L). 
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Figure 4.10. UV-vis of [L32FeCu(MeCN)]n(PF6)3n in acetonitrile (λmax= 294 nm, log ε = 
5.12 cm-1mol-1L). 
 
Figure 4.11. HRMS (ESI). Crystals of [L32FeCu(MeCN)]n(PF6)3n dissolved in acetonitrile. 
  
Figure 4.12. HRMS (ESI). Crystals of [L32FeAg]n(PF6)3n dissolved in acetonitrile. 
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4.3. Conclusions 
 
In summary, it has been shown that the linear bilateral extended terpy based Fe(II) “crossings” 
functionalized with 4-pyridiyl groups are able to assemble into the 3D or 2D MOFs by using 
metals preferring tetrahedral coordination geometry (Ag(I) and Cu(I), respectively). 
Substitution of flanking positions of linear bilateral extended terpy with directional functional 
groups allows constructing supramolecular assemblies and extended networks.  
Given the fact that the convenient synthesis of the previously mentioned ligands has 
been developed, various functional groups can be easily introduced to address other 
supramolecular interactions like hydrogen, donor-acceptor, coordination bonding as well as 
strong metal-carboxylate bonds extensively utilized in the field of MOFs.  
Therefore, linear bilateral extended terpy based fundamental building blocks with 
“crossing” and “corner” character are new tools in the hands of chemists and could inspire the 
creation of new designed molecular architectures. 
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4.4. Experimental Section 
 
4.4.1. Materials and Methods 
 
All reagents and solvents used for reactions were reagent grade and used without further 
purification unless otherwise noted. Commercial chemicals where used as received without 
special purification. Melting points were recorded on a Büchi B-540 melting point apparatus. 
For characterization purposes, proton nuclear magnetic resonance (1H-NMR) spectra were all 
recorded on Bruker instruments (AV2- 400 at 400 MHz, and AV-500 at 500 MHz). Chemical 
shifts are reported in ppm relative to CD3CN (δ 1.94). Carbon-13 nuclear magnetic resonance 
(13C-NMR) spectra were recorded on Bruker instrument (AV-500 at 125 MHz). Chemical 
shifts are reported relative to CD3CN (δ  1.3). Infrared spectroscopic data was recorded on 
Jasco FT/IR-4100 spectrophotometer. An Agilent 8453 UV/Vis spectrophotometer was used 
to record all UV/Vis spectra. ESI-HRMS spectra were recorded at the MS Facility of the 
Institute of Organic Chemistry of the University of Zurich. 
 
4.4.2.  Experimental Procedures 
 
Synthesis of Heterometallic 3D MOF [L32FeAg]n(PF6)3n 
 
A solution of AgPF6 (0.91 mg, 2.0 eq, 0.0036 mmol) in ethanol (0.5 mL) was layered over a 
solution of [L32Fe](PF6)2 (2.31 mg, 1.0 eq, 0.00180 mmol) in acetonitrile (0.5 mL). A small 
amount of cyclohexane (~0.05 ml) between the layers was used to slow down the diffusion 
process. In few days needle-like crystals formed which over 2 weeks transformed into the 
dark purple blocks. A supernatant was removed with pipette and the crystals were washed 
with additional amount of EtOH (x2), then collected by filtration to give [L32FeAg]n(PF6)3n 
(1.94 mg, 70%). The crystals for the single crystal X-ray diffraction analysis where kept in the 
mother liquor to avoid solvent loss. 
 
The analytical sample for characterization was dried under vacuum at rt for 8 h: 
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Mp > dec 250° C. 
1H NMR (500 MHz, CD3CN, δ): 8.99 (d, J = 8.2 Hz, 4H), 8.87 (s, 4H), 8.81 (t, J = 8.2 Hz, 
2H), 8.66-8.64 (AA′BB′ spin system, 8H), 7.66-7.65 (AA′BB′ spin system, 4H), 7.54 (d, J = 
0.9 Hz, 4H), 7.48 (s, 4H). 
13C NMR (125 MHz, CD3CN, δ): 161.6, 159.8, 153.3, 152.6, 151.8, 139.4, 138.7, 138.2, 
135.9, 123.5, 120.4, 118.0, 105.7. 
FT-IR (neat, cm-1): 3115w, 3078w, 3041w, 1607m, 1578m, 1450m, 1415m, 1320m, 1259w, 
1225w, 1174w, 1041w, 991w, 918w, 834s, 808s, 746m, 689m, 661m, 555m. 
HRMS (ESI) (solvent MeCN) m/z: [Ag]+ calcd for Ag: 106.90454; found: 106.90489; 
[Ag+MeCN]+ calcd for C2H3AgN: 147.93131; found: 147.93109; [L32Fe]2+ calcd for 
C58H34FeN10O4: 495.10522; found: 495.10546; ([L32FeAg]n(PF6)3n disassociates in MeCN, 
but [Ag]+ and [Ag+MeCN]+ species besides [L32Fe]2+ in the mass spectrum support 
incorporation of silver ions in the product). 
Crystallographic Data of [L32FeAg]n(PF6)3n·6.5nMeCN 
 
Crystallised from MeCN / EtOH/Cyclohexane  
Empirical formula C142H107Ag2F36Fe2N33O8P6  
Formula weight [g mol-1] 3600.82  
Crystal colour, habit dark purple, prism  
Crystal dimensions [mm] 0.10 × 0.25 × 0.35  
Temperature [K] 160(1)  
Crystal system triclinic  
Space group P
_
1  (#2)  
Z 2  
Reflections for cell determination 39813  
2θ range for cell determination [°] 4 – 55  
Unit cell parameters a [Å] 17.3266(2)  
 b [Å] 21.9786(3)  
 c [Å] 23.2172(2)  
 α [°] 99.5900(10)  
 β [°] 108.8320(10)  
 γ  [°] 107.2280(10)  
 V [Å3] 7649.13(15)  
F(000) 3628  
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Dx [g cm-3] 1.563  
µ(Mo Kα) [mm-1] 0.611  
Scan type ω  
2θ(max) [°] 54.7  
Transmission factors (min; max) 0.811; 1.000  
Total reflections measured 86017  
Symmetry independent reflections 31245  
Rint 0.032  
Reflections with I > 2σ(I) 23483  
Reflections used in refinement 31245  
Parameters refined; restraints 1858; 7163  
Final R(F) [I > 2σ(I) reflections] 0.0749  
 wR(F2) (all data) 0.2252  
Weights: w = [σ2(Fo2) + (0.1380P)2 + 8.9667P]-1 where P = (Fo2 + 
2Fc2)/3  
Goodness of fit 1.095  
Final Δmax/σ 0.002  
Δρ (max; min) [e Å-3] 5.42; -1.51  
σ(d(C – C)) [Å] 0.005 – 0.007  
 
Synthesis of Heterometallic 2D MOF [L32FeCu(MeCN)]n(PF6)3n 
 
A solution of [L32Fe](PF6)2 (4.75 mg, 1.0 eq, 0.00371 mmol) under N2 in degassed 
acetonitrile (0.5 mL) was layered over a solution of [Cu(CH3CN)4]PF6 (3.16 mg, 2.0 eq, 
0.00742 mmol) in degassed EtOH (0.5 mL). A small amount of cyclohexane (~0.05 ml) 
between the layers was used to slow down the diffusion process. Over 3 weeks purple block 
like crystals formed. A supernatant was removed with pipette and the crystals were washed 
with additional amount of EtOH (x2), then collected by filtration to give 
N
N
N OO
NN
N
N
N OO NN
Fe2+
[L32FeCu(MeCN)]n(PF6)3n
Cu+
+Cu Cu+
n
[Cu(CH3CN)4]PF6
MeCN, EtOH,
Cyclohexane
N
Me
[L32Fe](PF6)2
3n(PF6-) 4.5nMeCN
47%
 129 
[L32FeCu(MeCN)]n(PF6)3n (2.67 mg, 47%). The crystals for the single crystal X-ray 
diffraction analysis where kept in the mother liquor to avoid solvent loss. 
 
The analytical sample for characterization was dried under vacuum at rt for 6 h: 
 
Mp > dec 300° C. 
1H NMR (400 MHz, CD3CN, δ): 8.99 (d, J = 8.0 Hz, 4H), 8.87 (s, 4H), 8.81 (t, J = 7.99 Hz, 
2H), 8.66-8.64 (AA′BB′ spin system, 8H), 7.6-7.65 (AA′BB′ spin system, 8H), 7.54 (s, 4H), 
7.48 (s, 4H), 1.96 (s, 12H, corresponds to 4 CH3CN molecules). 
13C NMR (125 MHz, CD3CN, δ): 161.6, 159.8, 153.2, 152.6, 151.7, 139.4, 138.6, 138.1, 
135.9, 123.5, 120.4, 117.9, 105.6. 
FT-IR (neat, cm-1): 3109w, 3047w, 1607m, 1570m, 1541w, 1450m, 1414m, 1318m, 1255w, 
1178w, 1161w, 1042w, 988w, 962w, 917w, 837s, 740w, 690m, 655m, 556s. 
HRMS (ESI) (solvent MeCN) m/z: [Cu+MeCN]+ calcd for C2H3CuN: 103.95560; found: 
106.90489; [Cu+2MeCN]+ calcd for C4H6CuN2: 144.98215; found: 144.98194. [L32Fe+H]3+ 
calcd for C58H35FeN10O4: 330.40526; found: 330.40590; [L32Fe]2+ calcd for C58H34FeN10O4: 
495.10522; found: 495.10525; ([L32FeCu(MeCN)]n(PF6)3n disassociates in MeCN, but the 
presence of [Cu+MeCN]+ and [Cu+2MeCN]+ species besides [L32Fe]2+ species in the mass 
spectrum support the incorporation of copper ions in the product). 
Crystallographic Data of [L32FeCu(MeCN)]n(PF6)3n·4.5nMeCN 
 
Crystallised from MeCN / EtOH/Chex  
Empirical formula C69H50.5CuF18FeN15.5O4P3  
Formula weight [g mol-1] 1715.03  
Crystal colour, habit dark purple, prism  
Crystal dimensions [mm] 0.20 × 0.25 × 0.28  
Temperature [K] 160(1)  
Crystal system triclinic  
Space group P
_
1  (#2)  
Z 2  
Reflections for cell determination 20758  
2θ range for cell determination [°] 5 – 57  
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Unit cell parameters a [Å] 14.9414(2)  
 b [Å] 15.3956(2)  
 c [Å] 18.3235(2)  
 α [°] 94.4451(12)  
 β [°] 91.6360(11)  
 γ  [°] 113.0082(14)  
 V [Å3] 3860.05(9)  
F(000) 1734  
Dx [g cm-3] 1.475  
µ(Mo Kα) [mm-1] 0.626  
Scan type ω  
2θ(max) [°] 56.7  
Transmission factors (min; max) 0.820; 1.000  
Total reflections measured 44801  
Symmetry independent reflections 16211  
Rint 0.033  
Reflections with I > 2σ(I) 12223  
Reflections used in refinement 16211  
Parameters refined; restraints 1028; 1021  
Final R(F) [I > 2σ(I) reflections] 0.0643  
 wR(F2) (all data) 0.2069  
Weights: w = [σ2(Fo2) + (0.1266P)2 + 1.64P]-1 where P = (Fo2 + 2Fc2)/3
  
Goodness of fit 1.084  
Final Δmax/σ 0.002  
Δρ (max; min) [e Å-3] 1.01; -0.80  
σ(d(C – C)) [Å] 0.004 – 0.009  
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Chapter 5. Towards Kinetic Synthesis of the Molecular Borromean Link 
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5.1. Introduction 
 
Human mind is free in its ability to imagine and comprehend complex ideas, concepts, 
and geometrical shapes. The art and science are the mirrors of this freedom where human 
being is trying to crash the unsurpassable border between his mind and the physical world, in 
which we all are inevitably enclosed. Human imagination far exceeds the limitations of the 
real world – luckily, there are many people who are brave enough to step outside of what we 
can see, smell, hear, and feel. Our convenient 3D space, perception of time and matter is 
challenged by modern physics, mathematics, and chemistry. The quantum physics shows that 
the laws that apply to familiar macroscopic objects are not applicable to the atomic and 
subatomic particles1. Mathematics can open the doors to other dimensions.2 Whereas 
chemistry, the discipline of the science, which is privileged to transform the matter on the 
molecular scale, allows the creation of new forms of matter – substances that have never 
existed before3. This is where humans can surpass nature; however, to my mind, this is an 
ambiguous statement, because we are a part of nature. Let us leave this question to philosophy 
– other discipline celebrating the freedom of the human mind4. The field of chemistry allows 
the pure imagination of the human mind to be materialized on the molecular level. History has 
shown that fundamental research driven by pure curiosity creates a basis for the benefit of the 
whole society. Chemistry of “unnatural” products allows the creation of substances with new 
properties non-existent in nature5,6. 
 
5.1.1.  Chemistry and Topology 
 
Chemistry of topologically complex molecules deals with the structures whose 
abstract graphs cannot be represented in 2D plane. A graph without any embedding that can 
be represented in the plane is said to be nonplanar7. Topologically complex DNA 
superstructures and proteins with nonplanar graphs are known to occur in biology8,9; however, 
in chemistry this is an extremely uncommon phenomenon and requires special synthetic 
design10. Most molecules have abstract graphs with zero crossings of edges. Even such 
molecule as fullerene, which is known to have a ball-shaped structure11,12, from the 
perspective of topology, has a simple abstract graph, which can be represented in 2D plane 
(Figure 5.1), assuming that the bonds are flexible edges and the carbon atoms are nodes. 
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Figure 5.1. The planar topology of fullerene13,14. 
 
Mathematics and knot theory inspire chemists to look for topologically complex shapes.7 The 
knot can be defined as “a simple closed polygonal (or smooth) curve embedded in 3-space”15, 
whereas link is considered to be a combination of knots. Therefore, in mathematical sense all 
knots are based on a circle (unknot) (Figure 5.2, A). The simplest is a trefoil knot that exhibits 
three crossings, which is the smallest possible number (Figure 5.2, B). The simplest nontrivial 
knot consists of two interlocked rings (unknots), which is called Hopf link (Figure 5.2, C).16 
In three-dimensional space abstract graphs of both trefoil knot and Hopf link cannot be 
represented in plane; however, higher order dimensions could allow the transformation of 
these into separate unknots.17 
A B C  
Figure 5.2. A. Unknot18; B. Trefoil knot19; C. Hopf Link20. 
 
This kind of graphs are called extrinsically nonplanar. In 1930, Kuratowsky proved that only 
K5 and K3,3 graphs (Figure 5.3) can be intrinsically nonplanar, or truly topologically 
nonplanar.21 However, from the perspective of chemical topology both intrinsic and extrinsic 
graphs are of great interest to the field. Incredible progress of chemical science in recent 
decades has allowed many of these theoretical shapes to be materialized on the molecular 
level. 
 
Figure 5.3. Intrinsically nonplanar graphs K3,3 and K5. 
 
 136 
In 1961, Wasserman reported the first compound where description of the topology was 
important.22 Macrocyclization of diethyl tetratriacontanedioate in the presence of large 
deuterated cycloalkane provided statistical byproducts, and one of them consisted of two 
mutually interlocked rings (Figure 5.4). The identity of the product was established by 
chemical methods. In chemistry, such molecules with Hopf link topology are known as 
catenanes. This shift of paradigm has inspired the construction of other molecules of 
topological importance. 
 
Figure 5.4. Wasserman’s statistical synthesis of catenanes. 
 
In order to obtain topologically interesting targets, the major focus became the development 
of more efficient and directed synthetic strategies. 
In 1965, Schill published the first successful directed synthesis of catenane.23,24 This 
approach was based on the properly functionalized templating core, which allowed the 
construction of interlocked macrocycles around it (Figure 5.5). 
 
Figure 5.5. Schematic representation of Schill’s directed synthesis of catenane. 
 
Frisch and Wasserman envisioned the Möbius ladder approach towards various 
knotted and catenated structures. Different number of twists and rungs in the Möbius ladder 
could result in interesting topological consequences.25 The first successful synthesis of the 
Möbius strip was reported by Walba26, where the ladder with three rungs after 
macrocyclization afforded the mixture of the topologically desired product, as well as a 
conventional ring structure (Figure 5.6). However, attempts to obtain knotted or linked 
structures by cleavage of the rungs were not successful. 
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Figure 5.6. Walba’s synthesis of the Möbius strip via three rung ladder. 
 
The first molecule possessing the intrinsically nonplanar graph K5 (Figure 5.3) was 
synthesized independently by Simmons and Paquette in 1981.27,28 The K3,3 molecules were 
prepared by Walba29 and Siegel30.  
In 1983, Sauvage reported the first successful metal templated synthesis of catenanes, 
which was a real breakthrough in chemical topology.31,32 The complexation of two 
phenatroline ligands with copper(I) and subsequent alkylation/macrocyclization afforded 
metallo-catenane (Figure 5.7). The removal of metal ions liberated free catenanes. 
 
Figure 5.7. Sauvage’s metal template synthesis of catenane. 
 
Such approach stimulated the synthesis of various supramolecular architectures33,34 like 
rotaxanes35, knots and polycatenanes10, molecular grids36, ladders and helicates37. Also, other 
supramolecular interactions, like hydrogen and donor-acceptor, were successfully utilized for 
various topologically interesting targets.38 Leigh developed the active metal template strategy 
which is based on the principle that metal ions can be both the template and catalyst for 
macrocyclization at the same time.39,40 
The work presented in this chapter also deals with the control of the topology based on 
the metal templation.   
 
5.1.2. The Borromean Link 
 
The knot theory reveals a fascinating example of the nontrivial link consisting of three 
interlocked loops with remarkable topological properties – no two loops are mutually linked; 
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however, the combination of all three generates a linked structure. Cleavage of one loop 
results in separation of other two. 
 
Figure 5.8. The Borromean link.41 
 
Such link is known as the Borromean Link (Figure 5.8), which is named after the family crest 
of the Borromeos, an Italian family from the Renaissance42. The Rolfsen notation43 for this 
link is 623, where six stands for the minimal amount of crossings in its reduced representation, 
superscript describes the number of loops involved, and subscript is the index distinguishing 
between the links with the same number of components. The above-mentioned topological 
property can also exist for links with more than three rings, and these are called Brunnian 
Links. Another interesting feature of the Borromean link is that it is topologically achiral in its 
reduced presentation, even when all rings are oriented.17 
In 1961, Wasserman was the first to suggest that a molecule with the Borromean link 
topology could theoretically form in the macrocyclization reaction as a statistical side 
product.25 Afterwards, many other more rational approaches were offered. In 1985, Walba 
proposed a strategy which anticipated that three-stranded braid bound with two rungs, after 
cyclization and cleavage, could theoretically form the Borromean link (Figure 5.9).17 
 
Figure 5.9. Three-stranded braid approach towards the Borromean link. 
 
The Borromean link can be represented in various embeddings. The three most common 
representations are shown in Figure 5.10 44. Since the chemical synthesis deals not only with 
the topology of the molecular graph but also with the real molecular structure in 3D space, a 
x
x
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x
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particular embedding should be taken into consideration to develop a reasonable synthetic 
strategy. 
The most common is S6 symmetric Venn diagram45 depicted in Figure 5.10, example A. 
A B C  
Figure 5.10. The Borromean Link. A. Venn diagram; B. Chain rings; C. Orthogonal rings. 
 
In 2003, Loren, Yoshizawa and Siegel proposed retrosynthetic strategies towards these three 
Borromean link representations. A careful inspection of the Venn diagram reveals that it can 
be derived from the trefoil knot motif – triskelion (Figure 5.11).46,47 The retrosynthesis of 
chain rings leads to the properly functionalized rack structure (Figure 5.12).44 
 
Figure 5.11. Schematic retrosynthesis of the Venn diagram leading to the triskelion motif. 
 
Figure 5.12. Schematic retrosynthesis of chain rings. 
 
 
Figure 5.13. Schematic retrosynthesis of the orthogonal ring. 
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However, the orthogonal representation of the Borromean link could be obtained in a stepwise 
ring-by-ring synthesis (Figure 5.13).  
The nucleobases form base-pairs in a controllable manner48 – the necessary template 
for the synthesis of topologically complex structures. In 1997, Seeman and coworkers showed 
that the proper choice of complimentary DNA strands after ligation formed the first structure 
possessing the Borromean topology on the molecular scale (Figure 5.14).49 This DNA 
superstructure is derived from the Venn diagram by replacing each crossing with 1.5 turns of 
double helix. The correct topology was supported by a selective scission of only one ring. The 
digestion products were analyzed by the gel electrophoresis, which supported the liberation of 
two separate rings besides the breakdown products of the first ring. 
 
Figure 5.14. Seeman’s DNA superstructure with the Borromean topology. Adapted with 
permission from ref.48. Copyright Macmillan Publishers Ltd (1997). 
 
The spontaneous assembly, or sometimes called “programmed behavior”,5,50 is a 
powerful approach towards the complex supramolecular targets. In 2004, Stoddart group 
employed the thermodynamic assembly of the Borromean link zinc(II) complex by exploiting 
the reversible character of the imine bond formation and templating character of the Zn(II) 
ions51. They were able to obtain S6 symmetric structure that resembles the Venn diagram 
representation of the Borromean link (Figure 5.15). After reduction of the imine bonds and 
removal of zinc ions the free nanoscale Borromean link can be liberated.52 This one pot 
synthesis is a landmark of chemical topology and directed assembly process. 
  
Figure 5.15. Stoddart’s synthesis of the Borromean link. Adapted with permission from ref. 51. 
Copyright AAAS (2004). 
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bond length of 2.06 Å and cis O–Zn–N
bond angles, ranging from 89.0° to 99.3°)
belonging to aTFA– anion with a disor-
dered trifluoromethyl group. The six
equivalent bipyridyl ligands are sand-
wiched unsymmetrically between six pairs
of phenolic rings, such that the !–! stack-
ing distance is 3.61 Å in one direction and
3.66 Å in the other. The BR12" dodecaca-
tion contains an inner chamber (34 ) of
volume 250 Å3 lined with the van der
Waals surfaces of 12 O atoms that are
oriented in the form of a cuboctahedral
array toward the center of the chamber,
which contains species that give rise to
nonresolved and diffuse electron density.
At a supramolecular level, the BR12"
dodecactions are arranged (Fig. 3E) in hex-
agonal arrays with close (3.31 Å) intermo-
lecular !–! stacking interactions between
pairs of pyridyl rings in adjacent dodeca-
cations, which form (Fig. 3F) columnar
arrays in the orthogonal c direction that are
stabilized by six [C–H!!!O#C] interactions
between each BR12" dodecacation, the
centers of which are 16.3 Å apart. The six
cylindrical channels that surround each col-
Fig. 2. The 1H NMR spectra (CD3OD, 298 K) of (A) the exo-bidentate ligand-containing starting
material DAB-H4!4TFA (500 MHz), (B) the molecular Borromean rings BR!12TFA (600 MHz), and (C)
an inseparabl mixture of “ mpty” and “filled” Borromean rings, n mely BR!12TFA a d
Zn@BR!14TFA, respectively (600 MHz). The letters a to i are defined for BR12" with respect to the
appropriate protons on the structural formulas shown in Fig. 1E. Primed letters represent the
corresponding protons in Zn@BR14".
Fig. 3. Different structural and superstructur-
al representations of the BR12" dodecaca-
tion(s) in the solid state as deduced from
x-ray crystallography carried out on single
crystals of BR!12TFA. In the case of the illus-
trations of the single BR12" dodecacation,
the three equivalent macrocycles are fea-
tured, as tubular and space-filling represen-
tations, in the three primary colors, green,
red, and blue. The six Zn(II) ions are depicted
in silver. (A) Tubular representation viewed
down the S6 (and collinear C3) axis of BR
12".
(B) Space-filling representation of A, showing
the pore with a d ameter of 2.08 Å in BR12",
which leads to an inner chamber. (C) Space-
filling representation of BR12", highlighting
the mutually orthogonal arrangement of the
three interlocked macrocycles adopting
chairlike conformations wherein the distance
from the tip of one pyridyl ring to the other,
in any given macrocycle, is 24.5 Å. Multiple
!–! stacking interactions are evident to the
extent that all six equivalent bipyridyl ligands
are sandwiched between six pairs of flanking
phenolic rings, such that the plane-to-plane
separations are 3.61 Å in one direction and
3.66 Å in the other. In addition, there are six
[C–H!!!!] interactions (H!!!! distance 2.78 Å)
between H-h on all of the bipyridyl ligands and the faces of the six
pyridyl rings. The coordination sphere around each of the six equiva-
lent Zn(II) ions exhibits distorted octahedral geometry, with a single
TFA– anion (not shown) occupying the sixth coordination site in all
cases. (D) A stick representation of BR12", upon which are superim-
posed a platonic solid (i.e., the silver octahedron with its vertices
defined by the six Zn(II) ions and having edges that are all equal to
12.7 Å) and a slightly distorted Archimedean solid [i.e., the red cuboc-
tahedron with its vertices defined by 12 O atoms (each 5.1 Å distant from
the centroid of BR12") that line the inner chamber of BR12" and with a
volume of $250 Å3]. (E) Space-filling representation of the hexagonal
array of six individual columnar stacks of three BR12" dodecacations
clustered around a central column viewed down the c direction of the
crystal lattice, showing the TFA– anions (red and blue) coordinated to the
Zn(II) ions. Neighboring BR12" dodecacations are held together by
intermolecular !–! stacking interactions (3.31 Å) between matching
pairs of pyridyl rings. The small channels that run through the center of
the superstructures are separated by 22.5 Å, and the large channels,
which are 4.2 Å in diameter, are filled with Zn(II)-coordinated TFA–
anions (not shown) and separated from each other by 13.0 Å. (F)
Space-filling representation of three interdigitated BR12" dodecacations
present in superstructural columns that run through the crystal in the c
direction. Each BR12" (green) in the columnar array is linked above
(purple) and below (blue) itself by six [C–H!!!O#C] hydrogen bonds (with
a [H!!!O] distance of 2.52 Å), which arise from an interaction between
H-g in one BR12" and the carbonyl oxygen atom of a Zn(II)-bound TFA–
anion in the neighboring BR12". The distance within the columns be-
tween the centers of repeating BR12" dodecacations is 16.3 Å.
R E P O R T S
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Stoddart group also challenged the topologically achiral nature of the Borromean link by 
using enantiomerically pure starting materials. They were able to assemble the chiral version 
of the Borromean link Zn(II) complex which possesses C1 symmetry (Figure 5.16).53 The 
chirality results from the particular embedding of the molecular graph in 3D space; however, 
form the point of view of topology, the abstract graph of this structure still remains achiral. 
 
Figure 5.16. Stoddart’s synthesis of the chiral Borromean Link. Adapted with permission 
from ref.53. Copyright John Wiley & Sons Inc (2006). 
 
5.1.3. Attempts Towards the Borromean Link in Siegel Group 
 
In 2003, Loren et al. reported on the synthetic attempts towards the stepwise 
construction of the molecular Borromean link.44 The retrosynthesis of this approach is 
depicted in Figure 5.17. It was anticipated that the reaction of the macrocycle I, posessing 
endocyclic coordination sites, with the heteroleptic metal complex H could form the threaded 
macrocycle G. 
 
 
Figure 5.17. Lorens’s and Yoshizawa’s approach towards the Borromean link. 
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reducing the 12 imine bonds. Applica-
tion of a recently established proce-
dure[13] for demetallation and reduc-
tion gives a mixture of single rings,
linear fragments, and intact BRs—in
this case, (R)12-BRCl6H24—but without
the metals; that is, the Borromeands.
The CD spectrum (Figure 6) of the
crude demetallated chiral BRs exhibits
much weaker absorptions (at the same
concentrations of 8.0 mm) in the
absence of the metal. In fact, only
two main absorptions are apparent at
lmin= 248 nm (De=!8.09m!1 cm!1)
and at lmax= 277 nm (De=
6.61m!1 cm!1): the first bands are
within the optical activity range of
the free ligand. Furthermore, the CD
trace of demetallated (R)12-BRCl6H24
is conspicuously lacking any absorp-
tion at 310 nm, further suggesting that
chirality was induced at the metal
center. These results prompted us to
examine the octahedral disposition of
the ligands surrounding the ZnII ions
from the X-ray crystallographic data
(Figure 7). From this distorted octahe-
dron, it is apparent that the chiral
ligands wrap around the metal in a
helical, and thus chiral, fashion.[20] For
comparison, we re-examined the X-ray
crystal data for the original Borro-
meate and confirmed that each octa-
hedron around the zinc in the achiral
BR is an ideal octahedron with no
distortion. Hence, we conclude that
the presence of the nearby stereogenic
centers disturbs the neighboring coor-
dination sphere to produce chirality at
metal centers in the optically active
Borromeates.
In summary, two pairs of enantiomerically related Borro-
meates were synthesized stereospecifically from enantiomeric
phenylglycine derivatives. All four optically active com-
pounds have three macrocycles each containing four stereo-
genic centers. The one example whose crystal structure has
been determined adopts an asymmetric conformation. All
four compounds exhibit intense CD spectra in solution.
Furthermore, the ZnII octahedra, found in the X-ray crystal
structure of one of the compounds, deviate substantially from
ideal geometry, strongly suggesting that chirality is being
transferred rather efficiently from the 12 stereogenic centers
to the six ZnII centers. Removal of the ZnII ions and reduction
of the imine bonds present in the macrocyles affords a
Borromeand with a significantly different CD spectrum. In
the fullness of time, the chiral Borromeates could find
applications[21] in chemical biology and materials science; or
they could remain what they are presently—that is, stereo-
chemical curiosities.
Figure 2. X-ray crystal structure of (R)12-BRCl6·12TFA viewed a) from an orthogonal perspective
and b) down the core, revealing the low symmetry (C1) resulting from one “flipped” chairlike
macrocycle.
Figure 1. Partial 1H NMR spectra (600 MHz) recorded in CD3OD of a) the freshly deprotected
(R,R)-DAB-Hn·nTFA ligand, b) Cl-DFP, and c) the (R)
12-BRCl6· 2TFA isomer. If the structure of the
chiral Borromeate has C1 symmetry in solution, then all the protons in the molecule are
heterotopic. The observed line wi ths in the spectru are consistent with this structural
assignment.
Figure 3. View of the X-ray crystal structure of (R)12-BRCl6·12TFA down
the c axis with pendant alternating axial (ax) and equatorial (eq)
CH2OH groups.
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It was expected that G together with the cap F could be further converted to the ring-in-ring 
complex E. Subsequently, another threading with D would afford the macrocyclic complex C. 
The third and the final ring could be constructed by coupling the cap B with the threaded 
macrocycle C to give the Borromean link metal complex A.54  
The synthesis was started from the manisyl substituted terpyridine 85a which upon 
several functional group transformations was converted to the ethynyl substituted terpyridine 
85c (Scheme 5.1). Complexation with Cu(II) and the subsequent Eglinton reaction gave the 
macrocycle 87 in high yield. Then hydrogenation of the triple bonds gave the macrocycle 88 – 
the key intermediate for the further development of this synthetic strategy. 
Scheme 5.1. Lorens’s and Yoshizawa’s Synthesis of Ru(II) Ring-in-ring Complex 91  
 
Reaction conditions: a) Py-HCl, 185 °C, 4 h, 97%. b) Cs2CO3, TsO(CH2)2OCH2CCH (2.2eq), DMF, 
80 °C, 10 h, 69%. c) Cu(OAc)2·H2O (0.5 eq), EtOH, rt, 1 h. d) Cu(OAc)2·H2O (10.0 eq), EtOH (high 
dil.), reflux, 72 h, 91%. e) H2, 80 psi, 10% Pd-carbon, 1:1 EtOH:CH2Cl2, 6 h, 91%. f) 198 (2.1 eq), 
2:2:1 CH2Cl2:EtOH:ethylene glycol, reflux, 12 h, 65%. g) 6,6′-bisbromomethyl-2,2′-biypyridine (2.1 
eq), Cs2CO3, ACN, 72 h, 49%. 
Furthermore, threading of the ring 88 with the RuCl3 complex of the “W”-shaped terpyridine 
89 gave the Ru(II) complex 90. The distance between both phenolic hydroxyl groups on the 
opposite ligands is  ~8 Å. This allowed to perform alkylation of 90 with two equivalents of 
6,6′-bisbromomethyl-2,2′-biypyridine, affording the ring-in-ring complex 91.44 Unfortunately, 
all attempts to introduce the third ring fragment by complexation with copper were not 
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successful. Loren suggested that the problematic threading might be caused by the transoid 
conformation of uncomplexed 2,2′-bipydidine (bipy) coordination site. 
 
The metal complexation would switch the conformation of bipy to cisoid, thus causing a 
significant strain to the whole macrocyclic system (Figure 5.18, A.).54  
A  
B  
Figure 5.18. X-ray structures of A. Loren’s ring-in-ring Ru(II) complex 91. 
B. Klosterman’s ring-in-ring Ru(II) complex 9355,56.  
 
Therefore, Loren synthesized the two-ring structure 92 with phenantroline binding sites 
already having the correct conformation of the bidentated pockets (Scheme 5.2). However, 
the threading was also not successful (Scheme 5.3).  
Jeremy Klosterman was able to synthesize similar structures 93 and 94 with 
terpyridine cap to increase the cavity accessible for the threading (Scheme 5.2 and Figure 5.18, 
B.).55 However, all attempts to obtain the desired threading products failed, too (Scheme 5.3). 
 
 
 
 
 
 
N
N
N
N
M
 144 
Scheme 5.2. Ring-in-ring Structures Synthesized in Siegel Group 
 
Scheme 5.3. Unsuccessful Attempts for the Introduction of The Third Ring Motif 
 
Klosterman proposed an alternative strategy to avoid the problematic threading step (Figure 
5.19). This rout relies on an already preformed cap D which could be a heteroleptic Ru(II) 
complex.55  
 
Figure 5.19. Klosterman’s strategy based on the preformed hetereoleptic complex D. 
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This strategy would allow avoiding problems that are caused by the conformational change of 
polypyridine binding pockets. Unfortunately, the correct combination of the functional groups 
to successfully perform capping was never reached.55 
Derik Frantz proposed to use an orthogonal thioketal cap as an alternative to the metal 
coordination (Figure 5.20). Thioketal functional group can be cleaved in the hydrogenolysis 
reaction57, which would be helpful upon liberation of the interlocked rings. However, 
introduction of such cap on the threaded macrocycle 90 was unsuccessful.58 
 
Figure 5.20. Thioketal cap proposed by Derik Frantz.58 
 
Helen Seifert was able to modify the original Jon Loren’s double threaded macrocycle 90 by 
replacing “W”-terpyridine ligands with linear bilateral extended terpy (Scheme 5.4)59. The 
complex 98 was characterized by the single crystal X-ray diffraction analysis (Figure 5.21), 
which revealed that the distance between both flanking hydroxyl groups on the opposite 
ligands is around 19 Å – it is twice as much as for the Loren’s macrocycle 90 (8 Å). This 
opened the doors for the further investigation towards the kinetic synthesis of the Borromean 
link. 
Scheme 5.4. Seifert’s Threaded Ru(II) Macrocycle 98 
 
Reaction conditions: a) 1,2-dichloroethane/EtOH/ethylene glycol 3:3:2, 120 °C, 3 d, 26%. 
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Figure 5.21. X-ray structure of Seifert’s double threaded macrocycle 98.59 
 
 
5.2. Current Work 
 
The landmark of thermodynamic assembly and topological chemistry is the Stoddard’s 
approach towards the molecular Borromean link.51 However, there are several limitations to 
this approach; for example, the Borromean link consisting of three different rings cannot be 
obtained by the above described methodology. The control over the thermodynamic assembly 
is usually limited to specific substrates, and subtle modifications of such dynamic systems can 
bring an unexpected outcome; therefore, serendipity often plays the major role.60 The stepwise 
kinetic synthesis of the molecular Borromean link is still an open problem. However, this 
chapter describes a significant leap towards this long-standing goal.  
The goal of the current work is to combine all the knowledge that has been 
accumulated in Siegel group44,54,55,58,59 regarding the synthesis of extended ring-structures and 
extract the most promising directions towards the kinetic synthesis of the molecular 
Borromean link. Several problems “crystallized” out of the huge synthetic efforts performed 
before in the group (Figure 5.22):  
- Unsuccessful threading of the ring 3 motifs; 
- Insufficient cavity available for threading; 
- Limited flexibility of the ring 2; 
- Conformation change of terpy or bipy upon metal complexation, which causes a strain 
on the whole structure; 
- Correct choice of the denticity and size of the binding motif of the ring 2; 
- Selection of proper functional groups compatible with the further chemical 
manipulations.  
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Figure 5.22. Important parameters for the introduction of the third ring. 
 
Several objectives were set in our pursuit towards the improvement of the synthesis: 
- The linear bilateral extended terpy ligands could be further used to construct the rings 
2 and 3 to gain larger cavities available for threading; 
- A flexible chain motif could be incorporated in the ring 2, so that it could adjust a 
proper conformation when the third ring is constructed; 
- Synthetic route should be as convergent as possible; 
- Number of synthetic steps should be reduced, especially those that are applied on the 
highly advanced intermediates;  
- The final step of the synthesis should be reliable, efficient, and high yielding.  
The extended geometry of the linear bilateral extended terpyridine ligands make them a 
valuable building block for the further synthesis. Klosterman’s proposed strategy based on the 
pretemplated Ru(II) cap55 in combination with Seifert’s threaded ring 9859, offering potentially 
larger void space, seemed to be a promising approach to our pursuit towards the kinetic 
synthesis of the molecular Borromean link. However, the major challenge was expected when 
dealing with bigger structures that have more degrees of freedom – the potential formation of 
exo-/endocyclic stereoisomers. This chapter shows the feasibility of chemistry selected for the 
synthesis of the molecular Borromean link, but the control over stereochemistry is still an 
open problem. 
 
5.2.1. Sonogashira Coupling Strategy 
 
Initially, the synthetic route via heteroleptic Ru(II) complex was chosen, originally 
proposed by Klosterman55. A schematic representation of the retrosynthesis is shown in 
Figure 5.23. The pretemplated heteroleptic Ru(II) complex D should bear ligands with two 
different functional groups to discriminate reactivity necessary for the coupling with the 
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threaded macrocycle E and macrocyclization of the third ring with linker B. Therefore, the 
heteroleptic Ru(II) complex 99 (cap D) was chosen as the first synthetic target (Figure 5.24). 
The first ligand of the complex 99 could be functionalized with flexible linkers and good 
leaving groups suitable for the alkylation reactions61, but the second ligand could bear aryl 
bromide moieties suitable for the cross coupling chemistry62.  
 
Figure 5.23. Schematic retrosynthesis of the Borromean link via pretemplated Ru(II) cap D.  
 
 
Figure 5.24. Heteroleptic Ru(II) complex 99 as a potential pretemplated cap. 
 
The synthesis of necessary ligands was started from the diiodoterpyridine 69 (Scheme 5.5) 
which was coupled to the corresponding acetylenes 59 under the standard Sonogashira 
coupling conditions62 to give either bromo- or methoxy- substituted diacetylenes 78. The 
following one-pot MOM deprotection and cycloisomerization gave linear bilateral extended 
terpyridines L8 and L12. 
Scheme 5.5. Synthesis of Ligands L8 and L12 
 
The corresponding methoxy-derivative L12 in the presence of neat pyridinium chloride was 
converted to the dihydroxyl-substituted terpyridine L16 under microwave radiation59 (Scheme 
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5.6). Subsequent alkylation of the phenolic hydroxyl groups with 2-(2-chloroethoxy)ethanol 
in DMF, using Cs2CO3 as a base, resulted in the diethylene glycol substituted ligand L17. 
Scheme 5.6. Synthesis of L17 
 
The dibromo derivative L8 was heated with RuCl3·3H2O in ethanol to give the RuCl3 
complex 100 (Scheme 5.7) which, due to the extremely poor solubility, was used in the next 
step without further purification63. 
Scheme 5.7. Synthesis of 100 
 
The reaction between stoichiometric amounts of the ruthenium complex 100 and the ligand 
L17 in ethanol, using N-ethylmorpholine as the additive64, afforded the heteroleptic complex 
101 (Scheme 5.8). Treatment of 101 with methanesulfonyl chloride afforded the mesylate 99. 
Scheme 5.8. Synthesis of 99 
 
Furthermore, the work involved attempts to obtain a X-crystal structure for the heteroleptic 
Ru(II) cap in order to assess its suitability for the construction of the Borromean link. The 
crystals of the dihydroxyl intermediate 101 suitable for the X-ray analysis were obtained by a 
slow diethyl ether vapor diffusion into an acetonitrile solution. The crystal quality appeared to 
be good; however, the poor diffraction of the crystals on the in-house diffractometer did not 
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give an unambiguous solution of the structure. A synchrotron radiation was used to elucidate 
the structure, and the results are presented in Figure 5.25 and 5.26. The crystal structure was 
elucidated in space group P21/n. As expected, the molecular structure confirms the 
coordination of two different ligands around the ruthenium(II) center. 
A B  
Figure 5.25. A. ORTEP drawing (50% probability) and B. spacefill representation of 
heteroleptic Ru(II) complex 101. Hydrogen atoms and PF6- removed for clarity. 
 
Figure 5.26. Unit cell of the heteroleptic Ru(II) complex 101 
 
A unit cell and packing of the complex 101 is drawn in Figure 5.26. The 4-bromo-2,6-
dimethylphenyl groups of the neighboring cations are arranged antiparallel, and the distance 
between the both is ~3.7 Å, which suggests the intermolecular π-stacking within the crystal 
lattice. 
 The bite angles for the bromoaryl and diethylene glycol substituted ligands are C(1)-
N(2)-C(15) =145.94(5)° and C(36)-N(2)-C(15)=144.96(6)°, respectively (Figure 5.27). 
 151 
 
Figure 5.27. The bite angles of the bilateral terpy ligands in the complex 101. 
A
B  
Figure 5.28. Dimensions of A. Seifert’s threaded macrocycle 9859 and B. heteroleptic Ru(II) 
complex 101. 
 
The comparison of the dimensions of Seifert’s threaded macrocycle 9859 and the heteroleptic 
complex 101 is shown in Figure 5.28. The distances between both hydroxyl groups and 
bromines in 101 are around 30.5 Å and 23.8 Å, respectively. Furthermore, the distances 
between phenolic hydroxyl groups of the opposite and the same ligands in the threaded 
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macrocycle 98 are around 19.2 Å and 23.1 Å, respectively. The flexible character of the first 
macrocycle55 allows the combination of these two building blocks. Therefore, Williamsons 
ether synthesis61 between the threaded macrocycle 98 and the mesylate cap 99 was tested 
(Table 5.1). 
To establish the initial reaction conditions with a limited amount of the starting material, a 
rapid survey of the reaction conditions was performed on the microscale (Table 5.1, entries 1-
3). The reaction was controlled by the on-flow ESI-MS analysis. It was found out that the 
reaction is extremely sensitive to temperature; therefore, careful adjustment of the heating 
regime was necessary. The product formation was observed at 75 °C (Table 5.1, entry 3). 
Table 5.1. Screening of Reaction Conditions for Synthesis of the Threaded Ring-in-Ring 
Complex 102 
 
entry conc. 
98 
(mM) 
cap eq base eq. T, °C t, h results 
1 c 0.320 99 2.3 K2CO3 20 83 42 ESI-MS: 101, 
polym./decomp. of 
SM. No product 102 
 
2 c 0.315 99 2.2 K2CO3 20 65 24 ESI-MS: mostly 
unreacted 98, 99 and 
traces of product 102 
 
3 c 0.315 99 2.2 K2CO3 20 75 24 ESI-MS: ~1:1 product 
102 and 98 
 
4 0.310 99 2.2 K2CO3 26 75 72 ESI-MS: product 102 
and traces of 98. 
Isolated yield:24% 
 
5 0.315 99 2.2+0.2a K2CO3 20 75+80 b 24+18 b ESI-MS: product 102 
and traces of 98. 
Isolated yield: 36% 
 
6 0.431 99 1+0.65+0.65a K2CO3 25 75+75+75b 18+8+18b ESI-MS: product 102 
and 99. Isolated 
yield:41% 
a Stepwise addition of 99. b Heating was continued at specified temperature for indicated time after the 
next portion of 99 was added. c Reaction was run on microscale to indentify critical parameters for the 
reaction. The reaction products were not isolated. 
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Higher temperature caused decomposition and polymerization of starting materials 99 and 98 
(entry 1), whereas lower temperature resulted in a very slow conversion and gave only traces 
of the desired product 102 apart from mostly unreacted starting materials (entry 2). Stepwise 
addition and the higher excess of the mesylate 99 turned out to improve the outcome of the 
reaction (Table 5.1, entries 5 and 6). 
The formation of the product with the expected composition was supported by 
HRMS-ESI (Figure 5.29). The ion series characteristic to the highly charged Ru(II) 
complexes with sequential loss of PF6- anions can be observed in mass spectrum. 
 
Figure 5.29. HRMS-ESI spectrum of the threaded ring-in-ring complex 102. 
 
Figure 5.30. 1H-NMR (600 MHz, Acetone-d6) spectrum of the threaded ring-in-ring complex 
102. 
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Figure 5.31. 1H-1H COSY (600 MHz, Acetone-d6) spectrum of the threaded ring-in-ring 
complex 102. 
 
The 1H and 1H-1H COSY NMR spectra (Figure 5.30 and 5.31) show all the expected signal 
clusters of the desired product; however, the symmetry observed in NMR is lower then 
expected and the overlap of several signals with similar nature can be seen. This suggests that 
more than one isomeric species are present in the mixture. Besides the desired D2h symmetric 
endo/endo product 102, D2h symmetric exo/exo and C2v symmetric exo/endo could be also 
envisioned (Figure 5.32). The significant overlap of the signals did not allow the 
identification of the exact stereochemistry of all the involved species. So far, the separation of 
these isomeric species was not successful. 
 
Figure 5.32. Theorecitcal stereoisomers of the threaded ring-in-ring complex 102. 
 
Nevertheless, the product mixture 102 was subjected to the next step. The long enough linker 
103 having two acetylene groups at the terminal positions, suitable for the Sonogashira 
coupling62, theoretically could complete the synthesis of the Borromean link (Scheme 5.9). 
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coupling product was not observed. Instead, either there was no reaction, partial 
decomposition, or polymerization of the starting materials took place. 
Scheme 5.9. Unsuccessful attempts to complete the Borromean Link Synthesis via the 
Sonogashira Coupling  
 
Therefore, another approach was considered to overcome the problematic coupling reaction, 
and the structure of the heteroleptic Ru(II) cap was reconsidered.  
 
5.2.2.  Eglinton Reaction Strategy 
 
 The emphasis was placed on the creation of a more convergent route, reducing the 
total synthetic steps and the number of chemical manipulations with already advanced ring-in-
ring structures. It was decided to construct the preformed Ru(II) templated cap which in 
combination with the threaded ring 98 would contain all the necessary carbon atoms for the 
final Borromean link structure (Figure 5.33). 
 
Figure 5.33. Reconsidered retrosynthesis of the molecular Borromean link. 
 
The RCM reaction69,70 and Eglinton reaction71,72 turned out to be efficient final 
macrocycilzation steps in many total syntheses of natural products73,74 and supramolecular 
architectures47,75. The ethylene or acetylene groups are also chemically compatible with the 
basic conditions of the Williamson’s ether synthesis61. Therefore, the pretemplated cap 99 
could be modified in such a way that, instead of bromines, linkers of the proper length, 
functionalized with either olefin or acetylene groups, could be introduced at the terminal 
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positions (Figure 5.34). However, the olefin RCM reaction in large macrocycles can form a 
mixture of cis/trans isomers76; therefore, it was decided to use the acetylene homocoupling – 
Eglinton reaction – as the final cyclization step. Based on the estimated dimensions of all the 
involved building blocks, 2-(2-(4-ethynylphenoxy)ethoxy)ethanol (106) was selected as a 
suitable linker with the length of ~14.3 Å. 
 
Figure 5.34. The new design of the pretemplated cap and estimation of the length of linkers. 
 
The synthesis of the corresponding linker 107 was started from 4-iodophenol (104), which 
was alkylated with 2-(2-chloroethoxy)ethanol to afford 105 (Scheme 5.10).77,78 Subsequently, 
the Sonogashira coupling with trimethylsilyl acetylene79 and one-pot deprotection gave the 
acetylene 106, and after tosylation afforded the product 107. 
Scheme 5.10. Synthesis of  the linker 107 
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Scheme 5.11. Synthesis of 108 
 
 
The heteroleptic complex 108 was synthesized (Scheme 5.11) from the ligand L17 and the 
ruthenium trichloride complex 9759. The heteroleptic complex 108 has four hydroxyl groups; 
however, the phenolic OH groups are more acidic. This allowed performing selective 
alkylation of the complex 108 with two equivalents of the tosylate 107 in DMF, using Cs2CO3 
as a base, to afford the compound 109 (Scheme 5.12). The treatment of the Ru(II) complex 
109 with the corresponding sulfonyl chloride afforded either mesylate 110a or tosylate 110b. 
Scheme 5.12. Synthesis of the Pretemplated Cap 110 
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initial parameters such as base, leaving group, temperature, and way of addition of the 
pseudohalide 110 (Table 5.2). The reaction control was performed by on-flow ESI-MS. The 
best result for the synthesis of 111 was reached, when K2CO3 was used as a base, the 
mesylate 110a as a nucleophile, and the activated 4 Å molecular sieve powder as an additive 
(Table 5.2, entry 7). However, the yield is still rather low. Similarly to the synthesis of 
tetrabromo-complex 102, this reaction is extremely sensitive to temperature variations. Higher 
temperatures (80~83 °C) caused polymerization and decomposition of the starting materials 
giving no desired product 111 (entry 1). Whereas heating at lower temperature (70 °C) 
resulted in an extremely slow conversion of the starting materials, but it helped to decrease 
the rate of polymerization (Table 5.2, entry 6 and 7). Mass spectra showed that the desired 
product forms via several intermediates, such as 112, 113 and 114 (Scheme 5.13), which 
accumulated in the course of the reaction at 70 °C. However, at this temperature the formation 
of the product 111 is extremely slow. Therefore, after a certain time, when most of the 
starting materials were consumed, the reaction temperature had to be increased to 78 °C. This 
facilitated the formation of the desired product 111. The switching of the temperature regime 
during the reaction turned out to be crucial.  
 Analytical data (MS, NMR, IR) support the formation of the product 111. 1H NMR 
spectrum suggests that the isomeric species with lower symmetry are also present in the 
mixture, but, due to the strong overlap of the signals, stereochemistry of all involved species 
(exo/exo, endo/endo, endo/exo, or the mixture of all isomers) could not been determined.  
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Table 5.2.  Screening of Reaction Conditions for Synthesis of the Threaded Ring-in-Ring Complex 111 
 
entry conc. 
98 
(mM) 
solvent cap eq. base eq. T, °C t, h results 
1 0.323 DMF 110a 2.2 K2CO3 26 84 29 ESI-MS: 109, polym./decomp. of SM, no product 
 
2 0.193 DMF 110b 2.1 Cs2CO3 10 75 32 ESI-MS: 98, polym./decomp. of SM, no product 
 
3 0.189 DMF 110b 5.6a Cs2CO3 10 60 72 ESI-MS: 109, 98, mono alkylated side product, product 111. 
Isolated yield: 9% 
 
4b 0.270 DMF 110b 2.7a Cs2CO3 10 72 27 ESI-MS: 110b, 98, product 111. Isolated yield: 10% 
 
5b 0.630 DMSO 110b 2.2 Cs2CO3 15 70 24 ESI-MS: polym./decomp. of SM, no product 
 
6c 0.520 DMF 110a 2.2+0.5d K2CO3 26 70+83d 36+24d ESI-MS: mostly product 111, traces of 98. Isolated yield: 5% 
 
7 0.525 DMF 110a 2.2+0.5d K2CO3 26 70+78+81d 34+24+32d ESI-MS: mostly product 111, traces of 98. Isolated yield 20% 
a Stepwise addition. b 3 Å molecular sieves added. c 4 Å molecular sieves (powder) added. d Additional 110a was added, continued heating at specified 
temperature for the indicated time. 
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Scheme 5.13. Intermediates Observed in the Reaction Between 98 and 110 
 
Despite the uncertain stereochemistry, the ring-in-ring complex 111 was introduced in 
the Eglinton reaction71,75 to form the third and the final ring. The complex 111 was heated 
under reflux in acetonitrile together with excess of Cu(OAc)2 (Scheme 5.14). 
Scheme 5.14. The Final Macrocyclization Reaction Towards the Borromean Link 
 
The reaction progress was controlled by on-flow ESI-MS, which showed that after 18 h all the 
starting material was consumed. The MS data of the reaction product support the expected 
composition of 115 – the calculated isotope pattern corresponds to the experimental (Figure 
5.35). Sequential loss of PF6- counterions can be also observed, which is characteristic for 
such highly charged complexes. 
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Figure 5.35. Mass spectrum of the reaction product (or mixture of isomers) 115. 
 
Infrared spectroscopy also proves that all terminal acetylenes were consumed in the course of 
the reaction. The spectrum of 115 shows that the characteristic bands for the terminal 
acetylenes at ~3280 cm-1 are absent as compared to the spectrum of the starting material 111 
(Figure 5.36). 
 
Figure 5.36. Comparison of IR-spectra of 111 and 115. 
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The 1H NMR spectrum contains all the expected signal clusters necessary for the desired 
product; however, they are extremely broadened (Figure 5.36 and 5.37). 1H-1H COSY 
spectrum indicates that more than one chemical species of similar structure are present in the 
mixture (Figure 5.38). This might suggest, that in the course of the reaction, other topological 
isomers of the Borromean link are formed. As an exact stereochemistry and isomeric purity of 
the starting material 111 was not clear, after macrocyclization totally nine isomeric exo- and 
endo- structures 115, 116 and 117 can be envisioned, consisting of 3-, 4- and 5- rings Figure 
5.39.  
 
Figure 5.36. Labels for assignment  of  1H NMR spectra. 
 
Figure 5.37. The aromatic regions in 1H NMR of 98, 109, 111, and 115. 
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Figure 5.38. 1H-1H COSY (500 MHz, Acetone-d6) spectrum of 115. 
 
So far, all attempts to isolate these isomeric structures by means of chromatography, 
HPLC, or recrystallizations were not successful. The correct topology of the Borromean link 
should be supported by X-ray crystallography; however, there has been no success in 
obtaining suitable crystals for this purpose. In silico calculations could also be helpful for 
establishing the composition of the mixture by excluding the least probable isomers. This has 
not been achieved yet due to time constraints. 
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Figure 5.39. Theoretical isomers of the molecular Borromean link Ru(II) complex. 
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5.3. Conclusions and Outlook 
 
The kinetic or stepwise synthesis of the Borromean link consisting of three different 
rings is still a problem with some unanswered questions. However, this work shows that the 
new route via the pretemplated Ru(II) cap and Eglinton reaction is chemically feasible; 
however, the important stereocontrol element for obtaining the expected topology still 
remains a future challenge. The analytical data support the formation of the isomeric product 
mixture, and, presumably, it contains the desired Borromean link Ru(II) complex, but further 
evidences should be provided to prove this unambiguously. Nevertheless, this is a real 
breakthrough towards the kinetic synthesis of the Borromean link and establishes a solid base 
for further investigations.  
 In order to gain more control over the desired topology, we propose the following 
improvements for the synthesis:  
- More rigid linkers for the construction of the “ring two” could be used to force the 
formation of only endocyclic product; 
- Functionalization of a pretemplated cap with a bulky functional group at the “ring 
two” ligand might block the approach to it from the undesired side, again forcing the 
formation of the expected endocyclic product. 
With this work it has been shown that linear bilateral extended terpyridine ligands 
possess valuable geometric features for the construction of extended macrocyclic structures; 
therefore, there is great potential for designing other topologically challenging supramolecular 
architectures using this motif.  
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5.4. Experimental Section 
 
5.4.1. Materials and Methods 
 
All reagents and solvents used for reactions were reagent grade and used without further 
purification unless otherwise noted. Anhydrous THF and toluene was supplied from an 
Mbraun solvent purification system. Analytical thin-layer chromatography was performed 
with Macherey–Nagel POLYGRAM SIL N-HR/UV254 or ALOX N/UV254. Flash silica gel 
column chromatography was performed with Merck silica gel 60 (particle size 0.040–0.063 
mm). Flash alumina column chromatography was performed with deactivated (5% water) 
Fluka alumina (particle size 0.05–0.15 mm, pH 7.0±0.5). Melting points were recorded on a 
Büchi B-540 melting point apparatus. For characterization purposes, proton nuclear magnetic 
resonance (1H-NMR) spectra were all recorded on Bruker instruments (AV-300 and ARX-
300 at 300 MHz, AV2- 400 at 400 MHz, and AV-500 at 500 MHz). Chemical shifts are 
reported in ppm relative to CHCl3 (δ 7.26), CD2Cl2 (δ 5.31), CD3CN (δ 1.94) or DMSO-d6 
(2.50). Multiplicity and shape are indicated by one or more of the following abbreviations: s 
(singlet); d (doublet); t (triplet); q (quartet); dd (doublet of doublets); td (triplet of doublets); 
m (multiplet); br (broad). Carbon-13 nuclear magnetic resonance (13C- NMR) spectra were 
recorded on Bruker instruments (ARX-300 at 75 MHz, AV2-400 at 100 MHz, and AV-500 at 
125 MHz). Chemical shifts are reported relative to CDCl3 (δ 77.2), CD2Cl2 (δ 53.8), CD3CN 
(δ 1.3) or DMSO-d6 (δ 39.5). Infrared spectroscopic data were recorded on NaCl plates as 
thin films, as KBr pellets or neat sample on a Perkin Elmer Spectrum One (PE) or Jasco 
FT/IR-4100 spectrophotometer. The intensities are given as follows: s = strong, m = medium, 
and w = weak. An Agilent 8453 UV/Vis spectrophotometer was used to record all UV/Vis 
spectra. Emission spectra and lifetimes (ns) were recorded on an Edinburgh Instruments 
FLS920 spectrometer. Solid-state quantum yields were measured using an integrating sphere 
accessory for FLS920 spectrometer. X-ray structures were carried out by the Laboratorium 
für Computerchemie und Röntgenstructuranalyse of the Institute of Organic Chemistry of the 
University of Zurich using a Nonius KappaCCD diffractometer with MoKα radiation (λ = 
0.71037 Å). Dr. Philip Pattison collected the diffraction data for compound 101 on the Swiss 
Norwegian Beamlines at the European Synchrotron Radiation Facility. 
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5.4.2. Experimental Procedures 
 
2,6-bis-[2-(4-methoxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl]pyridine (L12) 
 
Prepared according to the procedure by Helen Seifert59. 
 
2,6-bis-[2-(4-hydroxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl]pyridine (L16) 
 
Prepared according to the procedure by Helen Seifert59. 
 
2,6-bis(2-(4-bromo-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine (L8) 
 
To a solution of 5,5′′-bis-(methoxymethoxy)-4,4′′-bis-((4-bromo-2,6-
dimethylphenyl)ethynyl)-2,2′:6′,2′′-terpyridine (78j) (543 mg, 0.707 mmol, 1.00 eq) in DMF 
(25 mL) was added 32% aq. HCl (0.347 mL, 3.54 mmol, 5.0 eq). The reaction mixture was 
heated to 80 °C for 20 h, then Cs2CO3 (10.4 g, 31.8 mmol, 45.0 eq) was added portion-wise. 
The resulting mixture was heated to 90 °C for 18 h. Evaporation of DMF gave the residue that 
was suspended in water (200 ml). The resulting solid was collected by filtration, washed on 
the filter with excess water and re-dissolved with CH2Cl2 (200 ml) into a clean flask. 
Evaporation of solvent gave a crude product, which was dissolved in minimum amount of 
CH2Cl2, introduced on a plug of neutral Al2O3 (deact. with 5% w/w H2O) and eluted with 
hexane:EtOAc 3:1. The solvent was evaporated under reduced pressure to give desired 
product L8 (414 mg, 86%) as an off-white solid. 
Mp 283.3–284.0 °C.  
1H NMR (500 MHz, CDCl3, δ): 8.95 (s, 4H), 8.47 (d, J = 7.8 Hz, 2H), 7.98 (t, J = 7.8 Hz, 1H), 
7.35 (s, 4H), 6.84 (s, 2H), 2.26 (s, 12H). 
13C NMR (125 MHz, CDCl3, δ): 157.9, 155.9, 152.6, 150.5, 140.7, 138.1, 136.2, 132.7, 130.8, 
128.8, 124.1, 120.6, 113.7, 106.8, 20.5. 
IR (film on NaCl, cm–1): 2957w, 2924w, 2853w, 1604m, 1571s, 1447vs, 1398m, 1307w, 
1291w, 1251w, 1239w, 1145m, 1112w, 1075w, 1010m, 914m, 856m, 824s, 802w, 733m, 651w. 
HRMS (ESI) m/z: [M + H]+ calcd for C35H26Br2N3O2: 678.03863; found: 680.03747. 
N
N
N OO
O O
N
N
N OO
HO OH
N
N
N OO
Br Br
 168 
2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))bis(3,5-dimethyl-
4,1-phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)diethanol (L17) 
 
To a mixture of 2,6-bis-[2-(4-hydroxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl]- pyridine 
(L16) (100 mg, 1.0 eq, 0.181 mmol) and anhydrous Cs2CO3 (177 mg, 3.0 eq, 0.542 mmol) in 
dry DMF (4 mL) under N2 atmosphere was added 2-(2-chloroethoxy)ethanol (0.055 mL, 2.9 
eq, 0.521 mmol). The reaction mixture was heated to 100 °C for 18 h. The reaction mixture 
was allowed to cool to room temperature and DMF was evaporated under reduced pressure. 
The resulting residue was treated with water and extracted with CH2Cl2 (4 × 80 ml). The 
combined organic layers were washed with brine, dried over MgSO4, filtered and evaporated. 
The resulting crude product was purified by silica gel column chromatography (eluent 
gradient CH2Cl2:MeOH 100:0 to 95:5) to give desired compound L17 (96 mg, 72%) as a 
sticky amorphous solid. (Treatment of the product with Et2O and evaporation under reduced 
pressure helped to obtain easy transferable, flocky solid). 
Mp 85.6–86.7 °C. 
1H NMR (400 MHz, CDCl3, δ): 8.94 (d, J = 1.0 Hz, 2H), 8.93 (t, J = 0.9 Hz, 2H), 8.45 (d, J = 
7.9 Hz, 2H), 7.97 (t, J = 7.9 Hz, 1H), 6.80 (d, J = 0.9 Hz, 2H), 6.74 (s, 4H), 4.21-4.18 (m, 4H), 
3.91-3.89 (m, 4H), 3.81-3.76 (m, 4H), 3.72-3.69 (m, 4H), 2.26 (s, 12H).  
13C NMR (125 MHz, CDCl3, δ): 159.6, 159.3, 155.9, 152.5, 150.2, 140.4, 138.0, 136.5, 132.4, 
122.6, 120.5, 113.9, 113.6, 106.5, 72.7, 69.8, 67.5, 61.9, 21.0.  
IR (film on NaCl, cm–1): 3356br, 2925m, 2866w, 1607s, 1570m, 1449s, 1400s, 1318m, 1285w, 
1161m, 1132m, 1070w, 1007w, 907m, 858w, 824m, 733m, 642w.  
HRMS (ESI) m/z: [M + H]+ calcd for C43H44N3O8: 730.31229; found: 730.31240. 
 
2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))bis(3,5-dimethyl-
4,1-phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)bis(ethane-2,1-diyl) 
dimethanesulfonate (L18) 
 
To a solution of 2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-
diyl))bis(3,5-dimethyl-4,1-phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)diethanol (L17) 
(30 mg, 1.0 eq, 0.0411 mmol) in anhydrous CH2Cl2 (1.5 mL) under N2 atmosphere was added 
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methanesulfonyl chloride (0.0112 ml, 3.5 eq, 0.144 mmol). The reaction mixture was stirred 
for 2 h at room temperature, quenched with water (3 ml) and extracted with CH2Cl2 (3 × 3 ml). 
The combined organic layers were dried over MgSO4, filtered and evaporated under reduced 
pressure. The obtained product was dried under vacuum to give desired compound L18 (36.2 
mg, 99%) as a white amorphous solid. 
Mp >170 °C dec. 
1H NMR (400 MHz, CDCl3, δ): 8.95 (s, 2H), 8.94 (s, 2H), 8.46 (d, J = 7.9 Hz, 2H), 7.97 (t, J 
= 7.9 Hz, 1H), 6.81 (s, 2H), 6.71 (s, 4H), 4.43-4.41 (m, 4H), 4.19-4.17 (m, 4H), 3.91-3.89 (m, 
4H), 3.87-3.85 (m, 4H), 3.07 (s, 6H), 2.26 (s, 12H). 
 13C NMR (125 MHz, CDCl3, δ): 159.5, 159.3, 155.8, 152.5, 150.1, 140.4, 138.0, 136.6, 
132.4, 122.6, 120.6, 113.9, 113.6, 106.5, 69.9, 69.4, 69.3, 67.4, 37.9, 21.0. 
IR (film on NaCl, cm–1): 2923w, 2875w, 1607s, 1570m, 1449s, 1400m, 1352s, 1319s, 1175s, 
1140s, 1074m, 1011m, 973m, 913s, 825m, 733m. 
HRMS (ESI) m/z: [M + H]+ calcd for C45H48N3O12S2: 886.26739; found: 886.26701. 
 
2,6-bis(2-(4-(2-(2-iodoethoxy)ethoxy)-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-
yl)pyridine (L19) 
 
To a mixture of 2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-
diyl))bis(3,5-dimethyl-4,1-phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)diethanol (L17) 
(25.5 mg, 1.0 eq, 0.0349 mmol), imidazole (12.8 mg, 5.4 eq, 0.189 mmol), iodine (30.2 mg, 
3.4 eq, 0.119 mmol) and triphenylphosphine (12.8 mg, 5.4 eq, 0.189 mmol) under Ar 
atmosphere was added anhydrous DCM (1.5 mL). The reaction mixture was stirred for 2 h at 
room temperature. After completion (followed by LC-MS) the mixture was quenched with 
10% aqueous Na2S2O3 (6 mL) and extracted with CH2Cl2 (3 × 10 mL). The combined organic 
extracts were dried over MgSO4, filtered and evaporated under reduced pressure. The residue 
was purified by neutral Al2O3 (deact. with 5% w/w H2O) column chromatography (eluent 
hexane:EtOAc 3:1) to give desired product L19 (25.7 mg, 76%) as an off white amorphous 
solid. 
Mp 123–126 °C. 
1H NMR (500 MHz, CDCl3, δ): 8.95 (s, 2H), 8.94 (s, 2H), 8.46 (d, J =7.8 Hz, 2H), 7.98 (t, J = 
7.8 Hz, 1H), 6.81 (s, 2H), 6.74 (s, 4H), 4.20-4.18 (m, 4H), 3.91-3.89 (m, 4H), 3.86 (t, J =6.7 
Hz, 4H), 3.31 (t, J =6.8 Hz, 4H), 2.27 (s, 12H).  
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13C NMR (125 MHz, CDCl3, δ): 159.5, 159.3, 155.8, 152.4, 150.0, 140.2, 137.9, 136.5, 132.3, 
122.4, 120.4, 113.9, 113.5, 106.4, 72.2, 69.3, 67.4, 20.9, 2.7.  
IR (film on NaCl, cm–1): 2952w, 2923w, 2866w, 1607s, 1569m, 1448s, 1399m, 1318s, 1285m, 
1160s, 1127m, 1074w, 1035w, 1007w, 904w, 824m. 
HRMS (ESI) m/z: [M + H]+ calcd for C43H42I2N3O6: 950.11575; found: 950.11528. 
 
Ru(2,6-bis-(2-(4-hydroxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)- pyridine)Cl3 (97) 
 
Prepared according to the procedure by Helen Seifert59. 
 
Ru(2,6-bis(2-(4-bromo-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine)Cl3 (100) 
 
A mixture of 2,6-bis(2-(4-bromo-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine (L8) 
(150 mg, 1.0 eq, 0.221 mmol) and RuCl3·3H2O (57.7 mg, 1.0 eq, 0.221 mmol) in ethanol (27 
mL) under N2 atmosphere was heated to reflux for 18 h. The dark brown suspension was 
allowed to cool to room temperature, and the solvent was evaporated under reduced pressure. 
The resulting brown solid was suspended in water (50 ml), collected by filtration, washed on 
the filter with addition amount of water (till filtrate colorless) and acetonitrile (till filtrate 
colorless). The product was dried under vacuum to give desired compound 100 (173 mg, 
88%) as an insoluble, dark brown solid.  
Mp >350 °C 
IR (KBr, cm–1): 3042w, 2920w, 2851w, 1617m, 1573s, 1456s, 1384m, 1318w, 1245m, 1011m, 
914m, 888w, 857m, 814w, 738w, 661w. 
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bis-(5′,5′′-bis-(4-(2-propoxyethoxy)-2,6-dimethylphenyl)-2,2′:6′,2′′-terpyridine) 
macrocycle⊃bis-(Ru(2,6-bis-(2-(4-hydroxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)-
pyridine))(PF6)4 (98) 
 
Prepared according to the improved literature procedure59. 
 
In dry 25 ml two-necked flask equipped with magnetic stirring bar, reflux condenser and 
septum a solid mixture of macrocycle 8844 (40 mg, 1.0 eq, 0.0311 mmol) and Ru(2,6-bis-(2-
(4-hydroxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)-pyridine)Cl3 (97) was 3 × degassed 
and refilled with Ar. To the mixture degassed EtOH (13 mL) was added through the septum. 
The reaction mixture was brought to reflux and N-ethylmorpholine (~4 drops or 6.3 µL, 1.6 
eq, 0.049 mmol) was added through the septum. The reaction mixture was heated to reflux for 
24 h and allowed to cool to room temperature. To the mixture sat. aq. KPF6 (20 ml) was 
added. The resulting brown precipitate was filtered over Celite, washed on the filter with 
excess water and Et2O, and then re-dissolved with acetone into a clean flask (green solid 
remains on Celite). The obtained red solution was evaporated under reduced pressure to give 
brown residue that was purified by silica gel column chromatography– first, a brown/green 
band was eluted by using the 1st eluent (MeCN:CH2Cl2:H2O:aq.KPF6 320:100:10:1), then it 
was switch to the 2nd eluent (MeCN:CH2Cl2:H2O:aq.KPF6 345:90:15:4) to move a red band 
which contained the desired product 98. The product fractions were evaporated, re-dissolved 
in acetone, and to the solution sat. aq. KPF6 was added. The resulting precipitate was 
collected by filtration over Celite, washed with excess water, Et2O and re-dissolved with 
acetone into a clean flask. After evaporation of solvent and drying under vacuum the desired 
product 98 (28.6 mg, 29%) was obtained as a red solid. 
Mp >295 °C dec.  
1H NMR (500 MHz, Acetone-d6, δ): 9.13 (d, J = 8.0 Hz, 4H), 9.12 (s, 4H), 8.88 (d, J = 8.3 Hz, 
4H), 8.87 (d, J = 8.4 Hz, 4H), 8.62 (t, J = 8.2 Hz, 2H), 8.37 (t, J =8.2 Hz, 2H), 8.10 (s, 4H), 
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7.90 (dd, J = 8.3, 1.9 Hz, 4H), 7.56 (d, J = 1.4 Hz, 4H), 7.12 (s, 4H), 6.62 (s, 8H), 6.58 (s, 8H), 
4.07 (t, J = 4.6 Hz, 8H), 3.70 (t, J = 4.4 Hz, 8H), 3.48 (t, J = 6.5 Hz, 8H), 2.01 (s, 24H), 1.58-
1.52 (m, 8H), 1.50 (s, 24H), 1.40-1.35 (m, 8H). 
13C NMR (125 MHz, Acetone-d6, δ) 163.7, 160.0, 159.8, 157.9, 156.9, 156.5, 153.5, 152.7, 
152.5, 141.1, 140.8, 140.3, 137.9, 137.8, 137.3, 137.2, 136.8, 128.3, 125.1, 124.6, 122.9, 
120.0, 117.8, 115.7, 114.6, 107.8, 71.7, 69.8, 68.2, 30.5, 26.7, 20.6, 20.4. 
IR (neat, cm−1): 3524w, 2929w, 2865w, 1705w, 1605w, 1454m, 1361w, 1313m, 1277w, 
1158w, 1075w, 1031w, 1007w, 840s, 739w, 558m.  
HRMS (ESI) m/z: [M]4+ calcd for C152H144N12O16Ru2: 649.22362; found: 649.22274. 
 
Ru(2,6-bis(2-(4-bromo-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine)⊃(2,2′-(2,2′-
(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))bis(3,5-dimethyl-4,1-
phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)diethanol))(PF6)2 (101) 
 
A mixture of Ru(2,6-bis(2-(4-bromo-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine)Cl3 
(100) (134 mg, 1.0 eq, 0.151 mmol), 2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-
c]pyridine-5,2-diyl))bis(3,5-dimethyl-4,1-phenylene))bis(oxy)bis(ethane-2,1-
diyl))bis(oxy)diethanol (L17) (110 mg, 1.0 eq, 0.151 mmol) and N-ethylmorpholine (44.6 µL, 
2.3 eq, 0.350 mmol) in EtOH (36 mL) was heated to reflux for 24 h. The reaction mixture was 
allowed to cool down to room temperature and sat. aq. KPF6 was added. The resulting brown 
precipitate was filtered over Celite, washed on the filter with excess water, EtOAc, Et2O and 
re-dissolved with acetonitrile into a clean flask. After evaporation of solvent the resulting 
brown solid was purified by silica gel column chromatography – first, a brown band was 
eluted by using the 1st eluent (MeCN:H2O:aq.KPF6 97:3:0.3), then it was switched to the 2nd 
eluent (MeCN:H2O:aq.KPF6 95:5:1) to move a red band which contained the desired product 
101. The combined product fractions were evaporated under reduced pressure, re-dissolved in 
acetonitrile and sat. aq. KPF6 was added. The resulting precipitate was collected by filtration 
over Celite, washed with excess water, Et2O and re-dissolved with acetonitrile into a clean 
flask. After evaporation the desired product 101 (114 mg, 42%) was obtained as a red solid. 
Recrystallization by slow Et2O vapor diffusion into the acetone solution of 101 gave single 
crystals suitable for X-ray diffraction analysis.  
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Mp >320 °C dec. 
1H NMR (400 MHz, CD3CN): 8.85 (d, J = 0.8 Hz, 2H), 8.82 (d, J = 0.8 Hz, 2H), 8.75 (d, J = 
8.2 Hz, 2H), 8.75 (d, J = 8.2 Hz, 2H), 8.43 (t, J = 8.1 Hz, 1H), 8.43 (t, J = 8.1 Hz, 1H), 7.72 (s, 
2H), 7.69 (s, 2H), 7.35 (s, 4H), 7.05 (d, J = 0.8 Hz, 2H), 6.98 (d, J = 0.8 Hz, 2H), 6.71 (s, 4H), 
4.14-4.06 (m, 4H), 3.84-3.73 (m, 4H), 3.65-3.57 (m, 4H), 3.56-3.50 (m, 4H), 2.69 (br. s, 2H), 
2.04 (s, 12H), 2.04 (s, 12H). 
13C NMR (126 MHz, CD3CN): 163.0, 161.3, 161.1, 156.9, 156.8, 153.1, 152.9, 152.7, 152.5, 
141.8, 141.3, 137.7, 137.5, 137.3, 137.2, 136.8, 136.8, 131.6, 128.4, 125.0, 123.2, 123.1, 
121.6, 117.8, 114.8, 108.4, 107.8, 73.5, 70.1, 68.5, 62.0, 20.7, 20.3. 
IR (film on NaCl, cm–1): 3427s, 2925w, 2866w, 1603m, 1454s, 1384w, 1313m, 1251w, 1162w, 
1127w, 1068w, 1007w, 842vs, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C78H68Br2N6O10Ru: 755.12012; found: 755.12074. 
 
Ru(2,6-bis(2-(4-bromo-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)pyridine) ⊃(2,2′-
(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))bis(3,5-dimethyl-4,1-
phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)bis(ethane-2,1-diyl) 
dimethanesulfonate)(PF6)2 (99) 
 
To a solution of 101 (44.2 mg, 1.0 eq, 0.0246 mmol) in a mixture of anhydrous THF (3.5 mL) 
and acetonitrile (1.5 mL) under Ar atmosphere were added triethylamine (0.137 mL, 40 eq, 
0.982 mmol) and methanesulfonyl chloride (0.048 mL, 20 eq, 0.491 mmol). The reaction 
mixture was stirred for 1 h at room temperature. To the mixture was added sat. aq. KPF6 to 
cause precipitation. The resulting red solid was collected by filtration over Celite, washed on 
the filter with excess water, Et2O and 1:1 hexane:EtOAc then re-dissolved with acetonitrile 
into a clean flask. After evaporation of solvent and drying under vacuum the desired product 
99 (47.5 mg, 99%) was obtained as a red solid. 
Mp >230 °C. 
1H NMR (400 MHz, CD3CN): 8.85 (d, J = 0.8 Hz, 2H), 8.82 (d, J = 0.8 Hz, 2H), 8.75 (d, J = 
8.2 Hz, 2H), 8.74 (d, J = 8.2 Hz, 2H), 8.44 (t, J = 8.2 Hz, 1H), 8.43 (t, J = 8.2 Hz, 1H), 7.72 (s, 
2H), 7.69 (s, 2H), 7.35 (s, 4H), 7.05 (d, J = 0.8 Hz, 2H), 6.98 (d, J = 0.8 Hz, 2H), 6.70 (s, 4H), 
4.35-4.28 (m, 4H), 4.15-4.07 (m, 4H), 3.83-3.76 (m, 4H), 3.79-3.72 (m, 4H), 3.02 (s, 6H), 
2.04 (s, 12H), 2.04 (s, 12H). 
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13C NMR (125 MHz, CD3CN): 162.0, 160.3, 160.0, 155.9, 155.9, 152.1, 151.9, 151.7, 151.6, 
140.8, 140.3, 136.7, 136.5, 136.3, 136.2, 135.8, 135.8, 130.6, 127.4, 124.1, 122.2, 122.1, 
120.7, 116.8, 113.8, 107.4, 106.8, 69.9, 69.3, 68.8, 67.3, 36.7, 19.7, 19.3. 
IR (film on NaCl, cm–1): 2957w, 2925w, 2858w, 1603m, 1455s, 1351w, 1313m, 1251w, 
1175m, 1164m, 1072w, 1008w, 840vs, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C80H72Br2N6O14RuS2: 833.09763; found: 833.09738. 
 
2-(2-(4-ethynylphenoxy)ethoxy)ethanol (106) 
 
To a mixture of 2-(2-(4-iodophenoxy)ethoxy)ethanol (105)77,78 (2.5 g, 1.0 eq, 8.11 mmol), 
Pd(PPh3)2Cl2 (171 mg, 3 mol%, 0.243 mmol) and CuI (46 mg, 3 mol%, 0.243 mmol) in 
triethylamine (30 mL) under N2 atmosphere was added trimethylsilylacetylene (2.3 mL, 2.0 
eq, 16 mmol). The reaction mixture was heated to 75 °C for 18 h. The mixture was allowed to 
cool to room temperature, and the solvent was evaporated under reduced pressure. The 
resulting residue was dissolved in minimum amount of CH2Cl2 and filtered through a plug of 
silica gel eluting with EtOAc. The filtrate was evaporated under reduced pressure to give 
crude 2-(2-(4-((trimethylsilyl)ethynyl)phenoxy)ethoxy)ethanol. 
1H NMR (400 MHz, CDCl3) 7.39 (AA′BB′ spin system, 2H), 8.83 (AA′BB′ spin system, 2H), 
4.16-4.08 (m, 2H), 3.89-3.82 (m, 2H), 3.78-3.72 (m, 2H), 3.70-3.62 (m, 2H), 0.23 (s, 9H). 
The obtained product was dissolved in a mixture of MeOH (32 mL) and CH2Cl2 (5 mL). To 
the solution KF (4.7 g, 10 eq, 81 mmol) was added and the mixture was heated to 50 °C for 4 
h. The solvent was evaporated under reduced pressure and the resulting residue was filtered 
through a plug of silica gel eluting with CH2Cl2. The solvent from the filtrate was evaporated 
under reduced pressure to give desired 2-(2-(4-ethynylphenoxy)ethoxy)ethanol (106) (1.65 g, 
99%) as a yellowish oil. 
 1H NMR (500 MHz, CDCl3): 7.42 (AA′BB′ spin system, 2H), 6.86 (AA′BB′ spin system, 
2H), 4.15-4.13 (m, 2H), 3.87-3.85 (m, 2H), 3.77-3.75 (m, 2H), 3.68-3.66 (m, 2H), 3.00 (s, 
1H), 2.09 (s, 1H). 
13C NMR (125 MHz, CDCl3): 159.2, 133.7, 114.7, 114.7, 83.7, 76.1, 72.7, 69.7, 67.6, 61.9. 
IR (film on NaCl, cm–1): 3418br, 3285s, 3043w, 2931s, 2877s, 2537w, 2105m, 1605s, 1572m, 
1505s, 1455s, 1356m, 1289s, 1250s, 1173s, 1131s, 1059s, 929m, 888m, 837m, 538w. 
HRMS (ESI) m/z: [M+Na]+ calcd for C12H14NaO3: 229.08352; found: 229.08328. 
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2-(2-(4-ethynylphenoxy)ethoxy)ethyl 4-methylbenzenesulfonate (107) 
 
To a solution of 2-(2-(4-ethynylphenoxy)ethoxy)ethanol (106) (1.49 g, 1.0 eq, 7.22 mmol), 
DMAP (26 mg, 0.3 eq, 0.22 mmol) and triethylamine (3.0 mL, 3.0 eq, 21 mmol) in CH2Cl2 
(50 mL) was added 4-toluenesulfonyl chloride (2.20 g, 1.5 eq, 11.6 mmol) in one portion. The 
reaction mixture was stirred for 2.5 h at room temperature. The reaction was quenched with 
water (100 ml), organic layer was separated, washed with water (2 × 50 ml), dried over 
MgSO4, filtered and evaporated under reduced pressure. The resulting crude product was 
purified by silica gel column chromatography (eluent hexane:EtOAc 3:1) to give 2-(2-(4-
ethynylphenoxy)ethoxy)ethyl 4-methylbenzenesulfonate (107) (1.99 g, 76%) as a yellowish 
oil. 
1H NMR (500 MHz, CDCl3): 7.79 (AA′BB′ spin system, 2H), 7.41 (AA′BB′ spin system, 2H), 
7.30 (AA′BB′ spin system, 2H), 6.82 (AA′BB′ spin system, 2H), 4.20-4.18 (m. 2H), 4.05-4.04 
(m, 2H), 3.79-3.77 (m, 2H), 3.76-3.74 (m, 2H), 3.00 (s, 1H), 2.41 (s, 3H). 
13C NMR (126 MHz, CDCl3): 159.1, 145.0, 133.7, 133.1, 129.9, 128.1, 125.5, 114.7, 83.7, 
76.1, 69.9, 69.3, 69.1, 67.6, 21.8. 
IR (film on NaCl, cm–1): 3281m, 3065w, 3045w, 2922w, 2877w, 2105w, 1605m, 1572w, 
1506s, 1454w, 1399w, 1355s, 1289m, 1249m, 1189m, 1176s, 1138m, 1018w, 919m, 836m, 
815m, 775w, 663m, 554w. 
HRMS (ESI) m/z: [M+Na]+ calcd for C19H20NaO5S: 383.09237; found: 383.09267. 
 
Ru(2,6-bis-(2-(4-hydroxy-2,6-dimethylphenyl)furo[2,3-c]pyridin-5-yl)- pyridine)⊃(2,2′-
(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-diyl))bis(3,5-dimethyl-4,1-
phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)diethanol))(PF6)2 (108) 
 
To a mixture of 2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-5,2-
diyl))bis(3,5-dimethyl-4,1-phenylene))bis(oxy)bis(ethane-2,1-diyl))bis(oxy)diethanol (L17) 
(200 mg, 1.0 eq, 0.274 mmol) and Ru(2,6-bis-(2-(4-hydroxy-2,6-dimethylphenyl)furo[2,3-
c]pyridin-5-yl)- pyridine)Cl3 (97) (209 mg, 1.0 eq, 0.274 mmol) in degassed EtOH (100 mL) 
under N2 atmosphere was added N-ethylmorpholine (0.081 mL, 2.3 eq, 0.636 mmol). The 
reaction mixture was heated to reflux for 20 h. The mixture was allowed to cool to room 
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temperature and sat. aq. KPF6 was added. The resulting precipitate was collected by filtration 
over Celite, washed on the filter with excess water, Et2O, hexane:EtOAc 1:1 and re-dissolved 
with acetonitrile into a clean flask. The solvent was evaporated and resulting residue was 
purified by silica gel column chromatography– first, a brown/green band was eluted by using 
the 1st eluent (MeCN:H2O:aq.KPF6 97:3:0.3), then it was switched to the 2nd eluent 
(MeCN:CH2Cl2:H2O:aq.KPF6 51:9:3:1) to move a red band which contained the product 108. 
The combined product fractions were evaporated under reduced pressure, re-dissolved in 
acetonitrile and re-precipitated by addition of sat. aq. KPF6. The resulting precipitate was 
collected over Celite, washed on the filter with excess water, Et2O and re-dissolved into a 
clean flask. After evaporation of solvent the desired product 108 (288 mg, 63%) was obtained 
as a red solid. 
Mp >200 °C dec. 
1H NMR (500 MHz, CD3CN): 8.82 (s, 2H), 8.82 (s, 2H), 8.75 (d, J = 8.2 Hz, 2H), 8.75 (d, J = 
8.1 Hz, 2H), 8.43 (t, J = 8.2 Hz, 1H), 8.43 (t, J = 8.1 Hz, 1H), 7.69 (s, 2H), 7.68 (s, 2H), 7.16 
(s, 2H), 6.97 (s, 2H), 6.94 (s, 2H), 6.70 (s, 4H), 6.56 (s, 4H), 4.15-4.06 (m, 4H), 3.79-3.74 (m, 
4H), 3.64-3.57 (m, 4H), 3.57-3.49 (m, 4H), 2.83 (t, J = 5.4 Hz, 2H), 2.03 (s, 12H), 1.99 (s, 
12H). 
13C NMR (125 MHz, CD3CN): 163.2, 162.9, 161.0, 159.4, 156.9, 153.0, 153.0, 152.6, 152.6, 
141.3, 141.3, 137.5, 137.5, 137.3, 137.3, 136.7, 123.1, 123.1, 121.8, 120.8, 117.8, 117.8, 
115.6, 114.8, 107.9, 107.8, 73.3, 70.1, 68.5, 61.9, 20.7, 20.6. 
IR (KBr, cm–1): 3431br, 3125w, 2953w, 2921w, 2871w, 1607m, 1454s, 1384w, 1313m, 
1288w, 1276w, 1158m, 1128w, 1065w, 1031w, 1005w, 843s, 739w, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C78H70N6O12Ru: 692.20529; found: 692.20595. 
Ru(2,6-bis(2-(4-(2-(2-(4-ethynylphenoxy)ethoxy)ethoxy)-2,6-dimethylphenyl)furo[2,3-
c]pyridin-5-yl)pyridine)⊃(2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-
5,2-diyl))bis(3,5-dimethyl-4,1-phenylene))bis(oxy)bis(ethane-2,1-
diyl))bis(oxy)diethanol))(PF6)2 (109) 
 
To a mixture of heteroleptic Ru(II) complex 108 (200 mg, 1.0 eq, 0.119 mmol), 2-(2-(4-
ethynylphenoxy)ethoxy)ethyl 4-methylbenzenesulfonate (107) (94.7 mg, 2.2 eq, 0.263 mmol) 
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and anhydrous Cs2CO3 (117 mg, 3.0 eq, 0.358 mmol) under N2 atmosphere was added 
anhydrous DMF (37 mL). The reaction mixture was heated to 80 °C for 9.5 h, allowed to cool 
to room temperature and sat. aq. KPF6 was added. The resulting red precipitate was collected 
by filtration over Celite, washed on the filter with excess water, Et2O, hexane:EtOAc 3:1 and 
re-dissolved in a clean flask. After evaporation of solvent and drying under vacuum the 
desired complex (109) was obtained as a red solid (226 mg, 92%). 
Mp >247 °C dec. 
1H NMR (500 MHz, CD3CN): 8.82 (s, 4H), 8.74 (d, J = 8.2 Hz, 4H), 8.43 (t, J = 8.2 Hz, 2H), 
7.69 (d, J = 0.9 Hz, 4H), 7.39 (AA′BB′ spin system, 4H), 6.98 (d, J = 0.9 Hz, 2H), 6.97 (d, J = 
0.9 Hz, 2H), 6.88 (AA′BB′ spin system, 4H), 6.71 (s, 4H), 6.68 (s, 4H), 4.13-4.09 (m, 12H), 
3.86-3.79 (m, 8H), 3.79-3.73 (m, 4H), 3.61-3.58 (m, 4H), 3.56-3.51 (m, 4H), 3.25 (s, 2H), 
2.67 (t, J = 5.6 Hz, 2H), 2.04 (s, 12H), 2.03 (s, 12H). 
13C NMR (125 MHz, CD3CN): 163.0, 161.1, 161.1, 160.3, 156.9, 153.0, 152.6, 141.3, 141.2, 
137.4, 137.3, 136.7, 134.5, 123.1, 121.6, 117.8, 115.7, 115.1, 114.8, 114.8, 107.8, 84.2, 77.5, 
73.5, 70.3, 70.3, 70.1, 68.6, 68.5, 68.4, 62.0, 20.7. 
IR (film on NaCl, cm–1): 3744w, 3310w, 3282w, 2953w, 2919w, 2871w, 2103w, 1604s, 
1506m, 1384w, 1313m, 1289m, 1250m, 1162m, 1130m, 1067w, 1031w, 1004w, 841s, 808w, 
735w, 558m. 
HRMS (ESI) m/z: [M]2+ calcd for C102H94N6O16Ru: 880.28820; found: 880.28864. 
 
Ru(2,6-bis(2-(4-(2-(2-(4-ethynylphenoxy)ethoxy)ethoxy)-2,6-dimethylphenyl)furo[2,3-
c]pyridin-5-yl)pyridine)⊃(2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-
5,2-diyl))bis(3,5-dimethyl-4,1-phenylene))bis(oxy)bis(ethane-2,1-
diyl))bis(oxy)bis(ethane-2,1-diyl) dimethanesulfonate)(PF6)2 (110a) 
 
To a solution of heteroleptic Ru(II) complex 109 (40.0 mg, 1.0 eq, 0.0195 mmol) in mixture 
of anhydrous THF (3 mL) and acetonitrile (0.5 mL) under Ar atmosphere was added 
triethylamine (163 µL, 60 eq, 1.17 mmol) and methanesulfonyl chloride (45 µL, 30 eq, 0.58 
mmol) that caused formation of precipitate. The reaction mixture was stirred for 2 h at room 
temperature. To the mixture sat. aq. KPF6 was added, and the resulting red precipitate was 
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collected by filtration over Celite, washed with excess water, Et2O, hexane:Et2O 1:1 and re-
dissolved into a clean flask. After evaporation of solvent and drying under vacuum the desired 
product 110a (39.4 mg, 92%) was obtained as a red solid.  
Mp >239 °C dec. 
1H NMR (400 MHz, CD3CN): 8.82 (s, 4H), 8.74 (d, J = 8.2 Hz, 4H), 8.43 (t, J = 8.1 Hz, 2H), 
7.69 (s, 2H), 7.69 (s, 4H), 7.39 (AA′BB′ spin system, 4H), 6.98 (d, J = 0.9 Hz, 2H), 6.97 (d, J 
= 0.9 Hz, 2H), 6.88 (AA′BB′ spin system, 4H), 6.70 (s, 4H), 6.68 (s, 4H), 4.35-4.28 (m, 4H), 
4.14-4.09 (m, 12H), 3.87-3.76 (m, 12H), 3.79-3.71 (m, 4H), 3.25 (s, 2H), 3.02 (s, 6H), 2.04 (s, 
12H), 2.03 (s, 12H). 
13C NMR (125 MHz, CD3CN): 163.0, 163.0, 161.1, 161.0, 160.3, 156.9, 153.0, 152.6, 141.3, 
141.2, 137.4, 137.3, 136.7, 134.5, 123.1, 121.7, 121.6, 117.8, 115.7, 115.1, 114.8, 114.8, 
107.8, 84.2, 77.5, 70.9, 70.3, 70.3, 70.3, 69.8, 68.6, 68.4, 68.3, 37.7, 20.7. 
IR (film on NaCl, cm–1): 3310w, 3281w, 3125w, 3043w, 2957w, 2919w, 2875w, 2103w, 
1604m, 1508m, 1455s, 1351m, 1313s, 1289m, 1251m, 1163m, 1133m, 1071w, 1005w, 974w, 
923w, 914w, 841s, 807w, 735w, 558w. 
HRMS (ESI) m/z: [M]2+ calcd for C104H98N6O20RuS2: 958.26572; found: 958.26570. 
 
Ru(2,6-bis(2-(4-(2-(2-(4-ethynylphenoxy)ethoxy)ethoxy)-2,6-dimethylphenyl)furo[2,3-
c]pyridin-5-yl)pyridine)⊃(2,2′-(2,2′-(4,4′-(5,5′-(pyridine-2,6-diyl)bis(furo[2,3-c]pyridine-
5,2-diyl))bis(3,5-dimethyl-4,1-phenylene))bis(oxy)bis(ethane-2,1-
diyl))bis(oxy)bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate))(PF6)2 (110b) 
 
To a mixture of heteroleptic Ru(II) complex 109 (40.0 mg, 1.0 eq, 0.0195 mmol), 4-
toluenesulfonyl chloride (54.7 mg, 14.7 eq, 0.286 mmol) and DMAP (1.4 mg, 0.6 eq, 0.012 
mmol) in anhydrous CH2Cl2 (3.5 mL) under Ar atmosphere was added triethylamine (65 µL, 
24 eq, 0.47 mmol). The reaction mixture was stirred at room temperature for 3.5 h. To the 
mixture sat. aq. KPF6 was added, and the resulting precipitate was filtered over Celite, washed 
with excess water, Et2O, hexane:EtOAc and re-dissolved into a clean flask. After evaporation 
of solvent and drying under vacuum the desired product 110b (45.2 mg, 98%) was obtained 
as red solid.  
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Mp >259 °C dec. 
1H NMR (500 MHz, Acetone-d6): 9.17 (s, 4H), 9.06 (d, J = 8.2 Hz, 4H), 8.60 (t, J = 8.2 Hz, 
2H), 8.10 (s, 2H), 8.10 (s, 2H), 7.78 (AA′BB′ spin system, 4H), 7.42 (AA′BB′ spin system, 
4H), 7.38 (AA′BB′ spin system, 4H), 7.13 (d, J = 0.9 Hz, 2H), 7.12 (d, J = 0.9 Hz, 2H), 6.92 
(AA′BB′ spin system, 4H), 6.72 (s, 4H), 6.71 (s, 4H), 4.20-4.14 (m, 12H), 4.11-4.05 (m, 4H), 
3.91-3.85 (m, 8H), 3.78-3.69 (m, 8H), 3.47 (s, 2H), 2.40 (s, 6H), 2.05 (s, 12H, overlap with 
acetone-d6 signal), 2.03 (s, 12H). 
13C NMR (125 MHz, Acetone-d6): 163.1, 163.1, 161.2, 161.1, 160.3, 157.1, 152.9, 152.9, 
152.9, 145.8, 140.9, 140.9, 137.6, 137.2, 137.0, 134.3, 134.2, 130.8, 128.7, 123.2, 121.4, 
121.3, 118.0, 115.6, 115.3, 114.8, 107.9, 84.2, 77.6, 70.7, 70.4, 70.4, 70.2, 69.4, 68.6, 68.4, 
68.2, 21.5, 20.8. 
IR (film on NaCl, cm–1): 3310w, 3281w, 3125w, 3073w, 2953w, 2921w, 2879w, 2103w, 
1604s, 1506m, 1455s, 1355w, 1313m, 1289m, 1250m, 1190w, 1176m, 1163m, 1134w, 1005w, 
913w, 841vs, 736w, 557m. 
HRMS (ESI) m/z: [M]2+ calcd for C116H106N6O20RuS2: 1034.29704; found: 1034.29805. 
 
Synthesis of Threaded Ring-in-Ring Complex 102 
 
A mixture of threaded macrocycle 98 (5.48 mg, 1.0 eq, 0.001725 mmol), mesylate Ru(II) cap 
99 (3.38 mmol, 1.0 eq, 0.001725 mmol) and anhydrous K2CO3 (5.96 mg, 25 eq, 0.0431 
mmol) in anhydrous DMF (4.0 mL) under Ar atmosphere was heated to 75 °C for 18 h, and 
then additional portion of mesylate 99 (2.20 mg, 0.65 eq, 0.00112 mmol) in DMF (0.5 mL) 
was added. The heating of the mixture was continued for 8 h, after which the final portion of 
99 (2.20 mg, 0.65 eq, 0.00112 mmol) in DMF (0.5 mL) was added. The reaction mixture was 
heated for another 18 h, allowed to cool to room temperature and sat. aq. KPF6 was added. 
The resulting red precipitate was collected by filtration over Celite, washed on the filter with 
excess water, Et2O, hexane:EtOAc 3:1 and re-dissolved with acetonitrile into a clean flask. 
After evaporation of solvent the red residue was purified by silica gel column 
chromatography (eluent MeCN:CH2Cl2:H2O:aq.KPF6 97:67:3:0.3). The combined product 
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fractions were evaporated; the residue was treated with CH2Cl2 filtered and evaporated to give 
the product (could also contain exo/exo and endo/exo isomers) 102 (4.7 mg, 41%) as a red 
solid.  
Mp >200 °C. 
1H NMR (600 MHz, Acetone-d6): 9.10-9.05 (m, 16H), 8.99-8.93 (m, 8H), 8.79 (s, 4H), 8.78 
(s, 4H), 8.54-8.46 (m, 6H), 8.28 (t, J = 8.1 Hz, 2H), 8.04 (s, 4H), 8.00 (s, 4H), 7.99 (s, 4H), 
7.81 (dd, J = 8.3, 1.8 Hz, 4H), 7.45 (d, J = 1.5 Hz, 4H), 7.21 (s, 8H), 7.14 (s, 4H), 7.06 (s, 4H), 
7.02 (s, 4H), 6.62 (s, 8H), 6.61 (s, 8H), 6.47 (s, 8H), 4.08-4.02 (m, 16H), 3.97-3.95 (m, 8H), 
3.76-3.68 (m, 16H), 3.62-3.58 (m, 8H), 3.40-3.36 (m, 8H), 1.95 (overlap with signal of 
acetone-d6, 48H), 1.91 (s, 24H), 1.50-1.42 (m, 8H), 1.40 (s, 24H), 1.29-1.26 (m, 8H).  
13C NMR (125 MHz, Acetone-d6): 163.3, 163.2, 163.1, 163.1, 161.3, 159.8, 158.0, 157.1, 
157.1, 157.0, 156.6, 153.6, 153.1, 153.0, 152.9, 152.8, 152.6, 141.6, 141.3, 140.9, 140.9, 
140.8, 138.0, 137.9, 137.8, 137.6, 137.6, 137.4, 137.3, 137.3, 137.3, 137.1, 137.1, 131.5, 
128.4, 128.3, 125.2, 125.0, 124.7, 123.3, 123.2, 123.2, 121.4, 121.3, 118.3, 118.1, 114.9, 
114.7, 114.7, 108.6, 108.0, 107.8, 71.9, 70.5, 70.4, 69.9, 68.7, 68.5, 68.1, 29.2, 26.9, 20.8, 
20.7, 20.5, 20.3. 
IR (film on NaCl, cm–1): 3091w, 2957w, 2919w, 2853w, 1603m, 1313m, 1280m, 1263m, 
1163m, 1009w, 842s, 807m, 701w, 558w. 
HRMS (ESI) m/z: [M]8+ calcd for C308H272Br4N24O32Ru4: 692.66692; found: 692.66787; 
[M+PF6]7+ calcd for C308H272Br4F6N24O32PRu4: 812.32858; found: 812.32970. 
 
Synthesis of Threaded Ring-in-Ring Complex 111 
 
A mixture of threaded macrocycle 98 (17.8 mg, 1.0 eq, 0.00560 mmol), mesylate Ru(II) cap 
110a (27.7 mg, 2.2 eq, 0.0125 mmol), anhydrous K2CO3 (20.1 mg, 26 eq, 0.146 mmol) and 
activated 4 Å molecular sieve powder (~30 mg) in anhydrous DMF (11 mL) under Ar 
atmosphere was heated to 70 °C for 34 h. Then the reaction temperature was increased to 
78 °C, and the heating was continued for another 24 h. To the mixture additional mesylate 
Ru(II) cap 110a (6.2 mg, 0.5 eq, 0.0028 mmol) in anhydrous DMF (1 mL) was added and the 
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mixture was heated to 80 °C for 32 h. The reaction mixture was allowed to cool to room 
temperature, and sat. aq. KPF6 was added. The resulting precipitate was collected by filtration 
over Celite, washed on the filter with excess water, Et2O, hexane:EtOAc 3:1 and re-dissolved 
with acetonitrile into a clean flask. After evaporation of solvent the red residue was purified 
by silica gel column chromatography– first, a band containing a mixture of unreacted 110a 
and hydrolysation product 109 was moved by using 1st eluent (MeCN:CH2Cl2:H2O:sat.KPF6 
139:11:5:1), then it was switched to 2nd eluent (MeCN:CH2Cl2:H2O:sat.KPF6 139:36:7:2) to 
elute band which contained the desired product 111. The fractions containing 111 were 
evaporated and the residue was subjected to the 2nd column chromatography (eluent 
MeCN:CH2Cl2:H2O:sat.KPF6 139:47:4:0.4). The desired product moved as a first band. After 
evaporation of product fractions, the residue was dissolved in CH2Cl2, filtered and evaporated 
under reduced pressure to give a desired product 111 (8.2 mg, 20%) as a red solid.  
Mp >250 °C dec. 
1H NMR (600 MHz, Acetone-d6): 9.19-9.10 (m, 16H), 9.09-9.02 (m, 8H), 8.91-8.85 (m, 8H), 
8.64-8.56 (m, 6H), 8.41-8.34 (m, 2H), 8.10 (s, 12H), 7.92 (dd, J = 8.2, 1.8 Hz, 4H), 7.55 (m, 
4H), 7.39-7.36 (m, 8H), 7.20-7.12 (m, 12H), 6.91-6.90 (m, 8H), 6.73 (s, 8H), 6.72 (s, 8H), 
6.70 (s, 8H), 6.57 (s, 8H), 4.18-4.14 (m, 32H), 4.06-4.05 (m, 8H), 3.89-3.83 (m, 32H), 3.73-
3.67 (m, 8H), 3.50-3.47 (m, 8H), 3.47 (s, 4H), 2.03 (s, 24H), 2.02 (s, 24H), 2.01 (s, 24H), 
1.62-1.52 (m, 8H), 1.50 (s, 24H), 1.40-1.36 (m, 8H). 
13C NMR (150 MHz, Acetone-d6): 163.1, 163.1, 161.6, 161.5, 161.2, 160.3, 159.8, 157.9, 
157.3, 157.1, 157.0, 153.6, 152.9, 152.8, 152.8, 152.6, 141.2, 140.9, 140.9, 140.8, 140.3, 
137.9, 137.9, 137.7, 137.6, 137.3, 137.2, 137.2, 137.0, 134.2, 128.4, 125.2, 124.7, 123.3, 
123.2, 123.0, 121.3, 118.0, 115.6, 115.3, 115.1, 115.0, 114.8, 114.7, 107.9, 84.2, 77.7, 71.9, 
71.7, 71.0, 71.0, 70.5, 70.4, 69.9, 68.6, 68.4, 30.3, 26.8, 20.8, 20.7, 20.7, 20.5. 
IR (film on NaCl, cm–1): 3315w, 3280w, 3122w, 3073w, 2924m, 2867w, 2103w, 1604s, 
1505w, 1454s, 1383w, 1313m, 1291m, 1279m, 1252m, 1162m, 1128w, 1072w, 1005w, 
841vs, 735w, 558m. 
HRMS (ESI) m/z: [M]8+ calcd for C356H324N24O44Ru4: 755.75166; found: 755.75142; 
[M+PF6]7+ calcd for C356H324F6N24O44PRu4: 884.42544; found: 884.42499; [M+2PF6]6+ calcd 
for C356H324F12N24O44P2Ru4: 1055.99046; found: 1055.98883. 
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Synthesis of the Borromean Link Ru(II) Complex 115 
 
A mixture of threaded ring-in-ring Ru(II) complex 111 (1.64 mg, 1.0 eq, 0.000228 mmol) and 
Cu(OAc)2·H2O (1.30 mg, 29 eq, 0.00651 mmol) in acetonitrile (2.0 mL) was heated to reflux 
for 23 h. The reaction mixture was allowed to cool to room temperature, and the solvent was 
evaporated under reduced pressure. The resulting residue was dissolved in CH2Cl2, filtered 
and the solvent was evaporated under reduced pressure. The residue was dissolved in 
acetonitrile and re-precipitated by additions of conc. aq. KPF6. The precipitate was collected 
by filtration, washed on the filter with excess water, Et2O, hexane:EtOAc 1:1 and re-dissolved 
into a clean flask. After evaporation of solvent and drying under vacuum the isomeric mixture 
of 115 was obtained (1.28 mg, 78%) as a red solid. 
Mp > 286 °C dec. 
1H NMR (400 MHz, Acetone-d6): 9.21-8.96 (m, 24H), 8.94-8.82 (m, 8H), 8.65-8.54 (m, 6H), 
8.43-8.36 (m, 2H), 8.09 (s, 12H), 7.94-7.89 (m, 4H), 7.60-7.55 (m, 4H), 7.43-7.38 (m, 8H), 
7.17-7.10 (m, 12H), 6.97-6.89 (m, 8H), 6.73-6.65 (m, 24H), 6.60-6.57 (m, 8H), 6.77-6.48 (m, 
32H), 4.26-4.02 (m, 40H), 3.93-3.65 (m, 40H), 3.53-3.40 (m, 8H), 2.00 (s, 24H, overlap with 
acetone-d6), 1.99 (s, 24H), 1.96 (s, 24H), 1.64-1.46 (m, 8H), 1.51 (s, 24H), 1.43-1.33 (m, 8H). 
13C NMR (125 MHz, Acetone-d6): 163.1, 161.5, 161.3, 161.1, 160.0, 159.8, 157.9, 157.3, 
157.0, 156.6, 153.7, 153.1, 152.8, 152.5, 140.8, 140.7, 140.6, 140.3, 137.8, 137.6, 137.2, 
137.0, 134.8, 128.3, 123.1, 121.3, 118.0, 115.9, 114.8, 107.9, 71.7, 70.5, 70.4, 69.8, 68.6, 68.3, 
32.6, 23.3, 20.8, 20.5. 
IR (film on NaCl, cm–1): 3125w, 3091w, 2953w, 2921w, 2254w, 2211w, 2138w, 1603m, 
1504w, 1455s, 1383w, 1313m, 1289w, 1252w, 1162m, 1128w, 1073w, 1005w, 840vs, 737w, 
559m. 
HRMS (ESI) m/z: [M]8+ calcd for C356H320N24O44Ru4: 755.24775; found: 755.24661; 
[M+PF6]7+ calcd for C356H320F6N24O44PRu4: 883.84953; found: 883.84914; [M+2PF6]6+ calcd 
for C356H320F12N24O44P2Ru4: 1055.31858; found: 1055.31955. 
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